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Abstract 
 
Beak and Feather Disease Virus (BFDV) is a circovirus which causes ill-thrift, feather 
loss and immunosuppression leading to secondary infections and eventually death in 
psittacine  birds.  The  development  of  standardised  reagents  for  the detection  and 
characterisation of BFDV infections and for the production of protective vaccines has 
been  difficult  as  no  cell  culture  system  has  yet  been  found  to  grow  the  virus 
successfully  in  vitro.  However,  the  development  of  consistent  and  effective 
diagnostic tests and vaccines is now more practical through the application of nucleic 
acid-based detection methods and recombinant technology. 
 
A quantitative real-time PCR assay for the detection of BFDV DNA was developed, 
using  primers  designed  to  amplify  a  conserved  81  bp  fragment  of  ORFV1  and 
SYTO9, a fluorescent intercalating dye, with assays run on a Corbett RotorGene 
3000.  A  synthetic  oligonucleotide  was  used  to  establish  standard  curves  for  the 
quantitation of viral load in both blood and feather preparations. The assay was very 
sensitive, with a detection limit of 50 copies/µL. The assay was developed using 
BFDV-positive DNA extracts from the feathers of 10 different species of birds and 
validated  with  blood  and  feather  samples  from  corellas  vaccinated  with  an 
experimental BFDV vaccine, then challenged with live virus. Viral DNA was reliably 
detected in the blood of all control (non-vaccinated) birds and in some vaccinated 
birds. Contamination of the environment with the feather dander of BFDV-infected 
birds  meant  that  HA  feather  preparations  were  unreliable  for  the  detection  and 
quantitation of viral excretion. Nonetheless, the assay should prove to be a useful 
and  sensitive  test  for  the  detection  of  viral DNA  in  a  range  of  samples in  future 
investigations.   iv 
 
A recombinant BFDV capsid protein was also produced and a specific monoclonal 
antibody  developed  against it.  The  behaviour  of  the  protein  in  haemagglutination 
(HA)  assays  and  the  behaviour  of  the  monoclonal  antibody  in  western  blotting, 
immunohistochemistry  (IHC),  ELISA  and  haemagglutination-inhibition  (HI)  assays 
were characterised. The protein had the ability to agglutinate galah erythrocytes as 
per the wild-type virus and this agglutination was successfully inhibited by antibodies 
to wild-type BFDV from naturally immune psittacine birds. Furthermore, the protein 
self-assembled into virus-like particles as determined by electron microscopy. The 
antibody was specific for both the recombinant BFDV capsid protein and the whole 
virus  and  had  similar  optimal  titres  when  used  in  western  blotting  and  IHC.  The 
antibody also had HI activity and detected BFDV virus from 3 genera of psittacine 
birds, including the recently described cockatiel BFDV isolate. A novel “blocking” (or 
“competitive”) ELISA (bELISA) for the detection of anti-BFDV antibodies in psittacine 
sera (Ab-bELISA) was also developed and validated with 166 samples from eastern 
long-billed corellas vaccinated with the recombinant capsid protein and challenged 
with  live  virus.  The  bELISA  was  found  to  be  both  sensitive  and  specific  and 
correlated strongly with the HI test, thus it should have wide application for the sero-
diagnosis of BFDV. 
 
A  survey  of  cockatiels  (n=88)  housed  at  commercial  aviaries  was  conducted  to 
investigate whether BFDV infection occurs in cockatiels. All birds were diagnosed as 
being virus-free by PCR and HA and had no detectable antibody titre by HI assay. In 
addition to this, the genomes of two BFDV isolates obtained from diseased cockatiel 
feathers were sequenced and cross-reactivity assays performed using virus eluted 
from  these  feathers  and  sera  from  naturally  immune  psittacine  birds.  Serological   v 
cross-reactivity  results  and  phylogenetic  analysis  of  the  nucleotide  sequences 
indicated that the cockatiel virus isolates were serologically and genetically different 
to other BFDV isolates. This is the first report of an antigenically distinct BFDV in 
psittacine  birds.  Since  the  Ab-bELISA  has  a  lower  limit  of  detection  than  the  HI 
assay,  it  was  used  to  repeat  the  cockatiel  sero-survey.  No  antibodies  were 
detectable  in  any  of  the  cockatiels  tested  and  thus  questions  about  the  real 
prevalence of BFDV infection in cockatiels and the possible existence of a novel 
BFDV serotype adapted to cockatiels remain unanswered. 
 
The  successful  control  of  PBFD  in  both  pet  and  wild  birds  depends  on  the 
development of vaccines that incite a strong specific immune response and can be 
efficiently  produced  in  large  quantities.  Recombinant  BFDV  capsid  proteins  have 
recently  been  considered  as  candidate  vaccines  against  BFDV  and  recombinant 
techniques  allow  the  development  of  other  candidate  vaccines,  including  DNA 
vaccines. In order to examine the potential of DNA vaccination as a strategy for the 
prevention  and  control  of  BFDV,  two  DNA  vaccines,  based  on  the  nucleotide 
sequence  encoding  the  capsid  protein  of  BFDV,  were  developed  using  the 
mammalian expression vector pVAX1. The vaccine constructs encoding both the full-
length and NLS-truncated capsid protein resulted in protein expression both in vitro 
and in vivo. Protein was detected in COS-7 cells transfected with the constructs with 
an indirect immunocytochemistry assay using the monoclonal antibody described in 
Chapter 5. Protein was present in the nucleus of cells transfected with the vaccine 
encoding  the  full-length  nucleotide  sequence  and  in  the  cytoplasm  of  cells 
transfected  with  the  vaccine  encoding  the  NLS-truncated  sequence  as  expected. 
Both DNA vaccine constructs induced detectable levels of anti-BFDV antibodies in 
vaccinated birds, determined using the Ab-bELISA described in Chapter 5. Thus,   vi 
DNA  vaccines  similar  to  those  presented  here  may  have  application  in  the 
prevention and control of BFDV and some options for the further development of 
these vaccines into effective methods for the control of BFDV are discussed.   vii 
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Chapter 1. General Introduction 
 
Psittacine Beak and Feather Disease (PBFD) is the most common viral disease of 
psittacine birds and causes either: a chronic debilitating feather disease, typically in 
adult birds (Albertyn et al., 2004, Pass and Perry, 1985, Rahaus and Wolff, 2003, 
Ritchie et al., 1989b), or a severe, acute disease syndrome in nestlings and African 
grey  parrots  (Psittacus  e.  erithacus)  (Doneley,  2003,  Raidal  and  Cross,  1995, 
Schoemaker  et  al.,  2000).  The  causative  agent,  beak  and  feather  disease  virus 
(BFDV), is a circovirus with a single stranded DNA genome, approximately 1.7-2.0 
kb in length (Bassami et al., 2001, Ritchie et al., 1989b) and is considered to have a 
worldwide  distribution  (Albertyn  et  al.,  2004,  Hsu  et  al.,  2006,  Kiatipattanasakul-
Banlunara et al., 2002, Kock et al., 1993, McOrist et al., 1984, Pass and Perry, 1985, 
Rahaus and Wolff, 2003, Ritchie et al., 1989a). 
 
The development of diagnostic assays and vaccines for the detection and prevention 
of BFDV have traditionally been hampered by the difficulty associated with producing 
suitable  reagents,  namely  purified  virus  and  polyclonal  antibodies.  At  present, 
haemagglutination (HA) and haemagglutination-inhibition (HI) assays (Raidal et al., 
1993c, Ritchie et al., 1991b) are commonly used for the detection of virus shed from 
feathers or faeces and anti-BFDV antibodies in psittacine sera, respectively. These 
tests, whilst useful and applicable to samples from a wide range of psittacine birds, 
are not ideal assays; they require erythrocytes from live animals, virus purified from 
the  feathers  of  infected  birds  and  polyclonal  antibody  preparations  in  order  to 
perform the assays. Variations in these reagents make consistency between tests 
difficult to achieve, underscoring the need for new tests with standardised reagents. 
The HI assay (Raidal et al., 1993c, Ritchie et al., 1991b) is so far the only method   2 
available for the detection of anti-BFDV antibodies in psittacine sera. This assay is 
useful in that it detects both IgM and IgG antibodies from a wide range of species of 
psittacine birds, but it suffers from an appreciable amount of inter-test variation due 
to the variability in quality and quantity between virus preparations and the sensitivity 
to the virus of the erythrocytes used in the test. 
 
A  killed  whole-virus  vaccine  has  been  developed  previously  (Raidal  and  Cross, 
1994a,  Raidal  et  al.,  1993a),  but  the  antigen  was  purified  from  the  feathers  of 
persistently  infected  birds.  This  process is expensive, ethically  questionable,  time 
consuming,  results  in  low  yields  of  virus  and  the  extraction  procedure  can  be 
contaminated with host proteins. Incomplete inactivation of the virus may also result 
in clinical disease in vaccinated birds (Raidal et al., 1993a, Wylie and Pass, 1987). 
New diagnostic tests and vaccines, based on reagents which are easily standardised 
and  able  to  be  produced  in  large  quantities,  are  therefore  both  desirable  and 
necessary.  
 
As a background to the research presented in this thesis, a review of the literature is 
presented  in  Chapter  2.  Particular  attention  is  paid  to  the  replication  and 
pathogenesis of circoviruses and phylogenetic analyses of various BFDV isolates. 
The volume of research on geminiviruses and porcine circovirus 1 and 2 is much 
greater than that of BFDV because these viruses are more economically important 
and a cell culture system has not yet been developed to successfully grow BFDV in 
vitro. As such, the discussion of circovirus replication presented here relies heavily 
on scientific studies of these other circoviruses. The second part of the discussion 
presents the current body of scientific knowledge on BFDV. The physical, chemical 
and molecular characteristics of the virus are summarised and the current thinking   3 
on  the  phylogenetic  relationships  of  various  virus  isolates  and  pathologic 
mechanisms are discussed. 
 
Various  polymerase  chain  reaction  (PCR)  assays  have  been  developed  for  the 
detection of BFDV, however none of these are quantitative. Chapter 3 describes the 
development of a quantitative real-time PCR assay for the detection of BFDV DNA, 
using  primers  designed  to  amplify  a  conserved  81  bp  fragment  of  open  reading 
frame  V1  (ORFV1)  and  SYTO9,  a  fluorescent  intercalating  dye.  A  synthetic 
oligonucleotide was used to make standard curves for the quantitation of viral load in 
blood and feather preparations. 
 
PBFD is known to occur in a wide range of psittacine species, however there are no 
scientific  or  credible  anecdotal  reports  of  PBFD  occurring  in  the  cockatiel 
(Nymphicus  hollandicus)  despite it  being  one  of  the  world’s  most  commonly  kept 
companion  bird  species.  Consequently  this  has  resulted  in  speculation  that  the 
species may have some innate resistance to BFDV infection. Chapter 4 details an 
investigation  into  the  presence  and  characteristics  of  BFDV  in  cockatiels  using 
existing diagnostic tests (PCR, HA and HI assays). 
 
In  order  to  address  the  need  for  repeatable  assays  based  upon  consistent  and 
standardised  reagents,  a  recombinant  BFDV  capsid  protein  was  produced  and  a 
specific monoclonal antibody developed against it. The behaviour of the protein in 
HA  assays  and  the  behaviour  of  the  monoclonal  antibody  in  western  blotting, 
immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA) and HI 
assays is described in Chapter 5. 
   4 
Chapter  5  also  presents  the  methods  used  to  develop  a  novel  “blocking”  (or 
“competitive”) ELISA (bELISA) for the detection of anti-BFDV antibodies in psittacine 
sera  (Ab-bELISA).  The  assay  was  developed  using  a  baculovirus-expressed 
recombinant  BFDV  capsid  protein  and  a  newly  developed  monoclonal  antibody 
raised against this protein. The assay was then validated using 166 samples from 
eastern long-billed corellas (Cacatua tenuiostris) and 82 samples from the cockatiel 
serosurvey described in Chapter 4. Some of these birds were vaccinated with the 
recombinant capsid protein and some  were non-vaccinated control birds, then all 
birds were challenged with live virus. 
 
The  successful  control  of  PBFD  in  both  pet  and  wild  birds  depends  on  the 
development of vaccines that incite a strong specific immune response and can be 
efficiently  produced.  Chapter  6  details  the  methods  used  to  develop  two  DNA 
vaccines against BFDV, utilising the nucleotide sequence encoding a full-length and 
truncated capsid protein. The expression of the DNA vaccine constructs in vitro and 
in vivo was examined utilising an indirect immunocytochemistry assay and the Ab-
bELISA  described  in  Chapter  5.  In  addition,  some  options  for  the  further 
development of these vaccines into effective methods for the control of BFDV are 
discussed.   5 
Chapter 2. Review of the Literature 
2.1 Introduction 
Presented here is a review of the literature relevant to the research conducted 
for the development of this thesis. It is divided into 2 broad sections. The first 
section provides background and introductory information on the circoviruses. 
It  discusses  their  classification,  taxonomy,  pathogenesis,  and  genomic 
structure and mode of replication. Particular attention is given to the mode of 
replication  of  circoviruses,  based  largely  on  studies  conducted  on  porcine 
circovirus  and  homologous  plant  viruses  (nano-  and  geminiviruses).  The 
second  section  summarises  the  body  of  literature  on  beak  and  feather 
disease virus (BFDV), including its history, physical, chemical and molecular 
characteristics, pathophysiology, diagnosis, treatment and prevention. 
 
2.2 The Circoviridae 
2.2.1 Introduction and taxonomy 
The system of nomenclature and classification used in this thesis is based on 
that proposed by Pringle (1999), Fauquet and Mayo (2001) and Fauquet et al. 
(2005).  Genes  and  open  reading  frames  (ORFs)  are  written  in  lowercase 
italics. Gene products (mRNA and proteins) are non-italicised and first letter is 
in  uppercase.  The definitions  of  “strain”,  “serotype” and  “isolate”  are  taken 
from  Blood  and  Studdert  (2000).  A  strain  is  defined  as  “one  or  more 
organisms  within  a  species  or  variety,  characterised  by  some  particular 
quality”. A serotype is defined as “the type of a microorganism determined by 
its  constituent  antigens  based  on  one  of  several  different  antibody-antigen 
reactions, or a taxonomic subdivision based thereon”. An isolate is defined as   6 
“a population of microorganisms that has been obtained in pure culture from a 
field case or location”. 
 
The  Circoviridae  are  small,  nonenveloped  icosahedral  animal  viruses 
characterised by circular single-stranded DNA (ssDNA) genomes (Crowther et 
al., 2003). Viruses within the Circoviridae are further grouped into 3 genera. 
The  genus  Gyrovirus,  of  which  chicken  anaemia  virus  (CAV)  is  the  only 
member,  the  genus  Circovirus,  which  includes  porcine  circovirus  1  and  2 
(PCV1  and  PCV  2)  and  BFDV  and  the  genus  Anellovirus,  comprising  the 
human and animal Torque teno viruses (TTV) and human TT-like mini virus 
(TLMV) (Biagini, 2004) (Tables 2.1 and 2.2). The type species of Gyrovirus, 
Circovirus  and  Anellovirus  is  CAV,  PCV1  and  TTV,  respectively.  The 
phylogenetic relationship between CAV, PCV and BFDV is demonstrated in 
Figure 2.1. 
 
Virus isolates which share features common to the Circoviridae but have not 
yet been formally classified by the ICTV are known as tentative circoviruses 
and anelloviruses. These viruses and their characteristics are summarised in 
Table 2.2. Because these viruses have been isolated from such a wide range 
of  host  species,  it  is  likely  that  the  Circoviridae  are  common  within 
vertebrates.  Certainly,  since  the  majority  of  tentative  members  of  the 
Circoviridae have been isolated from avian hosts, circoviruses are probably 
ubiquitous within the aves. 
 
Related to the Circoviridae are the Nanoviridae, formerly known as the “plant 
circoviruses”  and  the  Geminiviridae.  Representatives  of  the  Geminiviridae   7 
include  tomato  yellow  leaf  curl  virus  (TYLCV)  (Wartig  et  al.,  1997),  maize 
streak  virus  (MSV)  (Boulton  et  al.,  1989)  and  beet  curly  top  virus  (BCTV) 
(Briddon  et  al.,  1989).  Representatives  of  the  Nanoviridae  include 
subterranean clover stunt virus (SCSV) (Boevink et al., 1995), banana bunchy 
top virus (BBTV) (Wu et al., 1994), coconut foliar decay virus (CFDV) (Rhode 
et al., 1990) and faba bean necrotic yellow virus (FBNYV) (Katul et al., 1995). 
In fact it is hypothesised that circoviruses was the result of a recombination 
event  between  a  nanovirus  and  a  picorna-like  virus  such  as  a  calicivirus 
(Gibbs and Weiller, 1999). 
 
2.2.2 The viruses – history, clinical significance and biological 
properties 
2.2.2.1 Genus Gyrovirus: chicken anaemia virus (CAV) 
Chicken anaemia virus (CAV), first isolated in Japan in 1979 (Yuasa et al., 
1979),  causes  disease  in  chickens  less  than  3  weeks  old  and  in  older, 
immunosuppressed  birds.  Mortality is  usually  around  10%  (Cardona  et  al., 
2000).  Clinical  disease  is  characterised  by  a  severe  anaemia,  generalised 
atrophy of the lymphoid organs (bone marrow, spleen, thymus and bursa of 
Fabricus) and subcutaneous and intramuscular haemorrhages. The amount of 
virus detectable in the thymus and in clotted blood, which probably reflects 
replication  in  the  bone  marrow  and  viraemia,  directly  correlates  with  the 
severity of clinical signs (Tan and Tannock, 2005). All isolates characterised 
thus  far  belong  to  a  single  serotype  (Von  Bulow  and  Schat,  1997)  and  all 
known  strains  cause  a  disease  syndrome  known  as  chicken  infectious 
anaemia  (CIA)  (Cardona  et  al.,  2000).  The  genetic  and  ultrastructural 
characteristics are summarised in Table 2.1 and the phylogenetic relationship   8 
between  CAV  and  other  members  of  the  Circoviridae  is  demonstrated  in 
Figure 2.1. The three-dimensional structure of CAV particles is an icosahedral 
T=1  structure  arranged  in  12  pentagonal,  trumpet-shaped  capsomers.  The 
entire structure is made up of 60 capsid protein molecules (Crowther et al., 
2003). 
 
CAV can only be propagated in the T-cell lymphoblastoid cell lines MDCC-
MSB1 (MSB1) and MDCC-JP2 and the B-cell line LSCC-1104B1 (Todd et al., 
2001a), of which the MSB1 cell line is the most commonly used. Not all sub-
lines of MSB1 cells are susceptible to infection, however and some sub-lines 
lose susceptibility following repeated subculture. In addition, some isolates of 
CAV will not grow or have reduced replication rates in particular MSB1 cell 
lines which are susceptible to other isolates (Lucio et al., 1990, Nogueira et 
al., 2007, Soine et al., 1994). This variation in cell tropism has been mapped 
to a hypervariable region within the protein VP1 (Renshaw et al., 1996). CAV 
infection of cultured cells causes a cytopathic effect (CPE), characterised by 
the  death  of  some  cells,  enlarged  swollen  cells,  alkaline  medium  and  an 
inability to subculture (Todd et al., 2001a). 
 
CAV usually grows to moderate (10
5 to 10
6 TCID50/0.1 mL) titres in MSB1 
cells within 2-3 days of inoculation (Yuasa, 1983). After repeated passage, the 
pathogenicity  of  some  strains  is  unchanged,  whereas  others  become  less 
pathogenic, however the reasons for these differences are unclear (Tan and 
Tannock, 2005, Todd et al., 1998). Depending on their location, mutations in 
the protein VP2 may either retain the ability to replicate but reduce in vivo 
pathogenicity  (Peters  et  al.,  2007),  or  may  reduce  replication,   9 
cytopathogenicity and MHC1 down-regulation (Peters et al., 2006). Purified 
CAV  is  resistant  to  pasteurisation  and  after  freeze  drying  is  resistant  to 
inactivation by dry heat up to 120ºC (Welch et al., 2006). The protein encoded 
by ORF3, apoptin, a protein that induces apoptosis via G2/M cell cycle arrest 
in transformed  cells by interaction  with  the APC1  subunit  of  the anaphase 
promoting  complex/cyclosome  (APC/C)  (Lee  et  al.,  2007,  Teodoro  et  al., 
2004).  Nucleocytoplasmic  shuttling  is  required  for  proper  induction  of 
apoptosis (Heilman et al., 2006). 
 
CAV is vertically transmitted in utero and via infected semen (Cardona et al., 
2000,  Hoop,  1992,  Hoop,  1993)  and  can  also  be  transmitted  horizontally 
(Smyth  et  al.,  2006a).  The  resulting  immunosuppression  is  caused  by 
destruction of T-lymphocyte precursors in the bone marrow and thymic cortex, 
as  well  as  mature  T  lymphocytes  in  the  spleen  (Adair,  2000,  Todd,  2000, 
Todd et al., 2001a). The virus may persist in the gonads of immune birds and 
can  even  be  transferred  to  the  embryos  of  chickens  despite  high  virus 
neutralising  (VN)  antibody  titres.  It  is  unknown  whether  transfer  is  by 
infectious viral particles or as infective DNA, or whether this type of vertical 
infection is capable of inducing disease in infected chicks (Brentano et al., 
2005), as maternal antibodies are considered to be protective against clinical 
disease (McNulty, 1991). Horizontal infections in birds older than 21 days of 
age, after maternal antibodies have waned, usually result in seroconversion 
but can also result in thymic lymphocyte depletion without anaemia or bone 
marrow atrophy (Smyth et al., 2006a). 
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Few  studies  have  investigated  antigenic  variation  between  CAV  isolates. 
Wang et al. (2007a) identified three epitopes on VP2, the third of which is 
immunodominant.  Further  research  is required  to  determine  whether  these 
epitope sequences are involved in the scaffolding function of VP2. 
 
2.2.2.2 Genus Circovirus: porcine circovirus 1 and 2 (PCV1 and PCV2) 
and beak and feather disease virus (BFDV) 
Porcine circovirus – Porcine circovirus was the first animal circovirus to be 
discovered. Tischer et al. (1974) described “picornavirus-like particles” in the 
continuous pig kidney cell line PK-15 (ATCC-CCL 33). Experimental infection 
of pigs with the PK-15-derived PCV showed the virus to be non-pathogenic 
(Allan et al., 1995). However a new PCV, different to the PK-15 contaminant, 
was  discovered  associated  with  post-weaning  multisystemic  wasting 
syndrome (PMWS) (Clark, 1997). The two PCVs are distinct in terms of their 
antigenicity  and  DNA  sequence  (Table  2.1 and  Figure  2.1)  and  the  PK-15 
contaminant and PMWS-associated virus have been designated PCV1 and 
PCV2, respectively. Like CAV, the structure of PCV has been demonstrated 
to be an icosahedral T=1 structure, made up of 60 capsid protein molecules 
arranged  in  12  pentamers  (Crowther  et  al.,  2003).  In  contrast  to  CAV, 
however, PCV capsids have relatively flat capsomers. 
 
PCV1 and PCV2 are most commonly grown in PK-15 cells. However they can 
grow and produce infectious viral particles in other cells of porcine origin and 
Vero,  African  green  monkey  kidney,  cells  (Allan  et  al.,  1994a,  Dulac  and 
Afshar, 1989, Edwards and Sands, 1994, Misinzo et al., 2008b). PCV2 can 
replicate in macrophages, even though they are fully differentiated. Possibly   11 
this occurs because the virus takes advantage of the upregulation of DNA 
polymerases in these cells after DNA damage (Meerts et al., 2005a). When 
grown  in  PK-15  cells,  neither  PCV1  nor  PCV2  causes  CPE  under  normal 
growth conditions. PCV1 has also been shown to infect bovine and ovine cells 
in vitro, but virus antigen was only observed in the cytoplasm of cells and no 
infectious  virus  was  produced  (Allan  et  al.,  1994b).  Tischer  et  al.  (1995) 
demonstrated  that  PCV1  infected  cell  lines  can  be  established  by  cloning 
persistently  infected  primary  pig  kidney  cells  and  that  these  cell  lines 
demonstrated properties consistent with transformation (immortalisation and 
loss of contact inhibition). As the passage number of these cells increased, 
however, the growth rate decreased and CPE was observed, suggesting that 
the transformed state was unstable. Cap is usually the first protein detectable 
in  infected  cells  and  the  full  replication  cycle  of  PCV2  is  between  24-36h 
(Meerts et al., 2005a). 
 
Inhibition of endosome-lysosome system acidification reduces PCV2 infection 
of  monocyte/macrophage  cells,  but  enhances  infection  of  epithelial  cells  in 
vitro (Misinzo et al., 2008b, Misinzo et al., 2005). Administration of gamma 
interferon (IFN-γ) to PK-15 cells and monocytic cells enhances replication of 
PCV2, but not PCV1 in vitro by increasing internalisation of virus-like particles 
(VLPs).  Administration  of  alpha  interferon  (IFN-α)  after  inoculation  also 
enhances  infection,  but  pre-administration  of  IFN-α  decreases  infection  in 
vitro.  In  PK-15  cells,  combined  administration  of  IFN-γ  and  inhibitors  of 
endosome-lysosome system acidification increases the yield of PCV2 up to 
50  times  (Misinzo  et  al.,  2008a).  The  use  of  ionophores,  which  inhibit 
endosome-lysosome system acidification, may even enhance PCV infection in   12 
vivo, but this is yet to be confirmed experimentally. Purified PCV2 is resistant 
to pasteurisation and after freeze drying is resistant to inactivation by dry heat 
up to 120ºC (Welch et al., 2006) and in cell culture is resistant to heating at 
75ºC for 15 minutes but inactivated after 15 minutes at 80ºC (O’Dea et al., 
2008). 
 
PCV1 fails to produce clinical disease in pigs after experimental infection and 
does not cause detectable cytopathic effects in cell culture (Allan et al., 1995, 
Tischer et al., 1982). PCV2 is the crucial pathogen in PMWS, a syndrome 
characterised  by  weight  loss,  fever,  lymphadenopathy,  dyspnoea  and 
depletion of lymphocytes in the lymph nodes (Mankertz et al., 2004). PCV2 
has also been associated with reproductive failure (West et al., 1999) and 
myocardial disease (Opriessnig et al., 2006b) and has been isolated from pigs 
with  porcine  dermatitis  and  nephropathy  syndrome  (PDNS)  (Allan  et  al., 
2000b). PCV2 is suspected to be immunosuppressive, as pigs infected with 
PCV2 are more susceptible to secondary infections with organisms such as 
Pneumocystis sp. or Chlamydophila spp. (Todd et al., 2001a) and infection 
prior  to  vaccination  decreases  the  efficacy  of  vaccines  (Opriessnig  et  al., 
2006c).  
 
Following  natural  PCV2  infection,  IgM  antibodies  are  detectable  at  around 
week 8 post-infection, peaking by 12 weeks and IgG antibodies are detectable 
at around week 10 post-infection, peaking by week 16 (Carasova et al., 2007). 
After  experimental  infection,  IgM  and  IgG  are  detectable  around  1  and  3 
weeks post infection, respectively and peak IgM and IgG levels occur around 
3 and 7 weeks post infection, respectively (Darwich et al., 2008). Viral load   13 
has been reported to peak around week 10 following natural infection and 
persists into adulthood in piglets that survive (Carasova et al., 2007), whereas 
viral  load  is  reported  to  peak  around  3  weeks  after  experimental  infection 
(Darwich et al., 2008). PCV2 actively replicates in most tissues (peripheral 
blood mononuclear cells (PBMCs), lymphoid tissues, lungs, liver, kidneys and 
spleen)  by  14  days  post infection,  but  PBMCs  are  only  a  transient  site  of 
replication (Yu et al., 2007). Replication begins in lymph nodes closest to the 
site  of  inoculation  then  spreads  systemically.  In  early  infections,  viral 
replication in B lymphocytes is greater than in mononuclear cells and levels of 
viral DNA are consistent in monocytes, indicating that B lymphocytes are an 
important  site  of  replication  and  that  monocytes  may  be  a  site  of  viral 
persistence. 
 
The development of an appropriate adaptive immune response is required for 
protective  immunity  to  PCV2  (Meerts  et  al.,  2005c).  Levels  of  virus  vary 
inversely  with  the  amount  of  specific  neutralising  antibodies  and  IIFN-γ 
present. Variations in the pattern of infection and immunity can be observed 
after inoculation of a group of pigs with the same strain of virus, indicating that 
the  disease  course  is  multifactorial  (Meerts  et  al.,  2005c)  and  probably 
depends on differences in individual host-virus interaction and the presence of 
other diseases or immune stimulation (Allan et al., 2000a, Allan et al., 2000c, 
Krakowka et al., 2001, Kyriakis et al., 2002, Meerts et al., 2005c, Opriessnig 
et al., 2006a, Opriessnig et al., 2003). Experimental inoculation of pigs with 
different  strains  of  PCV2  has  also  been  shown  to  induce different  disease 
courses (Opriessnig  et  al., 2006d).  Interestingly,  the  less  pathogenic  strain 
replicated  to  greater  levels  early  in  the  course  of  infection  but  the  more   14 
pathogenic  strain  reached  greater  levels  later  and  both  isolates  were 
genetically identical to the respective inocula when they were recovered from 
the  experimentally  infected  pigs.  PCV2  may  be  transmitted  vertically 
(McIntosh  et  al.,  2006),  even  if  boars  have  circulating  antibodies  present 
(Larochelle et al., 2000). Serological surveys have shown that infection with 
PCV1  and  PCV2  is  widespread  and  likely  occurs  worldwide  (Allan,  1996, 
Allan et al., 1998). 
 
Further research, profiling serum cytokine expression, cytokine mRNA levels 
in lymphoid tissues and PBMCs in cell culture, suggests a T-cell mediated 
immunosuppression. Darwich et al. (2002) demonstrated that PCV2-positive 
pigs have lower levels of CD8
+ and CD4
+/CD8
+ PBMCs than negative pigs 
and this depletion in circulating lymphocytes correlates with a decreased level 
of circulating IgM
+ lymphocytes. Furthermore, the amount of PCV2 genome in 
various lymphoid organs correlates with the degree of lymphocyte depletion in 
those organs. Stevenson et al. (2006) showed that levels of serum interleukin-
10 (IL-10) and C-reactive protein are increased during experimental infection. 
Darwich et al. (2003b) demonstrated increased IL-10 mRNA in thymus tissues 
and IFN-γ mRNA in tonsils. Expression of mRNA of IL-2 and IL-12p40 in the 
spleen, IL-4 in tonsils and IFN-γ, IL-10, IL-12p40 and IL-4 in inguinal lymph 
nodes  was  decreased.  Overexpression  of  IL-10  was  also  histologically 
associated with thymic depletion. Darwich et al. (2008) determined that peak 
IL-10  levels  in  the  PBMCs  of  experimentally  inoculated  pigs  occurred  at 
around 3 weeks post infection, at the same time as the peak in viral load and 
the inversion of the IgM/IgG ratio. PBMCs infected with PCV2 in cell culture 
responded by expressing IL-10 and IFN-γ and were less able to produce IL-4,   15 
IL-2 or IFN-γ in response to challenge with mitogen or superantigen (Darwich 
et al., 2003a). The cultured PBMCs of experimentally inoculated pigs were 
also unable to produce IFN-γ after stimulation (Darwich et al., 2008). 
 
PCV2 also reduces immune memory, via an IL-10 mediated downregulation 
of  IFN-γ  and  IL-12  and  an  IL-10  independent  downregulation  of  IL-2 
(Kekarainen  et  al.,  2008).  In  contrast  to  the  upregulation  of  IFN-α  in  the 
PBMCs of previously naïve animals IFN-α production is also reduced in recall 
responses (Kekarainen et al., 2008). These findings are significant, as IL-10 
has  been  suggested  as  the  cause  of  immunosuppression  leading  to  the 
persistence of other viruses (Brooks et al., 2006). Importantly, induction of IL-
10 by PCV2 was independent of viral infectivity, suggesting that viral DNA is 
important in the regulation of host responses (Kekarainen et al., 2008, Vincent 
et al., 2007) and that interactions of viral and host proteins are probably not 
disturbed if infectivity is lost. 
 
The  ORFC2  protein  of  PCV2  has  been  shown  to  be  involved  in  the 
immunopathogenesis of the virus. The protein causes apoptosis (Liu et al., 
2005) via upregulation of the tumour suppressor gene p53 in a similar manner 
to many other viruses (Liu et al., 2007b). The ORFC2 protein of PCV2 also 
causes  lymphoid  depletion  and  reductions  in  CD4
+  and  CD8
+  T-cells  in 
experimentally  infected  mice  (Liu  et  al.,  2006b).  However,  Darwich  et  al. 
(2008) reported no significant differences in the relative proportions of CD4
+ 
and  CD8
+  PBMCs  by  69  days  post  infection  in  subclinical  experimentally 
infected pigs. The PCV2 DNA genome has also been shown to have both 
inhibitory and stimulatory effects on the induction of alpha interferon (IFN-α)   16 
and tumour necrosis factor – alpha (TNF-α) in natural interferon producing 
cells (NIPCs) (Hasslung et al., 2003, Stevenson et al., 2006, Wikstrom et al., 
2007).  The  actions  of  the  various  oligodeoxyribonucleotides  (ODNs)  are 
independent  of  viral  replication  or  the  presence  of  the  capsid  protein  and 
separate to the effect induced by non-PCV derived CpG ODNs. However, the 
secondary structure of the ODNs is important, as is the presence of a central 
CpG dinucleotide for IFN-α inducing ODNs, but not for inhibitory ODNs. 
 
Various  differences  in  antigenic  composition,  nucleotide  sequences, 
replication kinetics and pathogenicity have been documented between PCV1 
and  2  (Hughes  and  Piontkivska,  2007,  Lefebvre  et  al.,  2008,  Mahe  et  al., 
2000, Meehan et al., 1998) and between strains of PCV2 (Lefebvre et al., 
2008, Meerts et al., 2005a, Opriessnig et al., 2006d), but specific changes 
accounting  for  the  difference  in  pathogenicity  between  PCV1  and  2  or 
between PCV2 strains has not been documented. Lefebvre et al. (2008) found 
antigenic  differences  between  PCV2  strains  using  a  panel  of  monoclonal 
antibodies  and  Opriessnig  et  al.  (2006d)  found  differences  in  virulence 
between  PCV2  strains,  but  no  specific  differences  have  been  found  to 
account for differences in pathogenicity. 
 
Five overlapping epitopes on PCV2 Cap (Lekcharoensuk et al., 2004) and 
conserved immunoreactive epitopes recognised by both B and T lymphocytes 
(Mahe et al., 2000, Stevenson et al., 2007) have been identified. Interestingly, 
whilst T lymphocyte responses to epitopes of PCV2 Cap were greater than 
reactions to epitopes of Rep or the protein encoded by ORFC2, only epitopes 
within Rep and the protein encoded by ORFC2 were immunodominant. This   17 
indicates  that  T  lymphocyte  responses  to  PCV2  infection  are  primarily 
directed against the non-structural proteins, or that T lymphocyte reactions to 
Cap epitopes may depend on the conformation of those epitopes. Fan et al. 
(2008) also proposed the presence of an immunodominant epitope in the N-
terminal of PCV2 Cap between amino acids 20-41, within the NLS, but this is 
yet to be confirmed. Mahe et al. (2000) also identified epitopes within Rep that 
cross-reacted serologically between PCV1 and 2. The proposed existence of 
strains of PCV2 is supported by findings that different isolates cause different 
disease courses (Opriessnig et al., 2006d) and display differences in patterns 
of replication in vitro (Meerts et al., 2005a). 
 
Beak  and  feather  disease  virus  –  A  summary  of  the  genetic  and 
ultrastructural  characteristics  is  presented  in  Table  2.1  and  a  detailed 
description of BFDV is provided in Section 2.3, below. 
 
Other  circoviruses  –  Pigeon,  goose  and  canary  circovirus  have  all  been 
officially classified as members of the genus Circovirus (Fauquet et al., 2005) 
and  they  share  similar  genomic  and  structural  characteristics  to  other 
circoviruses (Table 2.1) and are more closely related to BFDV than PCV or 
CAV (Figure 2.1). Of these, PiCV is the best studied and is associated with 
lethargy,  anorexia,  runting  and  poor  racing  performance  as  part  of  a 
multifactorial syndrome known as young pigeon disease syndrome (YPDS) 
(Raue  et  al.,  2005).  PiCV  is  distributed  worldwide  (Coletti  et  al.,  2000, 
Hattermann et al., 2002, Soike et al., 2001) and in-situ hybridisation, a dot-blot 
assay and standard and multiplexed PCR assays have been developed to   18 
detect viral DNA (Freick et al., 2008, Smyth et al., 2001, Todd et al., 2006, 
Todd et al., 2002). 
 
Goose circovirus is associated with a runting syndrome (Soike et al., 1999) 
and is also expected to have a worldwide distribution (Ball et al., 2004, Chen 
et al., 2003). Dot-blot and PCR assays have been developed for the detection 
of  viral  DNA  (Ball et  al.,  2004)  and  an indirect immunofluorescence  assay 
using a recombinant GoCV capsid protein has been developed for serological 
screening  (Scott  et  al.,  2006).  CaCV  was  isolated  from  systemically  ill 
canaries (Serinus canaria) and its genome has been sequenced (Phenix et 
al., 2001). 
 
2.2.2.3 Genus Anellovirus: torque teno viruses (TTVs) and TT-like mini 
virus (TLMV) 
Torque teno virus (TTV) was first discovered in the plasma of a Japanese 
patient (initials T. T.) with post-transfusion non-A-G hepatitis (Nishizawa et al., 
1997)  and  TT-like  mini  virus  (TLMV)  discovered  as  a  result  of  a  survey 
investigating the prevalence of TTV (Takahashi et al., 2000b). The genetic 
and  ultrastructural  characteristics  are  summarised  in  Table  2.1.  Like  other 
members of the Circoviridae, TTV has an icosahedral structure (Itoh et al., 
2000). TTV may be cultured in vitro using the Chang Liver cell line, the Raji B 
lymphoblast cell line or PBMC cultures stimulated with phytohaemagglutinin 
(PHA), lipopolysaccharide (LPS) and IL-2 (Desai et al., 2005, Mariscal et al., 
2002). 
   19 
Despite numerous studies, TTV has yet to be definitively associated with a 
given lesion, thus it is considered an “orphan” virus (Bendinelli et al., 2001). 
TTV  is  widespread  amongst  the  general  population  and  has  a  worldwide 
distribution (Hohne et al., 1998, Niel et al., 1999, Prescott and Simmonds, 
1998, Takahashi et al., 1998). Viral DNA can be detected in sera, semen, 
saliva, stool, breast milk, vaginal secretions and cord blood, suggesting that 
the  virus  may  be  transmitted  both  vertically  and  horizontally  (Deng  et  al., 
2000, Fornai et al., 2001, Inami et al., 2000, Jones et al., 2005, Komatsu et 
al., 2004, Lin et al., 2000, Matsubara et al., 2001, Matsubara et al., 2000, 
Ohto et al., 2002, Ross et al., 1999, Saback et al., 1999). TTV infections are 
long lasting and possibly permanent (Bendinelli, 2001, Bendinelli et al., 2001, 
Maggi et al., 2001), but clearance of the virus after treatment with IFN-α has 
been  reported  (Akahane  et  al.,  1999,  Hagiwara  et  al.,  1999).  TTV  is  also 
considered to be extremely resistant and may persist in the environment for 
long periods of time (Haramoto et al., 2005). 
 
TT  viruses  have  also  been  discovered  in  non-human  species  including: 
chimpanzees,  pigs  (Sd-TTV),  dogs  (Cf-TTV),  cats  (Fc-TTV),  sheep,  cattle, 
chickens and tupaia (tree shrews) (Tbc-TTV) (Cong et al., 2000, Leary et al., 
1999b, McKeown et al., 2004, Okamoto et al., 2001, Verschoor et al., 1999). 
Swine TTV has a worldwide distribution (Brassard et al., 2008, Martelli et al., 
2006, McKeown et al., 2004) and is ubiquitous in both domestic and wild pigs 
(Martinez et al., 2006). Swine TTV DNA can be detected in up to 90.5% of 
plasma samples and 60.3% of faecal samples (Brassard et al., 2008) and can 
also be detected in boar semen, implying that the virus may be transmitted 
vertically (Kekarainen et al., 2007). Bovine TTV has been detected in 1.1% of   20 
cattle in Quebec (Brassard et al., 2008), but worldwide studies are limited. 
Even though Sd-TTV has not been shown to be pathogenic, higher levels of 
Sd-TTV DNA are detectable in pigs with PMWS, though this likely reflects the 
effect of PCV2 rather than Sd-TTV. As yet there is no evidence that animal 
TTVs can be transmitted to humans and TTVs have been shown to have poor 
viability in heterologous species (Mushahwar et al., 1999). Still, human TTV 
has  been  transmitted  to  chimpanzees  and  macaques  (Takahashi  et  al., 
2000a, Tawara et al., 2000) and so the significance of animal TTVs in terms 




Figure  2.1:  Phylogenetic  relationship  between  chicken  anaemia  virus  (CAV),  porcine 
circovirus 1 and 2 (PCV1 and 2), beak and feather disease virus (BFDV) and some other 
avian  circoviruses  [pigeon  circovirus  (PiCV),  goose  circovirus  (GoCV),  canary  circovirus 
(CaCV) and duck circovirus (DuCV)]. Neighbour-joining analysis with 1000 bootstrap cycles. 
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2.2.3 Genome organisation 
The  genome  size,  described  gene  products,  predicted  ORFs  and  putative 
gene products of CAV, PCV1 and BFDV, as well as the anelloviruses (TTVs 
and  TLMV)  and  some  novel  circoviruses,  are  displayed  in  Table  2.1.  The 
genome  organisation  of  these  viruses  is  depicted  in  Figure  2.2.  Where 
possible, the ORF-labelling used conventions for geminiviruses (Meehan et 
al., 1997, Niagro et al., 1998) are also used here. 
 
The genomes of viruses within the genus Circovirus are organised in a similar 
manner,  but  are  different  to  those  of  CAV,  the  only  member  of  the  genus 
Gyrovirus and members of the genus Anellovirus. CAV is unique within the 
animal DNA viruses in that it uses an unspliced, polycistrionic message for 
synthesis of its proteins (Todd et al., 2001a). The CAV genome contains 3 
partially overlapping proteins and transcriptional analysis has demonstrated 
that one major transcript, of approximately 2.1 kb is produced and encodes all 
3 ORFs (Noteborn et al., 1992). Further to this, the transcript was found to be 
complementary  to  the  encapsidated  DNA  and  its  genome  can  thus  be 
characterised as negative-sense (Noteborn et al., 1992). Kamada et al. (2006) 
also found transcripts of 1.6, 1.3 and 1.2 kb, but their precise significance is 
unknown.  ORF1  encodes  VP1,  the  capsid  protein  (Noteborn  et  al.,  1992), 
which  also  has  elements  of  replicase-associated  proteins.  ORF2  encodes 
VP2, a dual-specificity protein phosphatase (Peters et al., 2002, Peters et al., 
2005) and ORF3 encodes apoptin. Both VP1 and VP2 are required for the 
proper formation of virions (Lacorte et al., 2007, Noteborn et al., 1998), so 
VP2 likely acts as a scaffolding protein. Furthermore, both VP1 and VP2 are 
required for the development of protective immunity (Noteborn et al., 1998).   22 
Mutational analysis of apoptin has shown that it has an N-terminal nuclear 
export signal (NES) and a C-terminal nuclear localisation signal (NLS) and 
that  multimerisation  of the  protein is  required  for  the  NES  to  be  functional 
(Heilman et al., 2006).  
 
The  members  of  the  genus  Circovirus  differ  from  CAV  in  that  they  have 
ambisense genomes; i.e. they require proteins encoded by both the viral and 
complementary  strands  of  the  genome  in  order  to  replicate  (Niagro  et  al., 
1998). 
 
Within  the  genomes  of  the  porcine  circoviruses,  4  ORFs  have  been 
consistently  identified  in  PCV2  sequences  and  up  to  7  ORFs  have  been 
identified within PCV1. The whole-sequence nucleotide identity within PCV2 
isolates has been shown to be >96%, but <80% identity between PCV1 and 
PCV2  isolates  (Meehan  et  al.,  1998).  Transcriptional  analysis  and  studies 
using  infectious  clones  of  PCV  genomes  have  demonstrated  3  mRNA 
species,  of  1230+/-50,  990+/-50  and  750+/-50  nt  in  size  (Mankertz  et  al., 
1998) as well as an NLS located at the N-terminal of the capsid protein and 
the replication-associated proteins (Finsterbusch et al., 2005, Liu et al., 2001) 
and IFN-α modulatory CpG motifs (Hasslung, 2003). The nucleotides between 
the  V1  and  C1  ORFs  also  contain  a  putative  stem-loop  structure  with  a 
nonanucleotide  motif  that  is  thought  to  play  a  key  role  in  rolling  circle 
replication. 
 
Both PCV1 and 2 have three ORFs in common: ORFC1, V1 and C2. The C1 
ORF  encodes  the  capsid  protein  (Cap),  the  major  antigenic  determinant   23 
(Blanchard et al., 2003, Mahe et al., 2000, Nawagitgul et al., 2000, Zhou et 
al., 2005) and the V1 ORF encodes the two replication-associated proteins 
(Rep and Rep’) (Finsterbusch et al., 2005, Mankertz and Hillenbrand, 2001, 
Mankertz  et  al.,  2003,  Meehan  et  al.,  1997).  Rep’  is  generated  by  mRNA 
splicing, as occurs with geminiviruses (Schalk et al., 1989). Four amino acid 
sequences  required  for  replication,  conserved  across  nano-  and 
geminiviruses, are also found in PCV1 Rep. The first three sequences are 
found at the N-terminus of the protein and the fourth in the middle. The first 
conserved  motif  is  FLTNN,  the  second  is  HLQGF,  involved  in  metal  ion 
binding (Ilyina and Koonin, 1992), the third, YCSK, is a catalytic site for DNA 
cleavage (Laufs et al., 1995a) and the fourth, GKS, is a dNTP binding site 
(Ilyina and Koonin, 1992). The promoter of the capsid gene (cap) has been 
mapped to nucleotides 431-507 (Mankertz and Hillenbrand, 2002). Liu et al. 
(2005, 2006) demonstrated that the ORFC2 protein, whilst not necessary for 
viral replication, plays an important role in the pathogenesis of the disease. 
 
Similar genomic features to those described above have been reported for 
BFDV. Like PCV, the major ORFs and C1 and V1, which encode similar Cap 
and  Rep  proteins,  respectively  (Bassami  et  al.,  1998).  Similarly,  the  Cap 
protein of BFDV is also the major antigenic determinant (Stewart et al., 2007). 
Bassami  et  al.  (1998)  described  the  potential  stem-loop  structure  and 
nonanucleotide motif between ORFs V1 and C1 and identified up to 7 ORFs 
that code for potential proteins of >8.7 kDa. In contrast, Niagro et al. (1998) 
identified  only  the larger  ORFs:  V1,  C1  and  C2  and  Ritchie et  al.  (1989b) 
identified 3 proteins from virus purified from feather homogenates (Table 2.1). 
Transcriptional  analysis,  using  RNA  extracted  from  feather  pulp,   24 
demonstrated  transcripts  synthesised  from  both  reading  frame  strands 
(Niagro et al., 1998). Studies using recombinant proteins have demonstrated 
the presence of an NLS (Heath et al., 2006) within BFDV Cap, similar to that 
of PCV. Similar amino acid motifs involved in rolling-circle replication initiation 
are present in BFDV Rep, as is a putative NES (unpublished observations). 
BFDV  has  been  shown  to  cause  apoptosis  in  the  skin  of  infected  birds 
(Trinkaus  et  al.,  1998)  and  the  ORFC2  protein,  which  is  similar  to  that  of 




Figure 2.2: Genome organisation of A: Chicken Anaemia Virus, B: Porcine Circovirus 2, C: 
Beak and Feather Disease Virus, D: Torque-teno Virus  and E: TT-like Mini Virus showing 
putative open reading frames on the viral (V) and capsid (C) strands. Adapted from Todd 
(2001a) and Okamoto et al. (2001) 
 
 
The  human  and  animal  TTVs  and  TLMV  share  similar  genomic  features 
(Tables 2.1 and 2.2) and are more similar to CAV than PCV or BFDV, as they 
have negative-sense genomes. The genomes of human, chimpanzee, tupaia, 
swine,  dog  and  cat TTVs  have  been  characterised  (Okamoto  et  al.,  2001,   25 
Okamoto et al., 2002, Verschoor et al., 1999). Genome size varies markedly 
within the genus Anellovirus, the largest of which described so far is human 
TTV  at  3.8  kb  and  the  smallest  feline  TTV  at  2.1  kb.  The  genome  of  the 
anelloviruses is separated into a coding region and a non-coding region. Two 
partially overlapping ORFS can be deduced directly from the sequence of the 
coding region, the largest of which encodes a protein capsid homologous to 
the capsid protein of CAV and contains elements characteristic of the Rep 
proteins of the circoviruses (Biagini et al., 2001). The function of the protein 
encoded  by  ORF2 is  unknown,  but  it  contains  sequences  characteristic  of 
tyrosine phosphatases (Biagini et al., 2001). 
 
Transcriptional  analysis  has  revealed  3  mRNAs  from  both  the  human  and 
swine TTV genomes. The mRNAs from human TTV are 2.9, 1.2 and 1 kb 
long, revealing the existence of ORF3 which is obtained by splicing (Okamoto 
et  al.,  2000).  The  non-coding  region  occupies  between  24-31%  of  the 
genome, depending on the animal it was isolated from (Leary et al., 1999a, 
Miyata et al., 1999, Okamoto et al., 2002). It contains promoter and enhancer 
elements  (Kamada  et  al.,  2004),  a  GC-rich  sequence  that  probably  forms 
stem-loop  structures  (Okamoto  et  al.,  2002)  and  regulatory  sequences 
involved in rolling-circle replication (Mankertz et al., 2004). 
 
Due  to  the  amount  of  genetic  variation  between  TTV  isolates,  5  distinct 
genogroups exist within human TTV isolates (Devalle and Niel, 2004, Peng et 
al., 2002) and 2 genogroups exist within Sd-TTV isolates (Niel et al., 2005). 
Infection with multiple genogroups is common (Bendinelli et al., 2001, Jelcic et 
al.,  2004,  Khudyakov  et  al.,  2000,  Niel  et  al.,  2005)  and  each  genogroup   26 
produces  comparable  viral  loads  single-genogroup  infections.  However,  a 
form of infection facilitation may exist between genogroups 1 and 3, as co-
infection  with  these  genogroups  produces  higher  viral  loads  than  would 
ordinarily be expected (Maggi et al., 2005). 
 
The  Circoviridae  are  genetically  diverse,  even  within  species.  A  consistent 
pattern, though, is that the synonymous nucleotide diversity of rep is always 
lower  than  cap  of  circoviruses, indicating  functional  constraint  on  the  gene 
(Hughes and Piontkivska, 2007). Evidence of recombination has been found 
in both BFDV (Heath et al., 2004) and PCV2 (Ma et al., 2007, Olvera et al., 
2007), as well as CAV (He et al., 2007), human TTV and TLMV (Biagini et al., 
2001,  Worobey,  2000)  and  the  viruses  are  subject  to  past  and  ongoing 
purifying selection (Hughes and Piontkivska, 2007, Olvera et al., 2007). 
 
Hughes and Piontkivska (2007) also found that PCV2 rep showed a strong 
excess of rare polymorphisms, supporting theories of a population bottleneck 
followed by rapid worldwide spread of the virus (Meehan et al., 1998). Nei 
(2007) postulated that differences in pathogenicity may also arise as a result 
of effectively neutral mutations, as opposed to selection by Darwinian means. 
The nucleotide analysis conducted by Hughes and Piontkivska (2007) seems 
to support that this has occurred in the case of PCV2. As yet, no association 
has been found between the genotype and pathotype of any of the members 
of  the  Circoviridae.  However,  given  the  effect  of  random  mutations, 
recombination  and  purifying  selection  this  may  occur,  but  will  require 
experimental confirmation. References: 
1(Todd et al., 1990), 
2(Todd et al., 1991b), 
3(Todd et al., 2001a), 
4(Crowther et al., 2003), 
5(Claessens et al., 1991), 
6(Peters et al., 2002), 
7(Niagro et al., 1998), 
8(Tischer et al., 1982), 
9(Mankertz et al., 2004), 
10(Meehan et al., 1997), 
11(Todd, 2004), 
12(Bassami et al., 1998), 
13(Bassami et al., 2001), 
14(Ritchie et al., 1989b), 
15(Biagini, 2004), 
16(Biagini et al., 2001), 
17(Takahashi et al., 
2000b), 
18(Todd et al., 2001c), 
19(Coletti et al., 2000), 
20(Phenix et al., 2001), 
21(Todd et al., 2008), 
22(Yu et al., 2007b), 
23(Itoh et al., 2000), 
24(Ninomiya et al., 2007) 
 
Table 2.1: Comparison of the physicochemical properties, genomic organisation and gene products of A. Circoviridae and B. Nanoviridae 






No. of ORFs  Putative gene products 
(kDa) 
Described 







Chicken (gallus gallus)  19.1-26.5  1.33-1.36  2.17-2.3  C1: 449 aa, nt 876-2225 
C2: 133 aa, nt 101-502 




VP1 (Capsid): 45-52 






7  Pig (Suis domesticus)  16.8-20.7  1.36-1.37  1.76  ORFV1: 312 aa, nt 47-983  
ORFC1: 233 aa, nt 1723-1024 
ORFC2: 206 aa, nt 658-640 
ORFC3: 115 aa, nt 552-207 
ORFV2: 95 aa, nt 1163-1448 
ORFC4: 62 aa, nt 1518-1332 









  PCV2 
2,3,4, 
7,8,9,10,11 
Pig (Suis domesticus)  20.5    1.7-1.8  V1: 314 aa, nt 51-995 
C1: 233 aa, nt 1735-1034 
C2: 104 aa, nt 671-357 
C3: 59 aa, nt 565-386 
   
  BFDV 
2,3,4,7,11,12,13, 
14 
Psittacine birds (Order, 
Psittaciformes) 
12-22  1.35-1.378  1.7-2.0  ORFV1: 867 nt 
ORFC1: 741 nt 
ORFC2: 480 nt 
ORFV2: 318 nt 
ORFV3: 303 nt 
ORFC3: 264 nt 















13-18    2.032-2.04  ORFV1: 317 aa, nt 41-994 
ORFC1: 273 aa, nt 1987-1166 
ORFC2: 126 aa, nt 790-410 
ORFC3: 97 aa, nt 292-2036 
ORFC4: 82 aa, nt 984-736 
   
  GoCV 
18,22  Goose (Anser anser)  12-14    1.821  ORFV1: 293 aa, nt 73-954 
ORFV2: 120 aa, nt 1613-154 
ORFC1: 250 aa, nt 1761-1009 
ORFC2: 99 aa, nt 427-128 
   
  CaCV 
20  Canary (Serinus 
canaria) 
    1.952  ORFV1: 290 aa, nt 32-904 
ORFC1: 250 aa, nt 1906-1154 
ORFC2: 134 aa, nt 679-275 
ORFV1 (Rep): 33.4 








Human (Homo sapiens)  30-32  1.31-1.35  3.8  ORF1: 760-770 aa 
ORF2 120 aa 
ORF3: 260 aa 
ORF4: 250 aa 
   
  TLMV 
15,16, 
17 
Human (Homo sapiens)  <30  1.31-1.34  2.9  ORF1: 675 aa, nt 529-2556 
ORF2 100 aa, nt 341-640 
   
B. Nanoviridae  CFDV 
7  Coconut (Cocos 
nucifera) 




  BBTV 
7  Banana (Genus Musa)  18-22  1.01-1.11      V1 (Rep): 33.6 
V2 (Capsid): 20.1 
Others: 13.7,  17.4 
Capsid: 21 
  SCSV 
7  Subterranean clover 
(Trifolium 
subterraneum) 
17-19  0.991-1.02      V1 (Rep): 32.5-33.5 
V2 (Capsid): 18.7 











 Table 2.2: Comparison of the genomic organisation and gene products of some tentative 








No. of ORFs  Putative  gene 
products (kDa) 
  DuCV
1  Duck (Anas sp.)  1.996  ORFV1: 292 aa, nt 49-927 
ORFV2: 88 aa, nt 897-1163 
ORFV3: 85 aa, nt 1662-1919 
ORFC1: 257 aa, nt 1933-1160 
ORFC2: 120 aa, nt 1742-1380 
ORFC3: 78 aa, nt 400-164 
ORFV1 (Rep): 33.6 
ORFV2: 10.3 
ORFV3: 9.7 




2  Starling (Sturnus 
vulgairs, Sturnus 
unicolor) 
2.063  ORFV1: 289 aa 
ORFC1: 276 aa 
ORFC2: 106 aa 
ORFV1 (Rep): 33.2 
ORFC1 (Capsid): 32.5 
ORF3: 11 
  RaCV
3  Raven (Corvus 
coronoides) 
1.898  ORFV1: 291 aa, nt 36-911 
ORFC1: 243 aa, nt 1847-1116 
 
  FiCV
4  Finch (Chloebia 
gouldiae) 
1.962  ORFV1: 291 aa, nt 29-904 
ORFC1: 249 aa, nt 1961-1212 
 
  GuCV




2.035  ORFV1: 305 aa, nt 100-1017 
ORFC1: 245 aa, nt 1927-1190 
 
  SwCV
5  Swan (Cygnus 
olor) 
1.783  ORFV1: 293 aa, nt 48-929 










2.878  ORF1: 635 aa, nt 534-2438 
ORF2 73 aa, nt 430-648 





7, 9, 10 
Non-human 
primates (various) 
3.69  ORF1: 735 aa, nt 595-2799 
ORF2 122 aa, nt 350-715 









2.785  ORF1: 654 aa, nt 470-2431 
ORF2 91 aa, nt 305-578 




7  Dog (Canis 
familiaris) 
2.797  ORF1: 576 aa, nt 850-2577 
ORF2 101 aa, nt 662-964 




7  Cat (Felis cattus)  2.064  ORF1: 436 aa, nt 438-1745 
ORF2 105 aa, nt 268-582 




12  Tupaia (Tupaia 
belangeri 
chinensis) 
2.2  ORF1: 502 aa, nt 432-1937 
ORF2 59 aa, nt 343-519 





1(Hattermann et al., 2003), 
2(Johne et al., 2006a), 
3(Stewart et al., 2006), 
4(Todd et al., 
2007), 
5(Halami  et  al.,  2008), 
6(McKeown  et  al.,  2004), 
7(Okamoto  et  al.,  2002), 
8(Kekarainen  and 
Segales, 2008), 
9(Verschoor et al., 1999), 
10(Cong et al., 2000), 
11(Takahashi et al., 2000b), 
12(Okamoto 
et al., 2001)  29 
 
2.2.4 Mode of replication 
The replication strategy of any DNA virus must follow certain predetermined 
steps: 1) entry of the virus into the cell and transportation to the nucleus, 2) 
import  of  the  viral  genome  to  the  nucleus,  3)  import  of  viral  proteins,  4) 
replication of the genome and transcription of mRNAs, 5) export of mRNAs for 
translation  in  the  cytosol,  6)  import  of  viral  proteins  to  the  nucleus  after 
translation and virion assembly, 7) export of assembled viral capsids from the 
nucleus, 8) exit of virions from the cell (adapted from Whittaker and Helenius, 
1998). The Geminiviridae, Nanoviridae and Circoviridae utilise a number of 
methods to overcome these obstacles. 
 
Entry and transport to the nucleus – PCV2 has been shown to use heparin 
sulphate and glycosaminoglycan receptors to attach to monocyte/macrophage 
cells (Misinzo et al., 2006), enters via clatharin-mediated endocytosis and is 
dependent  on  endosomal  acidification  for  infection  (Misinzo  et  al.,  2005) 
(Figure  2.3a).  The  mechanism  of  entry  into  epithelial  cells,  however,  is 
unknown. The NLS probably plays a role in viral attachment and entry, since 
protein binding to these attachment receptors is limited to the basic amino 
acids lysine and arginine (Esko, 1999) and the NLS of circoviruses (and many 
other viruses) has a high proportion of arginine residues. It is likely that BFDV 
uses  a  similar  mechanism  for  cellular  entry  and  activation,  although  this 
remains unknown. Uncoating of the viral genome occurs by serine protease-
mediated capsid disassembly within endosomes (Misinzo et al., 2008b). 
 
Once the virus has entered the cell, the viral DNA must then be transported to 
the nucleus. The coat protein of geminiviruses encodes an NLS (Kunik et al., 30 
 
1998,  Palanichelvam  et  al.,  1998,  Qin  et al.,  1998,  Soto  et al.,  2005)  and 
studies by Finsterbusch et al. (2005) and Shuai et al. (2008) on PCV1, Liu et 
al. (2001) on PCV2 and Heath et al. (2006) on recombinant BFDV Cap have 
demonstrated  that  the  capsid  protein  localises  to  the  nucleus  of  cells  and 
binds both  single-stranded  and  double-stranded  DNA  (ssDNA  and  dsDNA, 
respectively).  Heath  et  al.  (2006)  also  demonstrated  that  co-expression  of 
Rep and Cap localised Rep to the nucleus, but without Cap, Rep was located 
in the cytoplasm. Thus, Cap is likely to be responsible for the transport of the 
viral  DNA  and  Rep  into  the  nucleus  of  the  cell  for  replication  in  a  similar 
manner to that exhibited by geminiviruses (Qin et al., 1998). The Rep and 
Rep’  of  porcine  circoviruses,  however,  contain  their  own  NLS  at  the  N-
terminus of the proteins and do not require the assistance of Cap to locate to 
the nucleus (Finsterbusch et al., 2005). Transport to the nucleus likely occurs 
by binding of Cap to dyneins and transport along microtubules (Radtke et al., 
2006), but this has not yet been investigated in the case of circoviruses. 
 
Import  of  the  viral  genome  to  the  nucleus  –  No  studies  to  date  have 
examined the mode of entry of circoviruses into the nuclei of infected cells, 
however it is known that other DNA viruses are able to transfer their genome 
through the nuclear pore complex (NPC) (Corbett and Silver, 1997, Whittaker 
and Helenius, 1998). Nuclear localisation signals have been shown to interact 
with importin α5 and then importin β in the process of docking with NPCs and 
the  sites  of  DNA  binding  and  importin  interaction  are  close  together 
(Fagerlund et al., 2002). As such, the situation with circoviruses is probably as 
follows: after uncoating and binding the DNA genome, the NLS of the capsid 
protein  docks  with  the  NPC  via  interaction  with  importins  and  then  DNA 31 
 
translocation occurs via a cycle of GTP hydrolysis (Corbett and Silver, 1997) 
(Figure  2.3a).  Alternately,  the  viral  genome  may  enter  the  nucleus  during 
mitosis by associating itself with cellular chromatin (Whittaker and Helenius, 
1998). 
 
Import  of  viral  proteins  –  Import  of  circovirus  proteins  likely  occurs  by 
interaction of the NLS with NPCs and subsequent energy-dependent transfer 
(Figure  2.3a).  Both  the  Cap  and  Rep  proteins  of  the  porcine  circoviruses 
contain NLSs (Finsterbusch et al., 2005, Liu et al., 2001), as does BFDV Cap 
(Heath et al., 2006). In contrast to the replicase-associated proteins of the 
PCVs, BFDV Rep does not contain an NLS, instead interaction between Cap 
and  Rep  is  required  for  nuclear  localisation  of  Rep  (Heath  et  al.,  2006). 
Transfer  of  circoviral  proteins  probably  occurs  in  their  native  form,  since 
proteins up to 39nm in diameter may pass through the NPCs in this manner 
(Dworetzky and Feldherr, 1984, Pante and Kann, 2002). 
 
Genome  replication  and  mRNA  transcription  –  Since  circoviruses  have 
small genomes and hence limited coding capacity, they are highly dependant 
on cellular enzymes for their replication. Indeed, they are the smallest viruses 
known to cause disease. The dependence on cellular functions for replication 
is  supported  by  observations  by  Tischer  et  al.  (1987)  that  PCV1  requires 
mitosis to be taken up into the nucleus and that CAV antigen can be detected 
in only 30-40% of cells in CAV-infected MSB1 cell cultures – this proportion 
probably corresponds to cells which have undergone division. Various studies 
suggest that replication not only requires the presence of cellular enzymes, 
but Cap and Rep as well (Bol, 2005, Boulton et al., 1989, De Graaff et al., 32 
 
1995, Jaspars, 1999, Nassal, 1992) and the shuttling and nucleic acid-binding 
effects of the NLS and NES (Birnbaum and Nassal, 1990, Cokol et al., 2000, 
Heath et al., 2006, Heilman et al., 2006). 
 
Once the viral DNA is in the nucleus of the cell, replication can commence. 
Like  circoviruses,  bacteriophages  and  plant  nano-  and  geminiviruses  also 
have  circular,  ssDNA  genomes  and  studies  of  their  modes  of  replication 
(Hanley-Bowdoin  et  al.,  1999)  have  been  useful  in  understanding  the 
replication  of  circoviruses.  The  first  step  in  the  replication  cycle  for 
bacteriophages, plant geminiviruses and circoviruses alike is the synthesis of 
a complementary strand to form the dsDNA replicative form (RF) (Figure 2.3a) 
and this is most likely performed using cellular enzymes (Gassmann et al., 
1988). The first 16-20 amino acids of the arginine-rich N-terminal of the capsid 
protein may play a role in formation of the RF, in a similar manner to the last 
19 amino acids of the C-terminus of Hepatitis B virus (HBV) (Nassal, 1992). 
With members of the genus circovirus, once this RF is produced, replication 
most  likely  continues  by  rolling  circle  replication  (RCR)  (Figure  2.3b),  as 
occurs  with  bacteriophage  φX174,  the  best  known  example  of  RCR. 
Geminivirus  Rep  proteins  have  been  shown  to  contain  conserved  motifs 
similar to those used by bacterial plasmids for RCR (Koonin and Ilyina, 1992). 
Similar motifs have also been discovered in PCV2 (Mankertz and Hillenbrand, 
2001) and exist in BFDV Rep (unpublished observations). The situation with 
CAV (genus Gyrovirus) is less clear and will be discussed below. 
 
Replication of PCV (and probably BFDV) begins when the positively-charged 
endonuclease  domain  of  Rep  and  Rep’  (Mankertz  and  Hillenbrand,  2001, 33 
 
Vega-Rocha  et  al.,  2007)  (encoded  by  ORFV1)  binds  to  the  origin  of 
replication (or minimal binding site (MBS)) (Steinfeldt et al., 2001, Steinfeldt et 
al., 2006) (Figure 2.3b), the 3’ part of the inverted repeat (5’-T/AAGTATTAC-
3’) and the twice-repeated 8 bp motif (5’-GGGGCACC-3’), located between 
the  stem-loop  and  the  initiation  codon  of  ORFV1  (Bassami  et  al.,  1998, 
Mankertz  et  al.,  2000,  Niagro  et  al.,  1998,  Steinfeldt  et  al.,  2001).  It  is 
important  to  note  that  both  Rep  and  Rep’  are  required  by  the  porcine 
circoviruses  for  initiation  of  replication  (Mankertz  and  Hillenbrand,  2001, 
Mankertz et al., 2003), so the transcription, mRNA export, translation and re-
import of at least a few  molecules of Rep and Rep’ are probably required 
before replication can begin. 
 
Both Rep and Rep’ bind to the origin of replication (Mankertz and Hillenbrand, 
2001,  Mankertz  et  al.,  2003)  and  both  contain  certain  conserved  motifs 
associated with RCR (Ilyina and Koonin, 1992). The first three sequences are 
found at the N-terminus of the protein and the fourth in the middle. The first 
conserved  motif  is  FLTNN,  the  second  is  HLQGF,  involved  in  metal  ion 
binding (Ilyina and Koonin, 1992), the third, YCSK, is a catalytic site for DNA 
cleavage (Laufs et al., 1995a) and the fourth, GKS, is a dNTP binding site (or 
P-loop) (Ilyina and Koonin, 1992). Rep’ lacks this dNTP binding site, so it may 
function as a nickase, whereas Rep likely functions as a helicase (Mankertz et 
al.,  2003).  Interestingly,  the  replication-associated  proteins  of  the  porcine 
circoviruses  are  conserved  to  an  extent  that  they  are interchangeable (i.e. 
Rep and Rep’ of PCV1 efficiently initiate replication of PCV2 and vice versa) 
(Mankertz et al., 2003). As yet it is not known whether BFDV also utilises 2 
transcripts of the replication-associated protein. 34 
 
 
In  the  presence  of  divalent  metal  ions,  the  endonuclease  activity  of  Rep 
(Mankertz  and  Hillenbrand,  2001,  Vega-Rocha  et  al.,  2007)  then  nicks  the 
conserved  nonanucleotide  motif  at  the  apex  of  the  stem-loop  structure 
(Hanley-Bowdoin  et  al.,  1999,  Laufs  et  al.,  1995b,  Steinfeldt  et  al.,  2006) 
(Figure 2.3b). Mutation of the first four nucleotides (Steinfeldt et al., 2006) and 
mutations  within  the  nonanucleotide  motif  of  PCV  (Mankertz  et  al.,  1997) 
result  in  total  loss  of  replicative  function,  as  do  mutations  within  the 
hexanucleotide  motif  (analogous  to  the  octanucleotide  of  BFDV)  (Cheung, 
2006).  The  stem  of  the  stem-loop  then  acts  as  a  primer  and  the  DNA  is 
extended by cellular DNA polymerases and displaces the original virus strand 
(Gassmann et al., 1988, Rigden et al., 1996) (Figure 2.3b). Once the circle 
has been completed, Rep cleaves the displaced virus strand, then ligates the 
displaced  strand  to  form  another  circular  ssDNA  viral  strand  (Laufs  et  al., 
1995b, Steinfeldt et al., 2006) (Figure 2.3b). 
 
The excision of unit-length viral genomes is accomplished primarily via this 
rolling-circle  replication  method;  homologous  recombination  plays  only  a 
minor role (Cheung, 2007). The stem-loop structure is not necessary for the 
cleavage of the nonanucleotide motif, as Rep is able to cleave both single-
stranded and double-stranded DNA, independent of the presence or absence 
of a hairpin within the sequence (Steinfeldt et al., 2006). However, the ligation 
of the newly synthesised DNA by Rep is dependant on the close proximity of 
the strands and this is accomplished by the hairpin structure of the stem-loop 
(Steinfeldt  et  al.,  2006).  Cap  likely  plays  a  role  in  the  regulation  of  virus 
replication,  as  geminivirus  Cap  has  been  shown  to  downregulate  the 35 
 
replication initiation function of Rep, controlling the conversion of ssDNA into 
dsDNA RFs (Malik et al., 2005). 
 
Export  of  mRNAs  for  translation  –  How  circovirus  mRNAs  are  exported 
from the nucleus for translation is not known, but export is likely to occur via 
the interaction of an NES in one of the viral proteins with the NPC (Whittaker 
and Helenius, 1998) (Figure 2.3a). BFDV Rep has been shown to localise to 
the  cytoplasm  (Heath  et  al.,  2006)  and  may  contain  a  putative  NES 
(unpublished observations), but the situation with the PCVs is unclear, since 
both  Rep  and  Rep’  contain  NLSs.  Alternately,  another  as-yet  undescribed 
protein with a nuclear shuttling function may be responsible. 
 
Import of viral proteins and virion assembly – After translation, import of 
the viral proteins likely occurs by interaction of the NLS (Finsterbusch et al., 
2005, Heath et al., 2006, Kunik et al., 1998, Liu et al., 2001) with NPCs, or 
interaction between Cap and Rep in the case of BFDV (Heath et al., 2006) 
(Figure 2.3a). 
 
Packaging of the newly synthesised viral DNA into encapsidated virions likely 
requires the participation of Cap. Nassal (1992) found that removal of the 19 
C-terminal amino acids of the C protein of HBV reduced the production of 
mature DNA genomes, but the genomes present were properly encapsidated. 
The N-terminus of the NLS of circoviral capsid proteins likely has a similar 
function, given the similar composition of the arginine-rich N-terminus of Cap. 
 36 
 
Export of assembled virions – How assembled virions are transported into 
the nucleus to form the characteristic paracrystalline arrays is not precisely 
known, but interaction between the NES and NPC is the likely method (Figure 
2.3a). CAV apoptin contains both an NLS and NES and multimerisation of 
apoptin is required for nuclear export of the protein (Heilman et al., 2006). 
Cap and Rep of BFDV are known to interact (Heath et al., 2006), so perhaps 
multimerisation  of  Rep  facilitates  transport  of  Cap  into  the  cytoplasm. 
Alternately,  circoviruses  may  use  as-yet  undescribed  shuttling  proteins 
produced in small amounts at the end of the replication cycle, in a similar 
manner to the geminiviruses (Qin et al., 1998). If nuclear export does occur 
using an NES, it likely occurs by interaction of the NES with CRM1 and export 
through the NPC (Henderson and Eleftheriou, 2000). Transport away from the 
nucleus  likely  occurs  by  binding  of  Cap  to  kinesins  and  transport  along 
microtubules  (Radtke  et  al.,  2006),  but  this  has  yet  to  be  specifically 
investigated in circoviruses. 
 
Export of virions from the cell – Geminiviruses use a second specialised 
shuttle protein to transport virions out of the cell (Qin et al., 1998, Sanderfoot 
and Lazarowitz, 1995), but the means by which circoviruses exit the cell is 
unknown. Epithelial cells are a common site of replication and have a rapid 
rate of turnover (Ross et al., 1995), so a possibility is the release of virions 
when cells degrade as part of the normal cycle of cell replacement. 
 
The  mode  of  replication  of  CAV  is  not  well  understood.  None  of  the  CAV 
proteins described thus far share similarities with the replication-associated 
proteins  of  other  animal  circoviruses  or  plant  geminiviruses.  However,  the 37 
 
capsid protein does contain the 3 peptide motifs involved in RCR (Ilyina and 
Koonin, 1992) and the VP2 protein is required for efficient replication (Peters 
et  al.,  2006,  Peters  et  al.,  2002).  The  nonanucleotide  motif  found in  other 
ssDNA viruses is semiconserved, but does not occur at the apex of a stem-
loop motif, so it is unknown whether it represents the cleavage site. Niagro et 
al.  (1998)  suggested  that  replication  of  CAV  likely  involves  host  cell 
topoisomerase  and/or  helicase  to  provide  an  unwinding  function. 
Multimerisation  of  apoptin  is  required  for  nuclear  export  and  shuttling  of 
apoptin is required for the induction of apoptosis (Heilman et al., 2006), so 







Figure  2.3:  Example  of  proposed  method  of  replication  of  circoviruses.  A:  Movement  of viral 
components into various cellular compartments 1. entry of the virus to the cell and uncoating in 
endosomes, 2. transfer of viral DNA and cap to the nucleus via the nuclear pore complex (NPC), 
3. generation of the double-stranded replicative form (RF), production of mRNAs and genome 
replication,  4.  export  of  mRNAs  to  the  cytoplasm  for  translation  in  the  rough  endoplasmic 
reticulum (RER), 5. transport of viral proteins to the nucleus through the NPC, 6. packaging of 
virions,  export  to  the  cytoplasm  and  formation  of  paracrystalline  arrays.  B:  Rolling  circle 
replication. 1. double-stranded DNA RF, 2. binding of Rep, 3. nicking of the stem-loop by Rep and 
binding of host cell polymerase (pol), 4. displacement of the original viral strand and ligation of the 
displaced strand, creating a new single-stranded DNA (ssDNA). The new ssDNA can then be 
encapsidated or form a new RF and continue rolling circle replication.  39 
 
2.3 Beak and Feather Disease Virus 
2.3.1 Introduction 
A  BFDV-like  syndrome  was  first  described  in  1907,  affecting  red-rumped 
grass parakeets (Psephotus haematonotus). Affected birds were described as 
“quite healthy, except being destitute of feathers” (Ashby, 1907). This disease 
was  attributed  as  being  responsible  for  the  decline  of  the  species  in  the 
Adelaide  Hills,  as  affected  birds  were  likely  to  be  more  susceptible  to 
predation. 
 
Pass and Perry (1984) were the first to describe the disease in captive birds in 
detail;  they  also  coined  the  term  “psittacine  beak  and  feather  disease 
syndrome” and postulated a viral cause. McOrist et al. (1984) described a 
similar syndrome in wild sulphur-crested cockatoos (Cacatua galerita) around 
the same time. The condition in budgerigars, known as “French moult”, had 
been recognised by aviculturists since the early 1970s. It has since come to 
be recognised as the most common disease of wild and captive psittacines, 
with a worldwide distribution (Albertyn et al., 2004, Bert et al., 2005, Ha et al., 
2007,  Hsu  et  al.,  2006,  Pass  and  Perry,  1985,  Rahaus  and  Wolff,  2003, 
Ritchie  et  al.,  1989a,  Tomasek  and  Tukac,  2007).  The  physicochemical 
properties  of  BFDV  were  first  described  by  Ritchie  et  al.  (1989b)  and 
experimental infections were first carried out by Wylie and Pass (1987). 
 
Other  avian  circoviruses  or  circovirus-like  syndromes  have  since  been 
identified and described in geese (Anser anser) (Todd et al., 2001c), pigeons 
and  doves (Order  Columbiformes.) (Coletti et  al.,  2000,  Todd  et al.,  2008, 
Todd et al., 2001c), canaries (Phenix et al., 2001, Todd et al., 2001b), ducks 40 
 
(Anas sp.) (Hattermann et al., 2003, Soike et al., 2004), common and spotless 
starlings  (Sturnus  vulgaris  and  Sturnus  unicolor)  (Johne  et  al.,  2006a), 
Australian ravens (Corvus coronoides) (Stewart et al., 2006), Gouldian finches 
(Chloebia  gouldiae)  (Shivaprasad  et  al.,  2004,  Todd  et  al.,  2007),  black-
backed, herring and black-headed gulls (Larus dominicanus, Larus argentatus 
and Larus ridibundus) (Smyth et al., 2006b, Todd et al., 2007, Twentyman et 
al., 1999) and mute swans (Cygnus olor) (Halami et al., 2008).  
 
2.3.2 Virus characteristics 
2.3.2.1 Physical  
BFDV  is  a  non-enveloped,  icosahedral  virus  of  approximately  17-20  nm 
diameter. Studies by various authors have revealed virions of between 12-15 
nm (Ritchie et al., 1990) and 20-22 nm (Wylie and Pass, 1987) in diameter 
(Table 2.3). BFDV has been shown to haemagglutinate the erythrocytes of 
goffin cockatoos (Cacatua goffini), guinea pigs (Ritchie et al., 1991b), galahs 
(Eolophus  roseicapillus)  (Raidal  et  al.,  1993b),  eastern  long-billed  corellas, 
sulphur-crested cockatoos, gang-gang cockatoos (Callocephalon fimbriatum), 
Major  Mitchell’s  cockatoos  (Cacatua  leadbeateri)  (Soares  et  al.,  1998), 
salmon-crested  cockatoos  (Cacatua  moluccensis),  umbrella  cockatoos 
(Cacatua  alba)  and  cockatiels  (Sanada  and  Sanada,  2000),  African  grey 
parrots, brown-headed parrots (Poicephalus cryptoxanthus) (Kondiah et al., 
2005)  and  some  geese  (Sexton  et  al.,  1994).  Interestingly,  Soares  et  al. 
(1998)  found  that  BFDV  did  not  haemagglutinate  erythrocytes  from  red-
shouldered macaws (Ara nobilis), orange-winged Amazon parrots (Amazona 
amazonica), blue and gold macaws (Ara ararauna) and blue-fronted Amazon 
parrots  (Amazona  aestiva).  These  are  all  South  American  birds,  which 41 
 
suggests  that  there  may  be  differences  in  the  physical  and  pathogenic 




Table 2.3: Electron micrographic studies of the virus by various authors 
 
Author  Virion size (nm) 
Pass and Perry (1984)  17-22 
Ritchie et al. (1989)  14-16 
Ritchie et al. (1990)  12-15 
Ritchie et al. (1991)  14-17 
Jacobson et al. (1986)  17-22 
Pass and Perry (1985)  20 
Latimer et al. (1991)  >10 
Wylie and Pass (1987)  20-22 
McOrist et al. (1984)  17-20 
Kiatipattanasakul-banlunara et al. (2002)  20 
 
 
2.3.2.2 Chemical  
Purification  of  beak  and  feather  disease  virus  by  differential  and isopycnic 
ultracentrifugation reveals a protein peak of between 1.35 g/mL (Raidal, 1994) 
and 1.378 g/mL (Ritchie et al., 1989b) in caesium chloride (CsCl) (Table 2.4). 
 
 
Table 2.4: Beak and Feather Disease Virus buoyant density in caesium chloride (CsCl) as 
described by various authors 
 
Author  CsCl equilibrium (g/mL) 
Ritchie et al. (1989)  1.378 
Ritchie et al. (1990)  1.35-1.375 
Raidal 1994  1.35-1.37 
 
 
2.3.2.3 Protein composition  
Ritchie  et  al.  (1989)  reported  that  there  are  three  major  viral-associated 
proteins, of approximately 26.3 kDa, 23.7 kDa and 15.9 kDa molecular weight. 
The authors analysed purified viral preparations by sodium dodecyl sulphate – 
polyacrylamide gel electrophoresis (SDS-PAGE) and found that the 26.3 kDa 42 
 
and  23.7  kDa  proteins  were  present  in  roughly  equimolar  amounts  and 
comprised 88% of the total protein. In a subsequent publication, Ritchie et al. 
(1990) also identified two other proteins, one of 48 kDa and another of 58 kDa 
in size, which were present in small amounts. 
 
2.3.2.4 Molecular 
Initial studies using virus preparations from cockatoos characterised the viral 
genome  as  single  stranded  DNA,  of  approximately  1.7-2.0  kb  in  length 
(Ritchie et al., 1989b). Dideoxynucleotide sequencing of the DNA of 9 isolates 
of BFDV by Bassami et al. (2001) revealed that the genomes of these isolates 
ranged in size from 1993 nucleotides (BFDV-AUS and Galah-WA, GenBank 
Accession Numbers AF080560 and AF311298)) to 2018 nucleotides (BB-WA 
and LB-WA, GenBank Accession Numbers AF311295 and AF311296) (Table 
2.5).  Sequencing  of  the  BFDV  genome  has  revealed  other  putative  ORFs 
which potentially code for proteins of 8.7 kDa or more (Bassami et al., 1998) 
(Tables 2.1, 2.5). Open reading frames 1 and 2 are similar to the replication-
associated (rep) and capsid (cap) genes (respectively) of porcine circovirus 
(Todd  et  al.,  1991).  Open  reading  frames  3  to  7  did  not  share  significant 
identity  with  any  known  genomic  sequence  in  the  GenBank  sequence 
database. Other isolates examined in the same publication had between 4 
and 7 ORFs coding for putative proteins greater than 8.7 kDa (GenBank). 
 
Bassami  et al.  (1998)  also identified  a  potential  stem-loop structure  with  a 
nonanucleotide  motif  at  the apex,  thought  to  be  the initiation  site  for  RCR 
(Steinfeldt  et  al.,  2001,  Steinfeldt  et  al.,  2006)  and  a  twice-repeated 
octanucleotide motif, thought to be the binding site for Rep (Mankertz et al., 43 
 
2000,  Steinfeldt et  al.,  2001)  (Figure  2.4b). Studies  by  Heath et  al.  (2006) 
using different variants of baculovirus-expressed BFDV capsid proteins have 
identified  an  NLS  within  the  first  41  amino  acids  of  the  N-terminal  of  the 
capsid protein. 
 
BFDV has a high amount of genetic diversity. The nucleotide identity of full-
length BFDV sequences has been reported to be between 84-97% (Bassami 
et al., 2001, Heath et al., 2004). The replication associated gene and protein 
are the most conserved, with nucleotide and amino acid identities of 86-99% 
and 87-98% (Bassami et al., 2001, Hess et al., 2004, Khalesi et al., 2005, 
Kondiah et al., 2006) respectively. The capsid-associated gene and protein 
are much more variable, with nucleotide and amino acid identities reported to 




Table 2.5: Genome size and predicted ORFs of nine isolates of Beak and Feather Disease 
Virus, adapted from Bassami et al. (1998) 
 




















1993  7  867  741  480  318  303  264  258 
Galah-
WA 
1993  7  867  741  495    303  264  318 
MMC-
WA 
1995  7  867  720  273  336  303  264  279 
ELBC-
SA 
1992  5  867  729  495    303  264   
BB-WA  2018  4  867  735  495    474     
LB-WA  2018  4  867  735  456    474    297 
LK-VIC  2007  5  870  741  498    474    282 
SCC1-
WA 
1993  6  867  741  495  318  474    306 
SCC-NT  1994  5  867  720    372  474     
BFDV-
USA 









Figure  2.4:  Organisation  and  features  of  the  Beak  and  Feather  Disease  Virus  genome, 
adapted from Bassami et al. (1998). A: Schematic diagram of the putative replicative form, 
showing the seven ORFs coding for potential proteins >8.7 kDa. B: The potential stem-loop 
structure with the nonanucleotide (bold) at the apex and the repeated octanucleotide motif 




Bassami et al. (2001) found that BFDV isolates grouped into genetic clusters 
and  that  the  same  isolates  grouped  together  when  different  methods  of 
analysis  were  used.  Overall  nucleotide  identity of  the  isolates ranged  from 
84% to 97%, indicating some genetic variation. Ritchie et al. (2003) also found 
that isolates  grouped into  clusters  and  proposed  cockatoo, budgerigar  and 
lorikeet lineages of BFDV based on their sequence data. Genetic variation is 
also  evident  with  restriction  digestion.  Albertyn  et  al.  (2003)  demonstrated 
different restriction enzyme digestion patterns between individual budgerigars 
(Melopsittacus undulatus) and between budgerigars and ring-neck parakeets 
(Psittacula krameri). Similarly, Kondiah et al. (2006) demonstrated 6 different 
restriction  enzyme  digestion  patterns  after  Hae  III  digestion  of  161  PCR-
amplified rep fragments. 45 
 
 
Analysis  of  a  section  of  the  capsid  gene  of  40  samples  from  a  range  of 
psittacine  species  by  Raue  et  al.  (2004)  found  that  isolates  did  not  group 
according to host species, but did find that isolates collected from an aviary 
with  an  outbreak  of  acute  PBFD  in  lorikeets  grouped  together.  Similarly, 
isolates  from  African  grey  parrots  with  leucopenia  grouped  separately  to 
isolates  from  African  greys  with  feather  lesions.  They  suggested  that  the 
course  of  disease  may  be  influenced  by  the  characteristics  of  a  particular 
BFDV  strain  and  that  strains  may  exist  that  preferentially  infect  a  certain 
species. The difference in nonsynonymous polymorphisms between isolates 
may represent the accumulation of random mutations and account for these 
apparent  differences  (Nei,  2007).  The  existence  of  geographically  distinct 
lineages has also been proposed (Heath et al., 2004, Kondiah et al., 2006); 
these  authors  also  found  that  sequences  organised  into  distinct  groups 
according  to  species  (cockatoo  [Cacatua  sp.,  Eolophus  sp.],  lorikeet 
[Trichoglossus sp.], budgerigar and lovebird [Agapornis sp.]). Given the high 
relative diversity of BFDV sequences and the large number of species within 
the  Psittacidae,  the  existence  of  genotypes  related  to  host  species, 
pathogenicity  or  geographic  location  is  to  be  expected.  Given  the  many 
different  strategies  used  to  investigate  the  phylogenetics  of  the  virus, 
amplification  and  analysis  of  whole  sequences,  cap  or  rep  or  fragments 
thereof, it is difficult to draw any consistent conclusions. 
 
It is highly likely that all species of psittacine birds are susceptible to all strains 
of  BFDV.  However  there  have  not  been  any  studies  thus  far  investigating 
whether  this  is  the  case  or  whether  strains  of  BFDV  cause  appreciable 46 
 
differences  in  the  progression  of  disease.  Of  interest  would  be  the 
determination of whether a bird infected with virus isolated from an African 
grey  parrot,  for  example,  was  more  likely  to  cause  acute  disease  and 
leucopenia or whether infection with virus isolated from lorikeets was more 
likely  to  be  associated  with  the  development  of  protective  antibody  than 
infection  with  a  virus  of  cockatoo  origin.  It  is  also  curious,  given  the  wide 
range of Psittaciforme species reported to be susceptible, that the cockatiel is 
greatly underrepresented in both the scientific and lay literature. As yet, no 
studies  have  investigated  the  possible  mechanism  behind  this  apparent 
difference in susceptibility. 
 
Most studies thus far have focused on cap as the main determinant of the 
pathogenicity of the virus (Heath et al., 2004, Raue et al., 2004) but parts of 
the sequence other than cap and rep contribute to pathogenicity. Work with 
PCV2  showing  that  CpG  motifs  play  a  role  in  the  modulation  of  IFN-α 
expression (Hasslung, 2003) and as such CpG motifs may play a similar role 
in modulating cytokines during the course of BFDV infection. Fenaux et al. 
(2003) demonstrated that when the capsid-coding region of PCV2 was cloned 
into the genomic backbone of PCV1, the resultant chimeric virus was less 
pathogenic than wild-type PCV2. This is not to say that cap and the capsid 
protein are not significant in the pathogenesis of the disease, simply that it is 
not the sole determinant of pathogenesis. 
 
A higher rate of genetic diversity has been found within cap (64.3% similarity 
between isolates) compared to rep (93.2% similarity) (Heath et al., 2004) and 
the bulk of this variation has been shown to occur within specific areas of the 47 
 
capsid sequence. This may represent an attempt by the virus to evade the 
immune  system,  or  may  be  the  result  of  host-virus  interactions  specific  to 
individual  species.  The  only  cross-reactivity  study  conducted  thus  far,  by 
Khalesi et al., (2005) did not demonstrate the existence of serotypes using 
polyclonal antisera. However, some of the individual epitopes of the capsid 
protein which correlate to particular psittacine species may vary. Without a 
panel of monoclonal antibodies and virus from a range of species to conduct 
epitope mapping studies, though, this is impossible to establish. 
 
In addition, the variation in genotypes and disease progression is not only 
dependant  on  the  characteristics  of  the  virus,  but  also  on  the  immune 
response of the host, which will also vary between species. As evidence of 
this, recombination within BFDV genomes has been described (Heath et al., 
2004,  Hughes  and  Piontkivska,  2007)  and  Hughes  and  Pionkivska  (2007) 
found  that  BFDV  and  other  circoviruses  were  subject  to  past and  ongoing 
purifying selection. The varied methods used to analyse sequences of BFDV 
isolates may severely compromise the value of the phylogenetic analyses, as 
analysis of genomic fragments ignores the effect of recombination (Posada 
and Crandall, 2001), so full-length gene and genome sequences should be 
used. 
 
Various  differences  in  antigenic  composition,  nucleotide  sequences, 
replication kinetics and pathogenicity have been documented between PCV1 
and  2  (Hughes  and  Piontkivska,  2007,  Lefebvre  et  al.,  2008,  Mahe  et  al., 
2000, Meehan et al., 1998) between strains of PCV2 (Lefebvre et al., 2008, 
Meerts et al., 2005a, Opriessnig et al., 2006d) and CAV (Lucio et al., 1990, 48 
 
Nogueira et al., 2007) and TT viruses are divided into genogroups (Devalle 
and  Niel,  2004,  Niel  et  al.,  2005,  Peng  et  al.,  2002).  It  is  likely  that  such 
differences exist between BFDV isolates, but any proposed differences must 
be confirmed experimentally. 
 
2.3.4 Pathophysiology 
2.3.4.1 Clinical signs 
There have been 2 distinct clinical syndromes described, an acute form which 
occurs  in  nestlings  (Pass  and  Perry,  1985,  Raidal  and  Cross,  1995)  and 
African grey parrots (Doneley, 2003, Pass and Perry, 1985, Schoemaker et 
al., 2000) and a chronic form which occurs in many species of psittacine birds. 
 
The acute form is characterised by the rapid development of hepatic necrosis, 
leucopenia and green diarrhoea after infection. The acute form of PBFD can 
be  fatal,  with  clinical  signs  occurring  in  wild-caught  nestling  and  fledgling 
cockatoos at a prevalence of up to 90% (Raidal and Cross, 1995). In contrast, 
African  grey  parrots  often  die  within  a  week  of  the  development  of  clinical 
signs (Schoemaker et al., 2000). 
 
More  commonly,  PBFD  develops  as  a  chronic  disease,  characterised  by 
progressive  feather  and  beak  dystrophy.  Claw  abnormalities  occur 
occasionally, and generally develop well after feather and beak lesions (Perry, 
1981) become apparent. Feather loss is roughly symmetrical, usually affecting 
the powder down feathers first (Pass and Perry, 1984), then flight and tail 
feathers before progressively involving the rest of the body until birds appear 
to be bald. 49 
 
 
The  pattern  of  feather  loss  is  not  consistent  between  birds,  however, 
depending on the stage of moult that the bird is in when disease symptoms 
start.  Normal  feathers  that  fall  out  are  replaced  by  dystrophic,  abnormal 
feathers. The beak becomes progressively elongated, develops fracture lines 
and  may  eventually  fracture  or  slough  off.  Chronically  affected  birds  are 
predisposed  to  secondary  infections  (Pass and  Perry,  1984,  Ritchie  et  al., 
1989a) and it is suspected that the virus is immunosuppressive. However, the 
precise mechanism of such immunosuppression is unknown. 
 
2.3.4.2 Clinical pathology  
The acute form of PBFD is associated with severe leucopenia in African grey 
parrots (Doneley, 2003, Schoemaker et al., 2000, Stanford, 2004). There has 
only been one report investigating the clinicopathologic changes in psittacines 
affected with the chronic form of PBFD (Jacobson et al., 1986). These authors 
did  not  find  any  consistent  differences  in  haematologic  or  serum  enzyme 
measurements  between  healthy  and  PBFD-affected  cockatoos.  They  did, 
however, find that the birds with PBFD had consistently lower serum protein 
concentrations, characterised by low prealbumin and gamma globulin. Ritchie 
et al. (1989a) proposed that this may be an indication of the mechanism of 
immunosuppression caused by the virus. 
 
2.3.4.3 Gross pathology 
The most obvious external gross lesions are the loss of feathers and beak 
and claw abnormalities. The pattern of feather loss is variable, depending on 
the stage of moult when disease signs start. Dystrophic feathers may have 50 
 
retained feather sheaths, blood within the feather shafts, curled and deformed 
feathers, stress lines evident in the vane, short clubbed feathers and feathers 
with  a  circumferential  constriction.  The  beak  may  be  overgrown,  with 
transverse  fracture  lines  and  parts  of  the  beak  may  fracture  off  or  slough 
(Figure  2.5).  Claw  abnormalities  are  similar,  but less  consistent (Pass  and 
Perry, 1985). Birds affected by the acute form of the disease will have feather 
lesions, but beak and claw abnormalities will typically not be evident, as they 
take longer to develop. 
 
Gross  internal  findings  may  include  bile  staining  within  the  proventriculus, 
ventriculus and intestine, the liver may appear swollen and mottled (Jergens 
et al., 1988) and there may be atrophy of the thymus and bursa of Fabricus 
(Pass and Perry, 1985, Raidal and Cross, 1995, Ritchie et al., 1989a). 
 
2.3.4.4 Histopathology 
Lesions  within  the  skin  and  epidermis  include  multifocal  epithelial  cell 
necrosis,  necrosis  of  distal  pulp  and  haemorrhage  into  the  distal  shaft  of 
feathers and epidermal hyperplasia and hyperkeratosis (McOrist et al., 1984, 
Pass and Perry, 1984, Wylie and Pass, 1987). There may also be infiltration 
of  heterophils  and  lymphocytes  into  the  pulp  of  some  feathers.  Basophilic 
intracytoplasmic inclusions can be found within macrophages in the feather 
pulp  (Figure  2.5)  and  some  epithelial  keratinocytes  may  contain 
intracytoplasmic or intranuclear inclusions (Pass and Perry, 1984, Raidal and 
Cross, 1995). Within the beak, degeneration and necrosis of epithelial cells 
occurs in the basal and intermediate cell layers. Chronic beak lesions are also 51 
 
associated with inflammation as a result of the presence of bacteria within 
exudate and the keratinised layers of epithelium (Pass and Perry, 1984). 
 
The  liver  may  be  congested,  with  multifocal  areas  of  necrosis  of  varying 
severity (Raidal and Cross, 1995). Characteristic basophilic inclusions may be 
present  in  Kupffer  cells  within  the liver  and  intranuclear inclusions  may  be 
present within epithelial cells of collecting ducts and tubules. The thymus and 
bursa may show varying degrees of atrophy and necrosis. Focal aggregates 
of necrotic lymphocytes often contain macrophages with typical inclusions and 
necrotic lymphocytes with intranuclear inclusions may also be visible (Pass 
and Perry, 1984, Raidal and Cross, 1995). Intracytoplasmic inclusion bodies 
within macrophages are variable in size and shape and electron microscopic 
examination shows that they are composed of particles 17-20 nm in diameter 
arranged  in  a  paracrystalline  array  (McOrist  et  al.,  1984,  Pass  and  Perry, 








Figure  2.5:  A:  sulphur-crested  cockatoo  (Cacatua  galerita)  with  severe  chronic  Psittacine 
Beak and Feather Disease (PBFD). B: feather from a PBFD-affected bird with a pinched tip 
and haemorrhage within the calamus. C: feather from a PBFD-affected bird demonstrating a 
retained feather sheath and clubbing at the tip. D: histological section of skin from a PBFD-
affected  bird  showing  botryoid  basophilic  inclusions  within  macrophages  (surrounded  by 





Transmission – The virus is excreted via the feathers and the gastrointestinal 
tract.  Consequently,  high  concentrations  of  virus  can  be  detected  in  liver 
tissue, bile, crop secretions, faeces and feather dander (Raidal and Cross, 
1994b, Ritchie et al., 1991a, Ritchie et al., 1991b). Infection is most likely by 
oral and/or intracloacal ingestion of virus, as demonstrated by experimental 
infection studies (Wylie and Pass, 1987). Experimental infection can also be 
accomplished by intramuscular administration of the virus (Raidal and Cross, 
1995, Raidal et al., 1993a, Wylie and Pass, 1987). 53 
 
 
BFDV is strongly suspected to be transmitted vertically (Rahaus et al., 2008, 
Ritchie et al., 1994). Both CAV and PCV2 may be transmitted vertically, via 
semen  (Hoop,  1992,  Hoop,  1993,  McIntosh  et  al.,  2006)  and  in  utero 
(Cardona et al., 2000) and BFDV DNA has been amplified from embryonated 
eggs (Rahaus et al., 2008). However, vertical transmission of BFDV has been 
extremely difficult to prove, due to the difficulty in finding BFDV-free aviaries 
and the difficulty involved in ruling out horizontal transmission to the embryo 
via cloacal secretions and nesting material.  
 
Progression of infection – The virus is epitheliotrophic (Latimer et al., 1991, 
McOrist et al., 1984, Pass and Perry, 1984, Ramis et al., 1994, Ritchie et al., 
1989b)  and  primary  sites  of  replication  include  the  skin  (including  the 
epithelium of the beak and claws), liver, gastrointestinal tract and bursa of 
Fabricus  (Raidal  and  Cross,  1994b,  Wylie  and  Pass,  1987).  The  virus 
replicates  to  high  titres  in  these  tissues  and  also  spreads  to  the  spleen, 
thyroid, parathyroid and bone marrow (Latimer et al., 1990). The incubation 
period of the virus is unknown, as the appearance of clinical signs depends on 
the stage of moult of the bird. Experimentally infected nestlings show signs of 
acute PBFD from 21-28 days post-infection (Raidal and Cross, 1995, Raidal 
et  al.,  1993a).  However,  as  the  disease  progresses,  feather  and  beak 
dystrophy  occur  as  described  above  and  chronically  affected  birds  may 
become  immunosuppressed.  Immunosuppression  as  a  result  of  BFDV 
infection  is  highly  likely,  as  lymphoid  atrophy  and  necrosis  has  been 
demonstrated histologically (Pass and Perry, 1984, Raidal and Cross, 1995) 
and chronically affected birds commonly excrete large amounts of virus as 54 
 
measured by HA with no detectable antibodies measurable by HI (Khalesi et 
al., 2005).  
 
Interferon-α-modulatory  CpG  sequences  have  been  described  in  PCV2 
(Hasslung  et  al.,  2003)  and  likely  also  exist  within  BFDV.  These 
oligodeoxyribonucleotides (ODNs) have been shown to have both inhibitory 
and stimulatory effects on the induction of IFN-α and an inhibitory effect on 
the production of TNF-α in NIPCs (Hasslung et al., 2003, Stevenson et al., 
2006, Wikstrom et al., 2007), independent of viral replication or the presence 
of  Cap.  Other  research  into  PCV2,  profiling  serum  cytokine  expression, 
cytokine  mRNA  levels  in  lymphoid  tissues  and  PBMCs  in  cell  culture, 
suggests a T-cell mediated immunosuppression under the influence of IL-10 
(Darwich  et  al.,  2003a,  Darwich  et  al.,  2003b,  Darwich  et  al.,  2008, 
Kekarainen et al., 2008, Stevenson et al., 2006) and the viral genome and 
ORFC2  protein  may  be  involved  in  this  (Hasslung  et  al.,  2003,  Liu  et  al., 
2006b, Liu et al., 2007b, Wikstrom et al., 2007).  
 
Individuals within some species of birds may recover from clinical PBFD. For 
example,  lorikeets  (Trichoglossus  sp.),  Eclectus  parrots  (Eclectus  sp.)  and 
king  parrots  (Alisterus  scapulatus)  often  develop  protective  HI  titres  and 
excretion of virus ceases. In contrast, other species appear highly susceptible; 
cockatoos  (Cacatua  sp.)  typically  develop  the  chronic  form  of  the  disease, 
with high HA titres detectable in feathers and faeces and no detectable HI 
titre.  African  grey  parrots  are  known  to  be  highly  susceptible  to  the  virus, 
typically developing the acute form of the disease. In contrast, there are no 
published reports of PBFD in cockatiels. There is only one published report of 55 
 
BFDV in a cockatiel, diagnosed by PCR (Khalesi et al., 2005). However, this 
diagnosis was made from a feather submitted to the laboratory by a third party 
and  the  identity  of  the  bird  was  not  confirmed.  Variations  in  nucleotide 
sequences,  antigenic  composition,  replication  kinetics  and  pathogenicity 
probably exist between BFDV isolates, as is the case with PCV1 and strains 
of PCV2 (Hughes and Piontkivska, 2007, Lefebvre et al., 2008, Mahe et al., 
2000, Meehan et al., 1998, Meerts et al., 2005a, Opriessnig et al., 2006d), but 
this is yet to be investigated. 
 
2.3.4.6 Epidemiology 
Horizontal  transmission  via  faeces,  feather  dander  and  crop  secretions  is 
likely the major means by which the virus is spread (Hess et al., 2004, Raidal 
and Cross, 1994b, Ritchie et al., 1991a). Vertical transmission is suspected 
but  not  confirmed,  as  has  been  discussed  previously  (Section  2.3.4.5).  All 
species  of  psittacine  birds  are  considered  susceptible  and  individual 
serotypes  were  not  found  in  the  one  cross-reactivity  study  (Khalesi  et  al., 
2005) undertaken. 
 
There are reports of BFDV infection worldwide in both wild (BusinessWorld, 
1996, Ha et al., 2007, Kock et al., 1993, McOrist et al., 1984, Raidal et al., 
1993b) and captive (Albertyn et al., 2004, Bert et al., 2005, Ha et al., 2007, 
Hsu  et  al.,  2006,  Kiatipattanasakul-Banlunara  et  al.,  2002,  Perry,  1981, 
Rahaus  and  Wolff,  2003)  psittacines.  McOrist  et  al.  (1984)  reported  the 
presence of clinical signs of PBFD in 10-20% of sulphur-crested cockatoos in 
3 wild flocks in Australia. The reported prevalence rates of viral DNA vary 
between 14.8-28.0% in wild flocks (Ha et al., 2007) and between 8.05-83.90% 56 
 
in captive flocks (Bert et al., 2005, Khalesi et al., 2005, Rahaus and Wolff, 
2003).  Seroprevalences  of  between  16%  and  62%  (Khalesi  et  al.,  2005, 
Raidal  and  Cross,  1994a)  among  captive  flocks  and  seroprevalence  of 
between 41% and 94% has been reported in wild flocks (Raidal et al., 1993b). 
 
2.3.5 Diagnosis, treatment and prevention 
2.3.5.1 Diagnosis 
Diagnosis of PBFD can be made on clinical signs alone, but signs can be 
confused with other diseases of the skin and feathers (see below). Different 
methods that have been used for the detection of BFDV include histology, 
electron  microscopy  (EM),  haemagglutination  (HA),  immunohistochemistry 
(IHC), DNA in-situ hybridisation (ISH), polymerase chain reaction (PCR) and 
real-time PCR. The serological detection of anti-BFDV antibodies has been 
conducted  by  haemagglutination-inhibition  (HI)  and  enzyme-linked 
immunosorbent assay (ELISA) assays. 
 
Histology  –  Histology  is  used  to  detect  viral  inclusion  bodies  in  tissue 
samples. Typical histological lesions include multifocal epithelial cell necrosis, 
necrosis of distal pulp and haemorrhage into the distal shaft of feathers and 
epidermal  hyperplasia  and  hyperkeratosis.  There  may  also  be  scattered 
infiltrates of inflammatory cells within feather follicles. Characteristic basophilic 
botryoid intracytoplasmic inclusions can often be seen within macrophages 
and  the  nuclei  of  necrotic  epithelial  cells  may  be  swollen  with  basophilic 
inclusions (Jacobson et al., 1986, McOrist et al., 1984, Pass and Perry, 1984, 
Raidal and Cross, 1995, Wylie and Pass, 1987). The principal advantage of 
histology  is  that  identification  of  the  characteristic  inclusion  bodies  is 57 
 
diagnostic  for  BFDV  infection.  Disadvantages  include  the  relative  lack  of 
sensitivity, as inclusion bodies can be difficult to detect and the need for a 
surgical procedure to collect tissue samples. 
 
Electron microscopy – EM has been used by many authors for the detection 
of viral particles, using preparations from faeces, feathers, skin, GIT and liver. 
Electron microscopic examination of these preparations demonstrates virus-
like particles 17-20 nm in diameter. Intracytoplasmic inclusion bodies within 
macrophages  are  variable  in  size  and  shape  and  electron  microscopic 
examination  shows  these  virus-like  particles  arranged  in  a  paracrystalline 
array (McOrist et al., 1984, Pass and Perry, 1984, Wylie and Pass, 1987). The 
advantages of EM are that it allows more detailed analysis of viral inclusions 
and  measurement  of  viral  particles.  Disadvantages  include  the  need  to 
identify viral inclusions by histology first and the extra cost and complexity 
involved in sample preparation and analysis. 
 
DNA  in-situ  hybridisation  –  Latimer  et  al.  (1994)  used  a  30-base 
oligonucleotide  to  detect  viral  DNA  in  the  skin,  feathers,  liver,  spleen, 
gastrointestinal  tract,  trachea  and  lungs,  kidney  and  myocardium.  The 
advantages of DNA in-situ hybridisation are its high sensitivity and specificity 
and  the  ability  to  identify  the  subcellular  location  of  viral  particles  within 
specific tissues. Disadvantages include the need for specialised reagents and 




Haemagglutination – HA is used to detect viral antigen. BFDV was shown by 
Ritchie et al. (1991b) to be a haemagglutinating virus, and a standardised HA 
assay was developed by Raidal et al. (1993c). HA activity can be detected in 
a variety of tissues such as feathers, faeces and liver but feathers are the 
most commonly used tissue. The advantages of HA include its use as a non-
invasive ante mortem diagnostic test and the ability to detect viral antigen in a 
wide  range  of  tissues.  The  main  disadvantages  include  the  need  for 
erythrocytes from suitable birds, virus purified from the feathers of infected 
birds and polyclonal antibody preparations. Other disadvantages include the 
variation inherent in these reagents and the need for specialised training to 
perform and interpret the assay. 
 
Haemagglutination inhibition – HI is used for the detection of antibodies to 
BFDV  in  serum  and  plasma  samples.  Polyclonal  anti-BFDV  serum  inhibits 
viral haemagglutination (Raidal et al., 1993c, Ritchie et al., 1991b). Raidal and 
Cross  (1993c)  developed  an  HI  assay  for  routine  diagnostic  use  and  this 
assay  has  been implemented  in  various  serological  studies  (Khalesi  et  al., 
2005, Raidal and Cross, 1994a, Raidal and Cross, 1995, Raidal et al., 1993a, 
Raidal et al., 1993b). Advantages and disadvantages are similar to the HA 
assay. 
 
Enzyme-linked  immunosorbent  assay  –  Only  one  indirect  ELISA  for  the 
detection of antibodies to BFDV in psittacine sera has been developed (Johne 
et al., 2004). However, this assay has not yet been validated with a large 
number of samples and uses a secondary antibody directed against IgY from 
an African grey parrot. Since the cross-reactivity between the IgY of different 59 
 
psittacine birds is not known, it is impossible to guarantee the validity of the 
assay when used with sera from other species. Another indirect ELISA has 
been  described  (Ritchie  et  al.,  1992),  however  it  was  only  used  to  screen 
mouse  sera  and  hybridoma  supernatants  during  the  development  of  anti-
BFDV monoclonal antibodies. Advantages of ELISA include its use as a non-
invasive  ante  mortem  diagnostic  test  and  the  ability  to  screen  multiple 
samples simultaneously. The main disadvantage is the need for specialised 
reagents and equipment to perform the assay. 
 
Immunohistochemistry  –  Various  authors  have  described 
immunohistochemical  techniques  for  the  detection  of  BFDV  antigens  in 
histological sections (Latimer et al., 1990, Latimer et al., 1991, Raidal and 
Cross, 1995, Ritchie et al., 1992). Most of these use polyclonal antibodies 
raised in rabbits or chickens; Ritchie et al. (1992) used monoclonal antibodies 
raised against virus purified from the skin and feathers of diseased birds. The 
advantages  of  immunohistochemistry  are  its  high  sensitivity  and  specificity 
and  the  ability  to  identify  the  subcellular  location  of  viral  particles  within 
specific tissues. Disadvantages include the need for specialised reagents and 
the extra cost and complexity involved in sample preparation and analysis. 
 
Polymerase chain reaction (PCR) and real-time PCR – A variety of PCR 
techniques  have  been  described  for  the  detection  of  BFDV  DNA,  from 
standard polymerase chain reaction (Albertyn et al., 2004, Ritchie et al., 2003, 
Ypelaar et al., 1999) to nested PCR (Kiatipattanasakul-Banlunara et al., 2002) 
and real-time PCR (Raue et al., 2004). A duplex shuttle PCR assay has also 
been developed to differentiate between BFDV and avian polyomavirus (APV) 60 
 
(Ogawa et al., 2005). Of these, only the method developed by Ypelaar et al. 
(1999) has been validated with a sufficiently large number of samples. PCR 
using  degenerate  primers  has  been  used  to  identify  novel  circoviruses  of 
starlings (Johne et al., 2006a), ducks (Hattermann et al., 2003), geese (Todd 
et al., 2001c), canaries (Phenix et al., 2001, Todd et al., 2001b) and ravens 
(Khalesi  et  al.,  2005).  Eisenberg  et  al.  (2003)  also  used  a  standard  PCR 
assay  to detect  circovirus  DNA  in  the  tissues  of  ostrich (Struthio  camelus) 
chicks.  The  advantages  of  PCR  assays  are  their  high  sensitivity  and 
specificity  and  the  ability  to  test  multiple  samples  at  once.  Disadvantages 
include the need for specialised reagents and training to perform the assays 
and the potential for sample contamination due to the high sensitivity of the 
assays. 
 
Multiply-primed rolling circle amplification (RCA) – RCA is a technique 
which  uses  random  hexamer  primers  to  amplify  circular  DNA  templates 
(Rector  et  al.,  2004).  It  can  be  used  to  amplify  DNA  from  plasmids, 
bacteriophages  and  viruses  with  circular  DNA  genomes  such  as 
papillomaviruses,  polyomaviruses  and  circoviruses.  It  has  been  used  to 
identify  novel  papillomaviruses  in  manatees  (Rector  et  al.,  2004), 
polyomaviruses in a Eurasian bullfinch (Pyrrhula pyrrhula griseiventris) and a 
Eurasian jackdaw (Corvus monedula) (Johne et al., 2006b), a novel circovirus 
in starlings (Johne et al., 2006a), human TTV and both genogroups of Sd-TTV 
(Niel et al., 2005). The advantages of RCA include its high sensitivity and the 
ability  to  detect  circoviral  DNA  from  a  range  of  avian  species.  The  main 





Treatment is mainly supportive, as no reliable specific treatment is currently 
available.  Birds  affected  with  chronic  BFDV  can  live  for  many  years,  even 
after  the  development  of  feather  and  beak  lesions  but  often  succumb  to 
chronic infections.  Cytokines  show  promise for  the  treatment  of  many  viral 
diseases, Stanford (2004) used chicken IFN-γ successfully to treat seven of 
ten African grey parrots affected with acute BFDV and IFN-α has been used 
to treat patients co-infected with hepatitis C and TTV (Akahane et al., 1999, 
Chayama et al., 1999, Hagiwara et al., 1999). Interferon of avian origin is not 
yet  commercially  available.  Consequently,  the  efficacy  of  interferon  in  the 
treatment  of  chronic  cases  is  yet  to  be  investigated,  especially  in  light  of 
findings that IFN-γ enhances PCV2 replication in cell culture (Meerts et al., 
2005a) and may have a deleterious effect on the development of protective 
immunity (Blanchard et al., 2003). 
 
Tomasek and Tukac (2007) claimed successful treatment of BFDV-infected 
birds with ß-(1,3/1,6)-D-Glucan, but their experimental design was poor – an 
insufficient number of birds was treated, no control group was included and no 
evidence was provided that absence of BFDV DNA was not simply due to the 
development  of  an  appropriate  antibody  response.  Even  though  the 
compound  has  been  shown  to  enhance  immune  responses  in  chickens 
(Cheng  et  al.,  2004,  Guo  et  al.,  2003)  and  may  actually  be  useful  in  the 
treatment  of  BFDV,  no  reliable  conclusions  can  be  drawn  from  this  study. 
RNA  interference  (RNAi)  has  been  used  successfully  to  inhibit  PCV2  viral 
DNA  replication  and  protein  synthesis  in  vitro  (Sun  et  al.,  2007)  and  in 62 
 
experimentally  infected  mice  (Liu  et  al.,  2006a).  RNA  interference  may 
therefore  be  useful  for  treatment  of  BFDV  infection  and  further  testing  is 
warranted. 
 
2.3.5.3 Prevention and control 
Prevention of BFDV in an avicultural setting is difficult and frustrating. The 
virus  is  highly infectious  and  resistant  to  the  extremes  of  temperature  and 
various chemicals (Raidal and Cross, 1994b). Strict quarantine and screening 
of new additions to the flock, using a combination of PCR, HA and HI tests to 
detect infected birds, is recommended. The source of birds is also important. 
Birds at pet shops or areas where many birds are mixed are more likely to be 
infected and infection may be difficult to detect, depending on which tests are 
selected.  Khalesi  et  al.  (2005)  showed  that  in  a  flock  of  56  peach-faced 
lovebirds (Agapornis roseicollis), of the 47 birds that were PCR-positive on 
blood samples, only 10 were also positive on feather samples. 
 
Prevention of access to the flock by wild birds is important, as is prevention of 
contamination  of  the  flock  with  faeces  from  wild  birds.  Stringent  hygiene 
protocols should be in place, including regular cleaning with an appropriate 
disinfectant  and  control  of  movement  between  quarantined  birds  and  the 
flock. Since BFDV cannot be propagated in vitro, the relative effects of various 
disinfectants  cannot  be  evaluated.  However,  disinfection  using  peroxide 
compounds  (Virkon  S)  has  been  recommended  by  the  Department  of 
Environment and Heritage, Australia, for use in captive breeding programs of 
endangered psittacine species (Cross, 2006). Virkon S at a 1% solution has 63 
 
been shown to inactivate non-enveloped viruses and bacterial spores, so in 
theory it is the only suitable disinfectant. 
 
Currently  there  is  no  commercially  available  vaccine  for  BFDV.  An 
experimental inactivated vaccine has been shown to be effective (Raidal and 
Cross, 1994a, Raidal et al., 1993a), but since virus purified from infected birds 
is  required,  the  vaccine  is  time  consuming,  expensive  and  ethically 
questionable to produce. As no cell culture system has been developed to 
grow the virus successfully in vitro, recombinant techniques show the most 
promise for the development of effective vaccines that may be produced on a 
large scale. Recombinant capsid proteins, expressed in mammalian, bacterial 
and insect-cell based systems have been proposed for use in diagnostic tests 
and vaccines for BFDV (Heath et al., 2006, Johne et al., 2004, Khalesi et al., 
2005, Stewart et al., 2007), PCV (Liu et al., 2004, Nawagitgul et al., 2002, 
Zhou et al., 2005) and GoCV (Scott et al., 2006). 
 
DNA vaccines and recombinant virus vectors also have the potential to be 
effective  vaccines.  DNA  vaccines  have  been  developed  against  many 
aetiological  agents  including  viruses  (Cheung  et  al.,  2004,  Li  et  al.,  2004, 
Wang et al., 2006, Yang et al., 2004), bacteria (Ko et al., 2005) and parasites 
(Lillehoj et al., 2005, Nagata et al., 1999, Wu et al., 2004) and virus-vectored 
vaccines  providing  protection  against  animal  diseases  are  already 
commercially available (Minke et al., 2007, Pardoa et al., 2007, Poulet et al., 
2003). However, since the vector used in these vaccines is a canarypox virus, 
an alternate viral vector would need to be developed for use in avian patients. 
In  theory,  apart  from  the  great  difficulty  and  expense  of  harvesting  native 64 
 
BFDV for vaccine production, recombinant vaccines are theoretically better 
than  vaccines  made  from  whole  inactivated  virus.  This  is  because  the 
modulation of immune memory is independent of viral infectivity (Kekarainen 
et al., 2008, Vincent et al., 2007). Thus, the presence of the viral genome and 
key  proteins  in  preparations  of  inactivated  virus  may  encourage  viral 
persistence  after  natural  infection  post-vaccination  and  may  reduce  the 
immune response to other pathogens. 65 
 
Chapter 3. A Quantitative, Real-Time Polymerase 




3.1 Introduction and Aims 
3.1.1 Introduction 
PCR-based assays for the detection of BFDV DNA are in widespread use 
throughout the world. Quantitative real-time PCR assays generally have a low 
limit of detection and have the advantages over standard PCR assays in that 
they do not require post-reaction processing to visualise PCR products and 
they can quantify the amount of DNA present in a sample. BFDV agglutinates 
the  erythrocytes  of  many  birds  (Kondiah  et  al.,  2005,  Raidal  and  Cross, 
1994b, Ritchie et al., 1991b, Sanada and Sanada, 2000, Sexton et al., 1994, 
Soares et al., 1998), which has allowed the development of HA and HI assays 
for the detection of virus and anti-BFDV antibodies respectively (Raidal et al., 
1993c). 
 
The  ambisense  viral  genome  contains  two  major  coding  regions.  ORFV1 
encodes the replication-associated protein and ORFC1 encodes the capsid 
protein. PCR assays based on the DNA sequence of both the V1 and C1 
ORFs have been developed (Albertyn et al., 2004, de Kloet and de Kloet, 
2004, Kondiah et al., 2006, Ogawa et al., 2005, Ritchie et al., 2003, Ypelaar et 
al., 1999), as well as nested (Kiatipattanasakul-Banlunara et al., 2002), duplex 
(Ogawa et al., 2005) and real-time (Raue et al., 2004) PCR assays. Despite 
the difficulties associated with performing and standardising HA assays, there 
are no alternative tests available for the quantitation of the virus. Quantitative, 66 
 
real-time  PCR  (qPCR)  assays  allow  the rapid  and  sensitive  quantitation  of 
genetic material and are in widespread use in studies of gene expression and 
the detection of infectious agents (Mackay, 2004, Nolan et al., 2006, Wong 
and Medrano, 2005). As such, a qPCR assay could be extremely useful for 
the detection of virus and characterisation of infection and excretion kinetics. 
Presented here is a novel qPCR assay for the detection and characterisation 
of BFDV infection. 
 
3.1.2 Aims 
The aims of this experiment were to develop and validate a quantitative, real-
time  PCR  assay  in  order  to  investigate  the  kinetics  of  the  acute  phase  of 
BFDV infection in both vaccinated and non-vaccinated psittacine birds. 
 
3.2 Materials and Methods 
3.2.1 Experimental design 
The independent and dependent variables were time and viral load, measured 
in  both  blood  and  feather  extracts,  respectively.  When  sample  types  were 
compared to determine their suitability for use in a diagnostic assay, blood 
viral  load  was  the  independent  variable  and  feather  viral  load  was  the 
dependent variable. For the calculation of diagnostic sensitivity and specificity, 
the results from the qPCR assay were compared to the results of the HA and 
standard PCR assays, both of which were conducted by Mr Nicolai Bonne. 
Insofar  as  was  practical,  the  qPCR  was  developed  and  validated  in 
accordance  with  guidelines  established  by  the  Office  International  des 
Epizooites (O.I.E.) for the development of PCR methods for the diagnosis of 
infectious  diseases  (Belak  and  Thoren,  2004,  Jacobson,  2004).  Assay 67 
 
validation  did  not  include  the  assessment  of  reproducibility  between 
laboratories or the continued testing of new samples over time, as these were 
beyond the scope of this experiment. The vaccination trial comprised samples 
from 18 eastern long-billed corellas, 13 vaccinated and 5 non-vaccinated, plus 
samples from 2 galahs. Therefore, at each sample collection there were 15 
replicates from vaccinated birds and 5 replicates from non-vaccinated birds 




DNA  extracts  used for  the  development  of the  qPCR  were  taken  from  the 
archive  of  samples  previously  tested  in  our  laboratory.  Samples  originated 
from  the  blood  and  feathers  of  many  psittacine  species, including  sulphur-
crested  cockatoos,  galahs,  rainbow  lorikeets  (Trichoglossus  haematodus), 
purple  crowned  lorikeets  (Glossopsitta  porphyrocephala),  eclectus  parrots 
(Eclectus roratus), budgerigar, Indian ringneck (Psittacula eupatria eupatria), 
Jardine’s  parrot  (Poicephalus  gulielmi),  green-cheeked  conure  (Pyrrhura 
molinae),  sun  conure  (Aratinga  solstitialis),  yellow-tailed  black  cockatoo 
(Calyptorynchus  funereus)    and  cockatiel.  After  DNA  was  extracted  as 
described below in Section 3.2.4, samples were stored at -20ºC for up to 5 
years. 
 
To validate the qPCR, the DNA extracts of 108 blood samples from eastern 
long-billed  corellas  vaccinated  with  a  recombinant  BFDV  capsid  protein 
(Bonne et al., 2008b, Stewart et al., 2007) and challenged with live virus were 68 
 
tested using the optimised qPCR assay. Crude DNA extracts from 108 feather 
eluates prepared for HA testing were also tested using the optimised qPCR 
assay. The vaccination trial was conducted in collaboration with Mr Nicolai 
Bonne.  Mr  Bonne  also  performed  the  HA  and  standard  PCR  assays,  the 
results of which were used in the validation of the qPCR assay. 
 
Blood was collected by venepuncture of the jugular or cutaneous ulnar vein 
and spotted onto filter paper (Whatmann Grade No. 3), then allowed to dry at 
room  temperature  as  described  by  Riddoch  et  al.  (1996).  Feathers  were 
plucked and placed into clean 1.5 mL microcentrifuge tubes or zip-lock bags. 
 
3.2.3 Birds and vaccination 
Nestling galahs and eastern long-billed corellas were provided by the Western 
Australian  Department  of  Environment  and  Conservation  (DEC).  Nestlings 
were  removed  from  the  nesting  sites  of  Carnaby’s  white-tailed  black 
cockatoos  (Calyptorhynchus  latirostris)  as  part  of  an  existing  conservation 
program.  Nestlings  were  kept  in  sibling  groups,  housed  in  temperature-
controlled incubators (Brinsea)  and  fed  a  commercial  hand-rearing  formula 
(Roudybush). Blood samples were collected as described above in Section 
3.2.2 on presentation and at weekly intervals thereafter until the vaccine trial 
started.  Mr  Nicolai  Bonne  performed  PCR  and  HI  assays  on  the  initial 
samples and PCR assays on the subsequent samples. Birds were considered 
BFDV-free if they tested negative on presentation and at three consecutive 
time points thereafter. When birds were being weaned they were transferred 
to individual wire cages in a separate room, then transferred to a free-flight 69 
 
area within that room once weaned. After weaning, the birds were maintained 
on a diet of commercial parrot pellets (Passwell, Wombaroo) and fresh fruit 
and  vegetables.  Strict  quarantine  was  maintained  during  hand  rearing, 
weaning and vaccination. 
 
The recombinant protein was expressed and purified as described by Stewart 
et  al.  (2007)  and  below  in  Section  5.2.2.  Vaccination  and  challenge  were 
conducted  as  described  by  Bonne  et  al.  (2008b).  Briefly,  the  vaccine  was 
prepared by emulsifying equal volumes of the recombinant protein solution 
with  Freund’s  incomplete  adjuvant  (Sigma  Aldrich)  prior  to  administration. 
Vaccinated  birds  (n  =  15)  received  10  µg  of  the  recombinant  protein  by 
intramuscular (IM) injection on day 0 of the trial, followed by 66.8 µg of the 
protein  on  day  11.  Non-vaccinated  birds  (n=5)  received  no  inoculum.  Mr 
Nicolai Bonne administered a challenge dose of 0.5 mL of live BFDV to all 
birds on day 27. Birds received 0.4 mL of virus suspension IM and 0.1 mL per 
os (PO). The virus suspension used for challenge was originally prepared by 
Associate Professor Shane Raidal (Raidal et al., 1993a) and had been stored 
at -20ºC for 13 years. The HA titre of the suspension was determined by Mr 
Nicolai Bonne to be log212 HAU/50 µL. Feathers and blood were collected on 
days 0, 11, 27, 40, 47, 53, 68 and 124 as described above in Section 3.2.2 
and processed as described below in Sections 3.2.4 and 3.2.5, respectively. 
 
3.2.4 Extraction of DNA from feathers 
Viral  DNA  was  extracted  from  feathers  using  the  methods  described  by 
Ypelaar et al. (1999). Five millimetres of feather calamus were aseptically cut 70 
 
and placed into a microcentrifuge tube (Eppendorf). To this, 200 µL of 70% 
(v/v) ethanol were added and the tube vortexed briefly, then the ethanol was 
removed and 200 µL of sterile distilled water were added and the tube again 
vortexed. The sterile water was removed and 500 µL of lysis buffer [50 mM 
KCl,  10  mM  Tris-HCl  (pH  8.0),  2.5  mM  MgCl2,  0.005%  (v/v)  Tween  20, 
0.005% (v/v) Nonidet P40], containing 250 µg/mL proteinase K (Qiagen) were 
added. The feather in lysis buffer was incubated at 37ºC for one to two hours, 
before being heated to 95ºC for 10 minutes. The solution was centrifuged and 
DNA  was  extracted  from  the  supernatant  with  the  Qiagen  blood  mini  kit 
(Qiagen), using the blood and body fluid spin protocol. 
 
Crude DNA extracts were also made using feather eluates prepared for HA 
testing.  Feathers  were  incubated  with  100  µL  phosphate  buffered  saline 
(PBS) at 60ºC for 1 hour in a microcentrifuge tube (Eppendorf). The solution 
was  centrifuged  briefly  after  incubation  and  10  µL  of  the  supernatant 
transferred to another microcentrifuge tube and then boiled at 100ºC for 10 
minutes. 
 
3.2.5 Extraction of DNA from dried blood spots: 
Viral DNA was extracted from dried blood spots with the Qiagen blood mini kit 
(Qiagen), using a modified dried blood spot protocol. Three spots of blood, 
each approximately 5mm in diameter, that had been applied to and dried on 
filter paper, were cut out using scissors or a hole punch and collected in a 
microcentrifuge  tube  (Eppendorf).  Scissors  and  hole  punches  were 
disinfected between samples using the methods described by Bonne et al. 71 
 
(2008a). 180 µL of lysis buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.0, 2.5 mM 
MgCl2,  0.005%  (v/v) Tween  20,  0.005%  (v/v)  Nonidet  P40)  were  added in 
place  of  the  Qiagen  lysis  buffer  and  the  tube  incubated  at  85ºC  for  10 
minutes, then centrifuged. Twenty microlitres of proteinase K (Qiagen) were 
then added to the tube, the tube vortexed and then incubated at 56ºC for 1 
hour. After incubation, the solution was centrifuged and DNA extracted from 
the supernatant according to the manufacturer’s protocol. 
 
3.2.6 Quantitative, real-time polymerase chain reaction assay 
Primers  were  designed  based  on  conserved  regions  of  known  BFDV 
sequences  (Kumar  et  al.,  2004,  Wishart  and  Fortin,  2001,  Wishart  et  al., 
2000). Primers P5 and P6 (Table 3.1) (Geneworks) were designed to amplify 
an  81bp  fragment  of  ORF  V1.  Magnesium  chloride  concentrations  and 
annealing  temperatures  were  optimised  using  an  Eppendorf  Mastercycler 
Gradient thermocycler (Eppendorf). The optimised PCR reactions consisted of 
2  mM  MgCl2,  5  µL  of  5x  polymerisation  buffer  containing  mixed 
deoxynucleotide  triphosphates  (dNTPs),  3.34  µM  SYTO9  fluorescent  dye 
(Invitrogen), 12.8 pmol of each primer and 0.1 U of Tth Plus DNA polymerase, 
ultrapure water in a total volume of 23 µL (all reagents Fischer Biotec, except 
SYTO9), plus 2 µL of extracted DNA. Known-copy-number DNA standards 
were included in each run for quantitation of viral load. 
 
Known-copy-number  DNA  standards  were  generated  using  sequential 
dilutions of a synthetic oligonucleotide, BFDV qST (Table 3.1) (Geneworks). 
The oligonucleotide was diluted to an initial concentration of 1x10
12 copies/µL 72 
 










2 and the 1x10
2 standard diluted 1:2 to give a standard of 
50 copies/µL. Two reactions using ultrapure water instead of DNA were used 
as negative controls in each run. 
 
 
Table 3.1: Oligonucleotides used for the quantitative, real-time PCR. 
 
Primer ID  Sequence  Position 
Real P5  5’ GGA CGC AAA ATG AAG GAA G 3’  491-509 
Real P6  5’ TAG CGA GAG GTT ATG CAA GC 3’  552-571 
BFDV qST  5’ ATG TCC GGA CGC AAA ATG AAG 
GAA  GTC  GCA  GCT  GAA  TTC  CGA 
AAT  TCC  TAC  GTC  AGG  CAT  GGG 
CGT GGC TTG CAT AAC CTC TCG CTA 




Reactions were carried out in a Corbett Rotor-gene 3000 (Corbett Research) 
real-time thermocycler. Cycling conditions are outlined in Table 3.2. 
 
 
Table 3.2: Cycling conditions used for the quantitative, real-time PCR. 
 
Step  Temperature (ºC)  Time (s)  Cycles 
1  95  5 min   
2  95  20   
3  58  30  40 
4  72  20   
5  72  10 min   
6  15     
 
 
3.2.7 Melt curve analysis 
A melt curve analysis was performed after each run, with the mixture being 
cooled to 60ºC for 45 seconds then heated in one-degree increments to 95ºC. 
Fluorescence was measured for 15 seconds at each increment and a graph 
plotting  the  second  derivative  of  the  melt  curve  displayed.  The  expected 73 
 
melting temperatures of the PCR products were between 80ºC and 85ºC; the 
melting temperature of the synthetic oligonucleotide was 82.3ºC. 
 
3.2.8 Quantitation of viral load 
The threshold cycle (CT) values of the known-copy-number standards were 
graphed  against  time  to  construct  a  standard  curve  using  the  software 
supplied  with  the  Rotor-Gene.  The  CT  of  each  of  the  samples  was  then 
compared against the graph to give an estimate of viral load. 
 
3.2.9 Statistical analysis 
Calculation of r-squared values of standard curves was performed using the 
software  supplied  with  the  Rotor-Gene.  Calculation  of  the  coefficient  of 
variation of the standards, the standard error of groups of replicates and the 
sensitivity, specificity and positive and negative predictive values of the assay  
(Jacobson,  2004)  was  performed  using  Microsoft  Excel.  Calculation  of  the 
lines of best fit and the correlation between blood and feather viral loads was 
performed using CoPlot (CoHort Software, 2005). 
 
3.3 Results 
3.3.1 A quantitative polymerase chain assay for BFDV DNA 
The qPCR assay successfully detected BFDV DNA in the DNA extracts of all 
known positive samples from all psittacine species tested. Negative control 
samples were consistently negative. 
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The assay successfully detected BFDV DNA in the blood of all control (non-
vaccinated)  corellas  (Figure  3.1a).  In non-vaccinated  control  birds  the  viral 
load ± SE was estimated at 1,358,473 ± 1,113,226 copies/µL (range 14,478 to 
5,768,973  copies/µL)  at  2  weeks  post  challenge  and  rose  to  a  peak  of 
4,850,482 ± 4,775,008 copies/µL (range 1,709 and 23,949,983 copies/µL) by 
4  weeks  post  challenge  before  dropping  to  575,486  ±  551,069  copies/µL 
(range 823 and 2,779,419 copies/µL) at 6 weeks post challenge. Transient 
low-level  viraemia  of  between  58  and  4,057  copies/µL  was  detected  in  6 
vaccinated birds at various time points, but all birds were seropositive at the 
times when viral DNA was present in blood samples. The viral load in blood 
samples  of  vaccinated  birds  followed  a  similar  pattern  to  that  of  the  non-
vaccinated  control  birds,  with  mean  viral  loads  increasing  in  a  curvilinear 
fashion from 58 copies/µL at 2 weeks post challenge to a peak of 1,177 ± 723 
copies/µL (range 209 to 4,057 copies/µL) by 6 weeks post challenge (Figure 
3.1a).  Specific  peaks  were  present  in  the  melt  curves  of  BFDV-positive 
samples between 82 – 84.5ºC. 
 
Intra-assay precision was good, with r-squared values for the standard curves 
achieving values between 0.92693 and 0.97477. Inter-assay variation of the 
standards was only fair, as the mean coefficient of variation of the standards 
was  37.16%.  The limit  of  detection  (LOD)  of  the  assay  was  50  copies/µL, 
however the effective limit of quantitation (LOQ) was 1,000 copies/µL, as the 
coefficient of variation of the 10
3 and 10
2 standards was close to 100% and as 
such  was  considered  too  high.  Even  though  the  qPCR  assay  successfully 
detected as few as 50 copies/µL of the standard, calculated quantities for the 




Figure 3.1: Viral load in A: blood and B: feather preparations of control (□) and vaccinated 
birds (▲) after challenge with live beak and feather disease virus (BFDV). Peak viral load was 




The assay also detected BFDV DNA in the crude DNA extracts of HA feather 
preparations (Figure 3.1b). The mean viral load ± SE in feather extracts of 
control birds was estimated at 8,831 ± 4,662 (range 262 to 20,639 copies/µL) 
at  2  weeks  post  challenge,  rose  to  a  peak  of  852,500,308  ±  681,941,583 
copies/µL  (range  2,591  to  3,409,766,576  copies/µL)  at  4  weeks  post-
challenge, then decreased to 380,734,071 ± 380,729,701 copies/µL (range 
430  to  1,903,652,876  copies/µL)  by  6  weeks  post  challenge.  Virus  was 
detectable by HA in the feather samples of only one control bird at 4 and 6 
weeks  post  challenge,  which  were  also  the  samples  that  had  the  greatest 
amount of viral DNA present. 
 
Viral  DNA  was  detected  in  the  feather  extracts  of  3  vaccinated  birds  at  2 
weeks post-challenge, 6 vaccinated birds at 4 weeks post-challenge and 10 
vaccinated birds at 6 weeks post-challenge. However, none of these 3 birds 76 
 
had detectable viral DNA in the equivalent blood sample at 2 weeks post-
challenge. At 4 and 6 weeks post challenge, only 1 of 6 and 4 of 10 birds 
respectively  had  detectable  amounts  of  viral  DNA  in  the  equivalent  blood 
sample  (between  193  and  420,451  copies/µL).  The  samples  which  were 
positive  on  qPCR  of  feather  extracts  but  negative  on  blood  samples  were 
considered false positives. Correlation of viral load between blood and feather 
samples was moderate (r
2 = 0.7465, p<0.05) at 2 weeks post challenge and 
very high (r
2 = 0.9999) at 4 weeks post challenge, but there was no significant 
correlation  at  3  and  6  weeks  post  challenge  (r
2  =  0.0048  and  0.0027, 







Figure 3.2: Correlation between blood and feather viral loads of both vaccinated and control 
birds. A: 2 weeks post-challenge, B: 3 weeks post challenge, C: 4 weeks post challenge, D: 6 
weeks post challenge. Values were highly correlated at 4 weeks post challenge, but did not 
correlate at 3 and 6 weeks post challenge. 
 
 
Two  sets  of  comparisons  were  made  for  the  calculation  of  sensitivity  and 
specificity.  Firstly,  similar  tests  were  compared.  For  blood  samples,  the 
standard PCR assay was considered the gold standard assay and was used 
for comparison with the results of the qPCR assay using blood samples. For 
feather eluates, the HA assay was considered the gold standard assay and 
was  used  for  comparison  with  the  results  of  the  qPCR  assay  using  HA 
samples.  Sensitivity  was  94.73%  and  specificity  87.61%,  with  positive  and 
negative predictive values of 56.25% and 99% respectively, when the qPCR 78 
 
using blood samples was compared to the standard PCR (also performed on 
blood samples). When comparing the qPCR using HA samples to HA test 
results, sensitivity was 100% and specificity 65.42%, the positive predictive 
value  dropped  to  5.13%  and  the  negative  predictive  value  was  100%. 
Secondly, dissimilar tests were compared (standard PCR with qPCR using 
HA  samples  and  HA  with  qPCR  using  blood  samples).  Comparing  qPCR 
results from blood samples to HA results gave a sensitivity and specificity of 
100%  and  71.43%,  respectively,  while  comparing  qPCR  results  from  HA 
samples  with  standard  PCR  results  gave  a  sensitivity  and  specificity  of 
72.22% and 61.43%, respectively. 
 
3.4 Discussion 
Given the high prevalence of BFDV infection worldwide, sensitive and specific 
detection methods which use standard methods and consistent reagents are 
both highly desirable and necessary. The qPCR assay described here has a 
very low limit of detection and can be used to quantify the amount of virus 
present in the blood and in feather preparations. As such, it should prove a 
useful  assay  for  the  detection  of  viral  DNA  in  samples  of  blood,  tissues, 
feathers and faeces. Only one other real-time PCR assay for BFDV has been 
described (Raue et al., 2004). This assay was not quantitative and tested only 
31 samples. However it could easily be modified to a quantitative assay using 




Although it is well accepted that qPCR assays have a much greater analytical 
sensitivity  than  standard  PCR  (Mackay,  2004, Wong  and  Medrano,  2005), 
currently the standard PCR assay is the gold standard for the detection of 
BFDV  nucleic  acid  and  hence  the  comparative  diagnostic  sensitivity  and 
specificity were determined. The analytical sensitivity of the qPCR assay was 
greater than that of the standard PCR assay, as it detected viral DNA in the 
blood of control birds that were negative by standard PCR assay. However, 
because  of  this  fact  the  analytical  sensitivity  could  not  be  determined 
precisely. Importantly, in this study it was impossible to differentiate between 
true positive results below the limit of detection of the HA and standard PCR 
assays  and  false  positive  results.  In  this  study,  the  effect  is  likely  to  be 
minimal since there was accurate information on the infection status of the 
birds. Ongoing comparisons between the qPCR assay and existing assays 
using birds of known infection status will still be necessary to elucidate the 
true analytical sensitivity and specificity. 
 
The  comparative  diagnostic  sensitivity  and  specificity  was  good,  however 
because  of  the  greater  analytical  sensitivity  of  the  qPCR,  the  absolute 
diagnostic sensitivity and specificity is likely to be higher. Given the calculated 
diagnostic sensitivity, 542 samples would be required to validate the assay 
with 95% confidence of an accurate result (Jacobson, 1998). Assuming the 
highest  calculated  diagnostic  specificity  of  88%,  the  number  of  known 
negative animals required is 1,014. Only 166 samples  were available from 
birds  of  known  infection  status  and  even  though  the  actual  diagnostic 80 
 
sensitivity is likely to be higher (and hence less samples required) ongoing 
testing is always recommended (Belak and Thoren, 2004, Jacobson, 2004). 
 
The precision and repeatability of the assay are within values accepted by the 
OIE (Jacobson, 1998); reproducibility could not be assessed since testing in 
other laboratories was impractical. Negative predictive values were uniformly 
high  and  the  low  positive  predictive  value  when  comparing  the  PCR  and 
qPCR  assays  on  blood  samples  is  likely  to  be  a  result  of  the  increased 
sensitivity of the assay. The effect of false positive results cannot be ignored, 
however, but remains to be elucidated. When comparing the HA assay with 
qPCR  assay  performed  on  feather  samples,  the  extremely  low  positive 
predictive  value  reflects  the  large  number  of  false  positives  as  a  result  of 
environmental contamination. Given the high prevalence of BFDV, the assay 
should be useful for testing samples from naturally infected birds, appropriate 
samples are collected and properly stored and processed. 
 
The  advantage  of  the  qPCR  assay  over  non-quantitative  methods  for  the 
detection of viral DNA is highlighted in this study and the vaccination trial of 
which it is a part. Not only did the qPCR assay detect viral DNA in birds that 
tested  negative  by  the  standard  PCR  (Bonne  et  al.,  2008b),  but  it 
demonstrated  that  the  viral  load  in  both  vaccinated  and  control  birds 
increased  for  the  first  4  weeks  after  challenge.  That  this  occurred  despite 
vaccinated  birds  having  anti-BFDV  antibodies  before  being  challenged 
(Bonne et al., 2008b, Shearer et al., 2009) indicates that vaccination does not 
prevent  viral  replication.  This  is  a  common  scenario  with  other  vaccines 81 
 
(Opriessnig et al., 2006c) and is not surprising in this case. This evidence of 
viral replication would not have been detected if a standard PCR assay alone 
had been used. Given that vaccination does not prevent viral replication, it is 
likely that the chicks of vaccinated birds may still be vertically infected despite 
the  presence  of  antibodies  in  the  parents, as  occurs  with  PCV2  and  CAV 
(Brentano et al., 2005, Larochelle et al., 2000). If this does occur, the clinical 
and molecular significance of such infections and the impact of this mode of 
transmission  on  quarantine  and  hygiene  programs  would  need  to  be 
thoroughly investigated. Prevention of vertical infection would be an important 
measure  in  reducing  the  incidence  of  PBFD  and  consequent  secondary 
infections over a bird’s lifespan. This information would also be most valuable 
for the management of conservation programs for endangered psittacine birds 
and non-endangered captive flocks alike. Of course, maternal antibody levels 
will wane soon after hatching and so horizontal infection is still probably the 
primary route of infection.  
 
The main advantages that this qPCR assay has over existing PCR assays are 
the ability to estimate the amount of pathogen present in the sample and that 
post-reaction  processing  is  not  required  to  visualise  reaction  products.  An 
absolute method of quantitation was selected for this assay, as it was useful 
to assign a set quantity to measurements. Notably, though, no quantitation 
method is foolproof and both absolute and relative quantitation methods are 
both legitimate, provided that the assay itself is properly validated. Peirson et 
al (2003) found that results using the two absolute and three relative methods 
of quantitation they evaluated compared very favourably. Relative quantitation 82 
 
methods have the distinct advantage over absolute quantitation methods in 
that  artificial  standards  are  not  required;  the  cumulative  error  induced  by 
spectrophotometry,  molecular  weight  calculations  and  pipetting  errors  can 
make calculations of absolute copy numbers  meaningless. This cumulative 
error is likely responsible for the moderate inter-assay coefficient of variation. 
 
Provided  that  this  variation  is  minimised  and  the  assay  properly  validated, 
absolute  quantitation  can  provide  results  in  units  (usually  copies/µL  or 
genome  equivalents)  that  are  common  to  both  scientists  and  clinicians 
(Mackay et al., 2002). The preparation of a “master batch” of standards and 
storage of these in pre-measured aliquots would likely go a long way to further 
ensuring consistency in this and other similar assays. In this assay, as few as 
50 copies/µL could be detected, similar to the assay described by Raue et al 
(2004),  however  the  actual  LOD  in  that  assay  is  unknown  as  the  authors 
relied on dilution factors rather than quantitative data. The LOQ of this assay 
was  determined  to  be  1,000  copies/µL.  The  distinction  between  LOD  and 
LOQ is important, as clinical interpretations made from samples with positive 
results below the limit of quantitation may be inaccurate. 
 
Many  qPCR  assays  normalise  the  data  from  the  target  gene  or  organism 
against one or more genomic controls (Hendriks-Balk et al., 2007). The data 
in this study were not normalised to a reference, or housekeeping, gene as 
candidate genes for normalisation of gene expression data in psittacine birds 
have not been evaluated. Normalisation is also more important when testing 
for cell-associated virus and this study was concerned with the detection of 83 
 
circulating  and  excreted  virus.  For  qPCR  assays  detecting  microbiological 
agents, unless the pathogen is being grown in cell culture the real value of 
normalisation  is  that  the  normalised  data  can  account  for  differences  in 
sample quantity and quality. Appropriate control genes for qPCR assays used 
to study BFDV will require studies to account for disease states, the tissue(s) 
sampled and the species of host psittacine (Li et al., 2005, Maccoux et al., 
2007,  Radonić  et  al.,  2005,  Robinson  et  al.,  2007,  Spinsanti  et  al.,  2006, 
Sturzenbaum and Kille, 2001, Tang et al., 2007, Tricarico et al., 2002). 
 
There have been surprisingly few studies investigating the suitability of avian 
reference genes (Li et al., 2005, Yamashita et al., 2007). As such, any BFDV 
qPCR assay that uses control genes for the normalisation of data should first 
thoroughly  investigate  the  variability  of  these  genes  in  the  various  tissues 
sampled  and  in  both  normal  and  BFDV-infected  birds.  The  evaluation  of 
suitable  reference  genes  for  use  in  this  assay  may  be  advantageous,  as 
feathers used for BFDV PCR assays typically vary in size and the quality of 
pulp  material  between  growing  and  mature  feathers  varies  dramatically.  In 
practice, however, as long as sample volumes are similar between assays the 
extra cost and complexity of data normalisation would probably outweigh the 
benefits. 
 
Because  of  the  high  degree  of  genetic  variation  between  BFDV  isolates 
(Bassami  et  al.,  2001,  de  Kloet  and  de  Kloet,  2004,  Heath  et  al.,  2004, 
Kondiah et al., 2006, Ritchie et al., 2003), intercalating dye chemistries are 
the  method  of  choice  for  the  detection  of  BFDV  DNA  in  quantitative  PCR 84 
 
assays. The dye SYTO9 was chosen for use in this assay in preference to 
SYBR  green,  as  the  melting  curves  are  highly reproducible  over  a greater 
range than with SYBR green, it has less of an inhibitory effect on the PCR 
reaction and does not appear to selectively detect particular amplicons (Monis 
et al., 2005). 
 
The qPCR assay described here has proven useful for the detection of BFDV 
DNA in blood samples, but the high sensitivity of the assay makes the use of 
HA feather preparations unreliable for the detection and quantitation of viral 
excretion. Firstly, as with HA testing, the difficulty in ensuring consistency in 
the amount of material tested makes standardisation problematic. Secondly, 
false positive results were reasonably common. The increased incidence of 
false positive results from feather preparations over time was almost certainly 
due  to  sample  contamination  via  aerosolised  feather  dander  and  faecal 
material. The shape of the graph of viral load in feather extracts of vaccinated 
birds  (Figure  3.1b)  is  similar  to  those  of  viral  load  in  blood  samples  of 
vaccinated  and  non-vaccinated  birds  (Figure  3.1a),  which  suggests  viral 
replication. However, this pattern more likely reflects the increased viral load 
in  the  environment  as  a  result  of  virus  excretion  by  non-vaccinated  birds. 
Although these results were accurate in that they detected the presence of the 
virus, they did not accurately represent the infection or health status of the 
birds and this is an important fact to remember when making a diagnosis of 
infection or disease using only the results of PCR-based assays. 
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Choanal/cloacal  swabs  will  most  likely  be  more  useful  than  feather 
suspensions for the detection and quantitation of excreted virus, but each new 
sample  type  should  be  properly  validated  before  use  in  routine  diagnostic 
testing (Hoorfar et al., 2004). Cloacal swabs have been found to be useful for 
the  detection  of  pigeon  circovirus  (Todd  et  al.,  2006),  however  no  firm 
conclusions on their usefulness can be drawn since the technique was not 
fully  validated.  Storage  of  swabs  will  be  important  if  environmental 
contamination is to be avoided; swabs which are left unshielded before and 
after sampling will likely come into contact with feather dander and/or faeces 
from BFDV-infected birds, thus rendering the test useless. 
 
Potential applications of this assay include the measurement of viral load in 
many tissues (including formalin-fixed, paraffin-embedded tissues) and from 
cloacal  swabs,  as  well  as  the  development  of  multiplexed  assays  for  the 
detection  of  common  psittacine  pathogens  (e.g.  Chlamydophila  psittaci, 
Macrorhabdos  ornithogaster  and  avian  polyomavirus).  The  development  of 
quantitative multiplex PCR assays that include the quantitation of BFDV DNA 
should first thoroughly evaluate the effect of primer and probe mismatches 
due to the variability of the BFDV genome. Alternately, a qualitative (quantal) 
multiplex assay could be developed more simply using an intercalating dye, in 
which the presence of the pathogen(s) is indicated by the melting peaks of the 
PCR product. A good example of a similar technique is the development of a 
standard multiplex PCR for the detection of PiCV, pigeon herpesvirus (PiHV) 
and fowl adenovirus (FAdV) causing young pigeon disease syndrome (YPDS) 
(Freick  et al.,  2008).  Furthermore,  if infectivity  bioassays  are  conducted to 86 
 
determine  the  ID50  of  BFDV  and  the  proportion  of  detected  virus  that  is 
infectious, as has been done for HIV-1 (Coombs et al., 1993, Rusert et al., 
2004),  then  the  qPCR  assay  could  be  used  to  determine  the  amount  of 
infectious virus in a sample. 
 
At  present,  the  haemagglutination  and  haemagglutination-inhibition  assays 
are commonly used for the detection of virus shed from feathers or faeces 
and  anti-BFDV  antibodies  in  psittacine  sera,  respectively.  They  require 
erythrocytes from live animals and virus purified from the feathers of infected 
birds. Polyclonal antibody preparations and variations in these reagents make 
consistency  between  tests  difficult  to  achieve.  Consequently,  most 
laboratories rely on PCR-based assays to test for the presence of viral DNA in 
blood, faeces or feathers, but the lack of consistent and reliable assays for 
serology and the detection of excreted virus is a problem. PCR assays can 
also vary in sensitivity and specificity between laboratories (East et al., 2004) 
and  are  susceptible  to  contamination  (Bonne  et  al.,  2008a)  and  inhibition 
(Knutsson et al., 2004). Variation in erythrocyte sensitivities between avian 
species and individual birds (Sanada and Sanada, 2000, Sexton et al., 1994) 
has  been  cited  as  a  problem  in  the  standardisation  of  HA  and  HI  assays 
(Johne  et  al.,  2004).  However,  in  regards  to  PCR  assays,  poor  sample 
collection  and  quality,  inter-laboratory  variation,  improper  attention  to  the 
prevention of contamination and assay-based factors (such as pipetting error, 
reagent  quality  and  the  presence  of  inhibitors)  can  also  introduce 
unacceptable levels of variation and render a test diagnostically and clinically 87 
 
useless.  The  susceptibility  to  contamination  of  such  sensitive  assays  is 
highlighted in this study. 
 
Reliance  on  PCR-based  diagnostic  tests  can  also  lead  to  false  clinical 
assumptions since the presence of viral DNA does not necessarily indicate 
active  infection.  Non-replicating  DNA,  present  as  either  neutralised  viral 
particles or free genomic DNA,  may be present in blood for up to 3 months 
(Lazizi and Pillot, 1993) and whole dead bacteria may continue to be excreted 
for  15  days  after  successful  therapy  (Gaydos  et  al.,  1998).  Additionally, 
seropositive birds may still be PCR positive whilst they are clearing the virus 
(Khalesi et al., 2005) and testing of these birds by PCR alone would miss this 
important  piece  of  information.  Nonetheless,  provided  these  factors  are 
considered, the qPCR assay described here should prove to be a sensitive, 
specific and accurate diagnostic tool for the detection and characterisation of 
BFDV infection. 88 
 
Chapter 4. Beak and Feather Disease Virus (BFDV) 
Infection in Cockatiels (Nymphicus hollandicus)  
 
 
4.1 Introduction and Aims 
4.1.1 Introduction 
Beak and feather disease virus (BFDV) is the most common viral infection of 
psittacine birds and the chronic debilitating feather disease that it causes has 
been confirmed in more than 60 psittacine species. Thus all psittacine birds 
are highly likely to be susceptible (Albertyn et al., 2004, Pass and Perry, 1985, 
Rahaus and Wolff, 2003, Ritchie et al., 1989b, Tomasek and Tukac, 2007). 
Surveys have been carried out in both wild and captive psittacine populations 
and reported virus prevalence rates vary between 10-94%, depending on the 
method of detection (Ha et al., 2007, Khalesi et al., 2005, McOrist et al., 1984, 
Rahaus  and  Wolff,  2003,  Raidal  et  al.,  1993b).  Given  the  wide  range  of 
Psittaciforme species reported to be susceptible, it is curious that the cockatiel 
is greatly underrepresented in both the scientific and lay literature. Indeed we 
know of no published reports of PBFD in cockatiels even though the species 
is  one  of  the  most  commonly  kept  companion  bird  species  worldwide.  It 
seems the only evidence of BFDV infection occurring in the cockatiel was a 
diagnosis made by polymerase chain reaction (PCR) in our own laboratory 
(Khalesi et al., 2005). 
 
In order to investigate the apparently low rate of BFDV infection in cockatiels 
a survey of cockatiels at 3 commercial aviaries in Perth, Western Australia 
was conducted using PCR, as well as HA and HI assays. In addition, BFDV 89 
 
DNA  samples  from  the  feathers  of  2  cockatiels  submitted  to  us  for  BFDV 
diagnostic testing were amplified by PCR, sequenced and analysed. 
 
4.1.2 Aims 
This  experiment  aimed  to  determine  whether  cockatiels  are  susceptible  to 
BFDV  infection.  If  cockatiels  were  found  to  be  susceptible  to  infection  by 
BFDV,  the  additional  aims  of  this  experiment  were  to  determine  the 
prevalence  of infected  birds  and  to  assess  the  differences  between  BFDV 
isolates from cockatiels and other psittacine species. 
 
4.2 Materials and Methods  
4.2.1 Experimental design 
When  investigating  the  existence  and  prevalence  of  BFDV  infection  in 
cockatiels, the identity of individual birds was the independent variable and 
the  assay  (HI,  HA  or  PCR)  result  was  the  dependent  variable.  When 
conducting  cross-reactivity  assays,  the  source  of  the  antibodies  and  the 
antigen were the independent variables and the HI titre was the dependent 
variable.  In  the  analysis  of  the  nucleotide  sequences  of  the  PCR-positive 
cockatiels, the identity of the individual bird was the independent variable and 
the sequence length and characteristics were the dependent variables. For 
the comparison of the BFDV sequences from the cockatiels with the BFDV 
sequences from other psittacine birds, the bird species was the independent 
variable and the CpG density, pairwise distances (nucleotide and amino acid) 
and phylogenetic grouping, bootstrap support and posterior probability were 




A survey of cockatiels in commercial aviaries was also conducted. Blood and 
feathers from 88 cockatiels at three commercial aviaries that had a laboratory 
confirmed history of housing PBFD-affected psittacine birds were taken for 
testing. Samples were collected as described in Section 3.2.2. 
 
Feathers  from  two  additional  cockatiels  (isolates  05-106  and  05-726)  with 
characteristic skin lesions consistent with PBFD and that had tested BFDV-
positive by PCR and HA were used for subsequent PCR analysis and DNA 
sequencing as described below. A formalin-fixed feather follicle skin biopsy, 
submitted along with the feather of 05-106, was also processed by routine 
histology  methods,  stained  with  haematoxylin  and  eosin  and  examined  by 
light microscopy for the presence of characteristic inclusion bodies (Fig 5.1a) 
and BFDV infection was confirmed by IHC (Fig 5.1b) as described below. 
 
4.2.2 Immunohistochemical (IHC) staining 
Immunohistochemistry was performed on tissue sections from case 05-106 as 
described in Section 5.2.5.4, except that antigen retrieval was not carried out 
and the monoclonal antibody was used at the optimal 1:500 dilution in TBS. 
 
4.2.3 Extraction of DNA from feathers 
Viral DNA was extracted from feathers of the two cockatiels 05-106 and 05-
726 using the methods described by Ypelaar et al. (1999). Five millimetres of 
feather calamus were aseptically cut and placed into a microcentrifuge tube 91 
 
(Eppendorf). To this, 200 µL of 70% (v/v) ethanol were added and the tube 
briefly  vortexed.  The  ethanol  was  then  removed,  200  µL  of  sterile distilled 
water added and the tube vortexed again. The sterile water was removed and 
500 µL of lysis buffer [50 mM KCl, 10 mM Tris-HCl (pH 8.0), 2.5 mM MgCl2, 
0.005%  (v/v)  Tween  20,  0.005%  (v/v)  Nonidet  P40],  containing  250  µg/ml 
proteinase K (Qiagen) were added. The feather in lysis buffer was incubated 
at 37ºC for one to two hours, before being heated to 95ºC for 10 minutes. The 
solution was centrifuged and DNA was extracted from the supernatant with 
the  Qiagen  blood  mini  kit  (Qiagen),  using  the  blood  and  body  fluid  spin 
protocol. 
 
4.2.4 Polymerase chain reaction 
Polymerase  chain  reaction  was  carried  out using  methods  similar  to those 
described by Ypelaar et al. (1999). Primers P2 and P4 (Table 4.1) amplify a 
717 bp fragment of ORF V1 of BFDV DNA and were used to test the surveyed 
cockatiels. Cockatiels 05-106 and 05-726 had previously tested positive for 
BFDV DNA using these two primers. Primers SeqP5 and SeqP10 (Table 4.1) 
were designed to amplify a 1479 bp fragment, the ends of which overlapped 
with the fragment generated by primers P2 and P4. Cockatiels 05-106 and 05-
726  were  tested  using  both  primer  sets;  the  two  overlapping  amplicons 
included the entire BFDV genome and were used in subsequent sequencing 
reactions.  The  PCR  reaction  consisted  of  2  mM  MgCl2,  5  µL  of  5x 
polymerisation buffer containing dNTPs, 12.8 pmol of each primer, 0.1 U of 
Tth-Plus  DNA  polymerase  and  made  to  a  total  volume  of  25  µL  using 
ultrapure water (all reagents Fischer Biotec). Reactions were carried out in an 92 
 
Eppendorf  Mastercycler  Gradient  thermocycler  (Eppendorf).  The  PCR 
reaction using primers SeqP5 and SeqP10 was identical, except that 3 mM 
MgCl2 was used and the annealing temperature was lowered to 48ºC. Cycling 
conditions are outlined in Table 4.2. PCR products were visualised on a 1% 




Table 4.1: Primers used for the amplification and sequencing of Beak and Feather Disease 
Virus DNA isolated from cockatiels. 
 
Primer ID  Sequence  Position 
P2 (forward)  5’ AAC CCT ACA GAC GGC GAG 3’  182-199 
P4 (reverse)  5’ GTC ACA GTC CTC CTT GTA CC 3’  879-898 
Seq P5 (forward)  5’ CTG CGA CCG TTA CCC ACA TA 3’  781-800 
Seq P10 (reverse)  5’ TCG CCC TTT TCC CGT CCA AC 3’  248-267 
 
 
Table.4.2: Cycling conditions used for the amplification and sequencing of Beak and Feather 
Disease Virus DNA isolated from cockatiels. 
 
Step  Temperature (ºC)  Time (s)  Cycles 
1  95  5 min   
2  95  30   
3  60 (P2P4)/ 
48 (SeqP5SeqP10) 
30  35 
4  72  90   
5  72  10 min   
6  15     
 
 
4.2.5 Haemagglutination (HA) assay 
Haemagglutination  assays  were  carried  out  as  described  by  Raidal  et  al. 
(1993c). Feathers were incubated with 100 µL PBS at 60ºC for 1 hour in a 
microcentrifuge  tube  (Eppendorf).  The  suspension  was  centrifuged  briefly 
after incubation and 50 µL of the supernatant were added to 50 µL PBS in a 
microtitre  plate  (Eppendorf).  Serial  dilutions  of  the  solution  were  made  by 
removing 50 µL of the solution from the first well, mixing with 50 µL PBS in the 93 
 
next  well and repeating the process across the row of the microtitre plate. 
Negative and positive control lanes were included for each batch of samples 
tested. The negative control consisted of PBS only and the positive control 
was a 50 µL suspension of virus purified from feathers and organs of a BFDV-
infected sulphur-crested cockatoo, diluted to give a HA titre of 4-8 HAU/50 µL. 
To each well 50 µL of a 0.75-0.85% (v/v) solution of type A galah erythrocytes 
were  then  added  and  the  microtitre  plate incubated  for  1  hour  at  37ºC.  A 
positive HA titre was indicated by suspension of the erythrocytes in the well of 
the  microtitre  plate,  whereas  a  negative  HA  result  was  indicated  by  the 
sedimentation of erythrocytes within the well. 
 
4.2.6 Haemagglutination-inhibition (HI) assays 
Haemagglutination-inhibition assays were carried out as described by Raidal 
et al. (1993c). The antigen preparation consisted of virus purified from the 
feathers of a sulphur-crested cockatoo with PBFD, diluted to give a HA titre of 
4-8 HAU/50 µL. Plasma, serum or dried blood spots on filter paper were used 
for testing. Plasma or serum was first heat-inactivated at 57ºC for 30 minutes, 
then 100 µL serum were added to 1 mL of 5% (w/v) acid-washed kaolin and 
the mixture incubated for 1 hour at room temperature, or overnight at 4ºC. 
Equal volumes of the supernatant were then haemadsorbed against a 10% 
(v/v) suspension of normal (non-haemagglutinating) galah erythrocytes for 18 
hours at 4ºC.  
 
For blood collected onto filter paper one 0.5 cm diameter spot of blood on 
filter paper was cut out using scissors or a hole punch and collected into a 94 
 
microcentrifuge tube (Eppendorf). One hundred microlitres of 5% (w/v) acid-
washed kaolin were added and serum eluted from the paper by incubating the 
mixture for 1 hour at room temperature, or overnight at 4ºC. Then 50 µL of the 
supernatant were haemadsorbed against 50 µL of a 10% (v/v) suspension of 
normal (non-haemagglutinating) galah erythrocytes for 18 hours at 4ºC. 
 
For testing, 50 µL of haemadsorbed serum were added to 50 µL PBS in a 
microtitre plate well (Eppendorf). Serial dilutions of the solution were made by 
removing 50 µL of the solution from the first well, mixing with 50 µL PBS in the 
next  well and repeating the process across the row of the microtitre plate. 
Negative and positive control lanes were included for each batch of samples 
tested. The negative control was a 50 µL suspension of purified virus, diluted 
to give a HA titre of 4-8 HAU/50 µL. The positive control was a serial dilution 
of  50  µL  of  chicken  anti-BFDV  polyclonal  sera,  processed  as  above.  A 
positive HI titre was indicated by the sedimentation of the erythrocytes within 
the well of the microtitre plate, whereas a negative HI result was indicated by 
the suspension of the erythrocytes in the well. 
 
4.2.7 Cross-reactivity assays 
An  additional  set  of  HI  assays  was  performed  to  investigate  the  possible 
existence of a cockatiel-specific BFDV serotype. HI assays were performed 
by  Mrs  Margaret  Sharp  as  described  above,  except  that  the  antigen  and 
negative  control  was  virus  eluted  from  the  feather  of  a  cockatiel  that  had 
tested positive for BFDV by PCR and HA. Sera from seven different psittacine 
species including two  short-billed  corellas, a  sulphur-crested  cockatoo,  two 95 
 
rainbow lorikeets, one long-billed corella, one red lory and one galah–corella 
hybrid with known HI titres were reacted against virus eluted from cockatiels 
05-106  and  05-726.  Sera  from  all  cockatiels  sampled  at  the  commercial 
aviaries were tested against BFDV eluted from the feather of cockatiel 05-106 
and  the  polyclonal  anti-BFDV  used  as  a  positive  control  was  also  tested 
against a more dilute (2 HAU/50 µL) sample of the same virus. 
 
4.2.8 Nucleotide sequence determination and analysis 
PCR  products  were  purified  using  an  Axyprep  PCR  cleanup  kit  (Axygen), 
according to the manufacturer’s instructions. Dideoxynucleotide sequencing 
was carried out using an ABI Prism Dye Terminator Cycle Sequencing Kit 
(Applied Biosystems) according to the manufacturer’s instructions, except that 
the  reaction  volume  was  reduced  to  10  µL and  the  annealing  temperature 
used  when  sequencing  the  1478  bp  products  was  reduced  to  50ºC. 
Sequencing reactions consisted of 2 µL of reaction buffer (containing Tris-
HCl,  MgCl2,  fluorescently-labelled  dNTPs  and  AmpliTaq  DNA  polymerase, 
concentrations  not  supplied;  Perkin  Elmer),  1  µL  of  5x  sequencing  buffer 
(composition not supplied, Perkin Elmer), 10-20 ng of 717 bp PCR product or 
20-40 ng of the 1479 bp PCR product, then made up to a total of 10 µL with 
ultrapure water (Fischer Biotec).  
 
DNA sequences were determined using an Applied Biosystems 3730 DNA 
Analyser and edited using Sequence Scanner v1.0 (Applied Biosystems) and 
GeneTool Lite (BTI Software). Edited sequences were analysed using MEGA 
3.1  (Kumar  et  al.,  2004) and  MrBayes (Ronquist  and  Huelsenbeck,  2003). 96 
 
Neighbour-joining (NJ), maximum parsimony (MP) and Bayesian trees were 
constructed with 1, 000 bootstrap cycles for NJ and MP trees. Sequences 
used for construction and analysis of phylogenetic trees are listed in Appendix 
1. 
 
4.2.9 Statistical analysis 
Pairwise  distances  between  the  sequences  derived  from  cockatiels  and 
sequences derived from other psittacine birds and bootstrap support for NJ 
and  MP  trees  were  calculated  using  Mega  3.1  (Kumar  et  al.,  2004).  For 
Bayesian analysis of phylogeny, posterior probabilities were calculated using 
MrBayes (Ronquist and Huelsenbeck, 2003). 
 
4.3 Results  
4.3.1 Survey of cockatiels for evidence of BFDV and cross-
reactivity assays 
Of the 88 cockatiels tested using primers P2 and P4, none were positive for 
BFDV by PCR or HA and none had detectable antibodies to BFDV. None of 
the cockatiels surveyed had detectable HI activity against BFDV eluted from a 
cockatiel  feather.  Six  of  the  8  known  anti-BFDV  HI  positive  sera  tested 
inhibited HA eluted from the feather of cockatiel 05-106 and similarly 5 of the 
8 sera inhibited HA eluted from isolate 05-726. The polyclonal chicken anti-
BFDV antibody used in the cross-reactivity assays did not inhibit agglutination 
by either cockatiel virus isolate (Table 4.3). When the polyclonal chicken anti-
BFDV antibody was tested against a more dilute sample of the same virus, 
however, some HI activity was observed (Figure 4.1). 
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Table  4.3:  Haemagglutination  inhibition  cross-reactivity  of  known  positive  anti-Beak  and 
Feather Disease Virus (cockatoo) psittacine sera against virus eluted from the feathers of two 
cockatiels with Psittacine Beak and Feather Disease.  
 
Antibody Source  Cockatoo BFDV   Cockatiel 05-106  Cockatiel 05-726 
Chicken anti-BFDV  +  neg  neg 
Red Lory                                +  neg  neg 
Long-billed Corella                      +  +  neg 
Galah/Corella  hybrid                  +  +  + 
Rainbow lorikeet              +  +  + 
Rainbow lorikeet              +  +  + 
Short billed corella           +  neg  neg 
Short billed corella           +  +  + 






Figure 4.1: Haemagglutination-inhibition assay using a dilute (2 HAU/50 µL) sample of Beak 
and Feather Disease Virus eluted from the feather of cockatiel 05-106 as the antigen. Row 1: 
A back-titration of the virus; row 2: polyclonal chicken anti-BFDV antibody, raised against 




4.3.2 Analysis and sequencing of PCR-positive samples from 
cockatiels 
Characteristic  basophilic  intracytoplasmic  inclusions  were  visible  on 
haematoxylin and eosin-stained skin sections from cockatiel 05-106 (Figure 
4.2a). Immunohistochemical staining revealed large amounts of BFDV capsid 
antigen in the nucleus and cytoplasm of epidermal cells (Figure 4.2b). 
Primer  sets  P2/P4  and  SeqP5/SeqP10  amplified  overlapping  717  bp  and 
1497 bp fragments of the BFDV genome, respectively, from samples 05-106 
and 05-726. Analysis of the sequences revealed that both sequences were 
1993  nt  long  and  had identical  features  to other  described  circoviruses.  A 
potential stem-loop structure, formed between bases 1976-1993 and 1-12, as 
well  as  a  repeated  octanucleotide  motif  (GGGCACCG)  were  present 98 
 
immediately downstream of the stem-loop. Potential polyadenylation signals 
were present in both sequences at identical positions, CATAAA between nt 
1019-1024  on  the  viral  strand  and  AATAAA  on  the  complementary  strand 
between nt 758-763 (nt 1231-1236 of the viral strand). A TATA box was also 
present, between nt 86-89 of the viral strand. The area of the complementary 
strand between nt 60-207, containing putative nuclear localisation signals as 
described by Heath et al. (2006) was highly conserved across all sequences 




Figure  4.2:  A.  Histological  section  of  feather  follicle  from  cockatiel  05-106,  showing 
characteristic basophilic inclusions within macrophages in the feather pulp (arrow heads). 
Bar=0.5µm  B.  Immunohistochemical  stain  of  the  same  section  showing  strong  positive 
(brown) reaction to Beak and Feather Disease Virus antigen throughout the epidermis. Bar = 
50 µm. 99 
 
4.3.3 Comparison of nucleotide sequences of BFDV isolated from 
cockatiels with other known BFDV sequences 
4.3.3.1 Full-length sequences 
Pairwise  distances  between  cockatiel  sequences  and  26  other  BFDV 
sequences varied between 3.2-15.5% (05-106) and 3.8-14.5% (05-726) at the 
nucleotide level and between 3.8-19% (05-106) and 5.2-19.2% (05-726) at the 
amino acid level. Neighbour joining phylogenetic analysis showed that both 
cockatiel  sequences  (isolate  05-106  and  05-726  GenBank  Accession  Nos. 
EF457974  &  EF457975,  respectively)  clustered  within  cockatoo  and  galah 
isolates,  however  maximum  parsimony  (not  shown)  and  Bayesian  analysis 
grouped  the  cockatiel  isolates  distinctly  separately,  with  a  high  posterior 
probability  (Figure  4.3).  Bayesian  analysis  also  identified  3  distinct  clades 
within the sequences (Figure 4.3): the cockatiels comprised clade number 1; 
the cockatoos and galahs plus 3 African grey parrots (AY521236, AY450443 
and  AY450435),  a  white-bellied  caique  (AY450434)  and  a  Cape  parrot 
(AY450439) made up clade 2 and the remaining clade was made up of all 
Agapornis sp. isolates, the remaining African grey parrot and Poicephalus sp. 





Figure 4.3: Bayesian phylogram constructed using full-length Beak and Feather Disease Virus 
nucleotide sequences demonstrating the distance between cockatiel (Nymphicus hollandicus) 
BFDV  sequences  (EF457974  &  EF457975)  in  relationship  to  published  BFDV  sequences 
isolated from  other  Psittacidae  and  Cacatuidae.  Numbers  at  the  nodes  indicate  posterior 
probability. 101 
 
A plot of CpG islands within the cockatiel sequences showed high proportions 
of  CpG  motifs  throughout  most  of  the  sequence.  Gardiner-Garden  and 
Frommer (1987), defined a candidate CpG island as having a Y-value of >0.6 
on the CpG plot and a GC content of >50%. As such, the first 200 bases of 
the sequence, then bases 240-650, 680-1160, 1210-1380 and 1760-1993 of 
the  viral  strand  contain  candidate  CpG islands.  The  complementary  strand 
had candidate CpG islands within the first 30 nt and between nt 420-600, 640-
1120, 1150-1570 and 1575-1993 (Figure 4.4). 
 
Particular points of interest are spikes in the CpG plot at nt 280-400, 672, 
1167 and 1660-1880 of the viral strand and nt 30-360, 630, 1120 and 1330-
1540 of the complementary strand (Figure 4.4a). The spikes at nt 672, 1167 
and  1660-1760  of  the  viral  strand  and  nt  630,  1130  and  the  first  spike 
between  nt  30-360  of  the  complementary  strand  are  less  likely  to  be 
significant, though, as the GC content in these regions is less than 50%. The 
whole sequence was GC-rich, as the GC content was only less than 50% 
between  bases  200-240,  650-680,  1160-1210  and  1380-1760  of  the  viral 
strand  and  nt  60-400,  580-640,  1120-1145  and  1550-1600  of  the 
complementary strand (Figure 4.4b). Comparison of CpG plots derived from 
the  cockatiel  isolates  demonstrated  subtle  differences  compared  to  plots 
derived  from  published  BFDV  sequences  from  a  sulphur-crested  cockatoo 
(AF080560),  rainbow  lorikeet  (AF311299)  and  peach-faced  lovebird 
(AF311296).  GC  density  plots  for  these  isolates  demonstrated  minimal 




Figure 4.4: A (i and ii): CpG plots of the complementary and viral strand, respectively, of the cockatiel (Nymphicus hollandicus) 05-106 isolate, overlain on 
respective CpG plots of Beak and Feather Disease Virus (BFDV) isolates from a sulphur-crested cockatoo (Cacatua galerita), rainbow lorikeet (Trichoglossus 
haematodus) and peach-faced lovebird (Agapornis roseicollis). B (iii and iv): GC plots of the complementary and viral strand, respectively, of the same 






Sequences  of  both  cockatiel isolates  had  a  start  codon of  ATG located at 
position 131. The stop codon for both isolates was TGA, located at nt 997. 
The  predicted  size  of  ORFV1  was  867  nt.  Distances  between  cockatiel 
sequences and other BFDV sequences varied between 2.5-11.9% (05-106) 
and 2.4-11.1% (05-726) at the nucleotide level and between 2.2-11% (05-106) 
and  1.1-10.4%  (05-726)  at  the  amino  acid  level.  Neighbour-joining  and 
maximum  parsimony  phylogenetic  analysis  showed  that  both  cockatiel 
sequences  clustered  closest  to,  but  separate  from,  cockatoo  and  galah 
isolates (Figure 4.5). 
 
4.3.3.3 ORFC1 
Sequences  of  both  cockatiel  isolates  had  a  putative  start  codon  at  nt  16 
(CTG) of the complementary strand (or nt 1978 of the viral strand), as per 
Bassami et al. (2001). The stop codon for both isolates was a TAA at nt 757 
of the complementary strand (nt 1235 of the viral strand). Distances between 
cockatiel sequences and other BFDV sequences varied between 2.0-18.9% 
(05-106)  and  5.9-19.1%  (05-726)  at  the nucleotide level  and between  6.0-
28.5% (05-106) and 6.8-27.4% (05-726) at the amino acid level. Neighbour-
joining  and  maximum  parsimony  phylogenetic  analysis  showed  that  both 
cockatiel sequences clustered within a clade of cockatoo and galah isolates 
(Figure 4.6). Alignment of translated amino acid sequences showed that 121 
of 260 amino acids were conserved across all the isolates examined and 133 
of 260 were variable. The areas between aa 68-83, 94-97 and 228-241 were 





Figure 4.5: Phylograms constructed using the nucleotide sequence encoding the replicase-
associated protein of various Beak and Feather Disease Virus (BFDV) isolates. A: Neighbour-
joining  phylogram,  B:  Maximum  parsimony  phylogram.  The  distance  between  cockatiel 
(Nymphicus  hollandicus)  BFDV  sequences  (EF457974  &  EF457975)  in  relationship  to 
published BFDV sequences isolated from other Psittacidae and Cacatuidae is demonstrated. 






Figure  4.6:  Phylograms  constructed  using  the  nucleotide  sequence  encoding  the  capsid 
protein of various Beak and Feather Disease Virus  (BFDV) isolates. A: Neighbour-joining 
phylogram, B: Maximum parsimony phylogram. The distance between cockatiel (Nymphicus 
hollandicus) BFDV sequences (EF457974 & EF457975) in relationship to published BFDV 
sequences isolated from other Psittacidae and Cacatuidae is demonstrated. Note that the 





4.4 Discussion  
The data presented in this chapter provides histological, DNA sequence and 
serotyping evidence of BFDV infection in cockatiels, thus confirming that the 
species is susceptible to BFDV infection. Immunohistochemical staining and 
DNA sequence data and CpG analysis demonstrated antigenic and genetic 
relationship with BFDV isolates obtained from other Psittaciformes.  However, 
maximum parsimony and Bayesian analysis of the cockatiel isolates placed 
them  into  a  clade  genetically  distinct  from  other  BFDV  sequences  and  HI 
cross-reactivity analysis also demonstrated evidence of antigenic variation in 
one of the cockatiel BFDV isolates when it was used as the antigen against 
known positive BFDV antisera.  
 
BFDV  is  a  genetically  diverse  virus  and  there  have  been  numerous 
phylogenetic studies on the now many isolates that have had their complete 
nucleotide  sequences  determined.  Broad  genotype  lineages  aligned  to  the 
major  families  of  psittacine  birds;  namely  the  cockatoos,  loriids  and  other 
parrots  have  been  demonstrated  but  the  biological  significance  of  this 
clustering has not been well understood. There have been few papers that 
have investigated antigenic variation in the virus. Beak and feather disease 
virus isolates harvested from a diverse range of psittacine genera were found 
to be antigenically similar by Ritchie et al. (1990) and antigen derived from the 
feathers of diseased cockatoos has proven to be useful for detecting antibody 
to BFDV using HI assay.  Within the Cacatuidae there are 6 genera and 21 
species  and  within  the  Psittacidae  there  are  78  genera  and  332  species. 
Various  papers  have  found  the  HI  assay  suitable  for  detecting  anti-BFDV 
antibodies in sera from a large proportion of these 353 species (Raidal et al., 107 
 
1993a,b; Raidal & Cross 1994a; Ritchie et al., 1991; Riddoch et al., 1996; 
Khalesi et al., 2005). Khalesi et al. (2005), using an identical technique to that 
described in this present paper, demonstrated no evidence of any antigenic 
serotypes  by  HI  cross-reactivity  studies  using  feather  and  blood  samples 
obtained from a range of psittacine bird species. The fact that HI antibodies 
against  a  single  antigen  has  been  successfully  used  to  detect  BFDV  in  a 
range of psittacine bird species is good evidence that there is a considerable 
degree  of  cross  reactivity  between  the  different  genotypes  that  infect 
cockatoos, lorikeets and parrots.  
 
The low reported incidence of BFDV infection in cockatiels and our negative 
serological  survey  results  are  somewhat  puzzling  for  such  a  supposedly 
common and infectious virus to which all Psittaciformes are presumed to be 
susceptible.  It  is  highly  unlikely  that  the  negative  PCR  results  of  all  birds 
surveyed represent a failure of the test. Khalesi et al. (2005) reported only 1 
false negative PCR result from a total of 623 samples tested. The authors 
also showed that the PCR test detected the cockatiel BFDV isolate and this 
was confirmed in this study. It could be that all of the cockatiels we surveyed 
in  this  present  paper  were  naïve  to  infection,  and  truly  antibody  negative. 
However, they were from commercial aviaries that had a high turn-over of a 
wide variety of psittacine bird species many of which we knew from clinical 
observations were expressing clinical signs of PBFD. Typically the birds in 
such establishments have a high incidence of BFDV infection, PBFD and a 
high HI antibody prevalence with budgerigars and lovebirds (Agapornis spp.) 
having the highest rates of infection (Khalesi et al., 2005).   108 
 
 
According to published epidemiologic data an expected seroprevalence of 30-
40% would be a conservative estimate (Raidal et al., 1993a, Raidal & Cross 
1994b;  Khalesi  et  al.,  2005)  of  the  expected  seroprevalence  within  the 
population of cockatiels that we sampled and a sample size of 88 should have 
provided  a  95%  level  of  confidence  of  the  estimate  of  the  prevalence  of 
infection (Thrushfield 1986). Failure to detect evidence of antibody in such a 
sample  size  provides  strong  evidence  (95%  confidence  level)  that  the 
seroprevalence  in  the  population  of  cockatiels  sampled  was  less  than  5% 
(Thrushfield  1986).  This  is  a  very  low  figure  in  comparison  with  other 
Psittaciforme species. 
 
The lack of documented cases of cockatiels with PBFD in the literature along 
with the negative PCR and serological results obtained in our survey could be 
interpreted  as  evidence  that  cockatiels  are  somewhat  innately  resistant  to 
BFDV infection. However, the PCR results in individual cockatiels reported 
here and by Khalesi et al. (2005) along with the histological evidence of BFDV 
infection  (Figure  4.2)  indicates  that  the  species  is  susceptible  to  BFDV. 
Furthermore, the PCR results, DNA sequence analysis and HI cross-reactivity 
data provide evidence of a cockatiel-adapted BFDV which may be sufficiently 
different,  genetically  and  antigenically,  to  most  other  BFDV  isolates  to  be 
considered a separate strain. This is not surprising given evidence that avian 
circoviruses  have  coevolved  with  their  host  species  (Ritchie  et  al.,  2003; 
Stewart  et  al.,  2006).    Assessment  of  the  phylogeny  of  Psittaciforme  birds 
using mitochondrial DNA has placed the monotypic Nymphicus more closely 109 
 
related to the black cockatoos (Calyptorynchus & Callocephalon) and not the 
more distantly related white cockatoos (Cacatua & Eolophus) as was once 
thought (Brown & Toft, 1999) and the results presented in this present paper 
provide further support to this hypothesis. It is assumed that all species of 
psittacine birds are susceptible to all isolates of BFDV, however to date there 
have been limited studies investigating the infectivity of BFDV isolates (Raidal 
et  al.,  1993a,  Wylie  and  Pass,  1987)  and  none  comparing  the  relative 
infectivity and pathogenicity of different isolates. Experimental confirmation of 
the infectivity of the cockatiel BFDV and comparison of the pathogenicity of 
this isolate with other BFDV isolates would be desirable but may be hard to 
accomplish given the difficulty in finding BFDV-free birds. 
 
Given the data presented in this present study, there are some aspects of 
BFDV evolution and epidemiology that are difficult to explain. Based on the 
phylogenetic  analysis  (Figure  4.3),  the  cockatiel  BFDV  sequences  are 
genetically  distinct  from  those  obtained  from  other  psittacine  species.  
However, the same method of analysis and other similar studies have also 
found  similar  distinct  genetic  differences  between  BFDV  isolates  from 
lovebirds,  lorikeets  and  cockatoos.  In  addition,  cross-reactivity  work  using 
BFDV  eluted  from  the  feathers  of  two  rainbow  lorikeets,  a  musk  lorikeet 
(Glossopsitta  concinna),  a  red  lory,  two  swift  parrots,  a  sulphur-crested 
cockatoo  and  a  scarlet  chested  parrot  and  anti-BFDV  antibodies  from  the 
same panel of birds as in this study has shown these not to be serologically 
distinct (Khalesi et al., 2005). Therefore, specific mutation or genetic variation 110 
 
in the cockatiel sequences cannot be clearly associated with any biological or 
antigenic characteristics.  
 
Phylogenetic analysis of full length sequences and rep sequences grouped 
the  cockatiels  separately  to  other  isolates,  but  analysis  of  cap  sequences 
alone grouped the cockatiel sequences appropriately within a cockatoo clade 
(data not shown). Most studies thus far have focused on cap as the main 
determinant of the pathogenicity of the virus (Heath et al., 2004, Raue et al., 
2004). However, the fact that cap grouped within a known clade while rep and 
full length sequences grouped separately suggests three likely possibilities. 
Firstly, that rep may have other functions than first thought. Secondly, parts of 
the sequence other than cap and rep play a part in pathogenesis. Thirdly, host 
factors (such as the presence or absence of cell surface receptors for virus 
attachment  or  major  histocompatibility  complex  (MHC)  presentation)  play a 
significant role.  
 
The second of these possibilities is supported by work with PCV2 showing 
that CpG motifs play a role in the modulation of IFN-α expression (Hasslung, 
2003) and as such CpG motifs may play a similar role in modulating cytokines 
during the course of BFDV infection. Fenaux et al. (2003) demonstrated that 
when  the  capsid-coding  region  of  PCV2  was  cloned  into  the  genomic 
backbone  of  PCV1,  the  resultant  chimeric  virus  was  less  pathogenic  than 
wild-type PCV2. Furthermore, Hughes and Piontkivska (2007) found a greater 
proportion  of  nonsynonymous  polymorphisms  within  PCV2  rep,  which  are 
likely  to  be  associated  with  random  mutations  that  have  affected  the 111 
 
pathogenicity  of  the  virus.  Recombination  also  plays  a  role  in  the  genetic 
reassortment of the Circoviridae (Biagini et al., 2001, He et al., 2007, Heath et 
al., 2004, Ma et al., 2007, Olvera et al., 2007, Worobey, 2000). The effect of 
these  random  mutations,  recombination  and  ongoing  purifying  selection 
probably do account for the apparent antigenic and pathogenic differences 
between  BFDV  isolates    (Nei,  2007).  This  may  even  lead  to  the  eventual 
existence  of  distinct  strains,  pathotypes  or  even  serotypes,  as  has  been 
suggested  for  PCV2  and  CAV  (Lucio  et  al.,  1990,  Meerts  et  al.,  2005a, 
Nogueira et al., 2007, Opriessnig et al., 2006d) and as such it is unlikely that 
the full spectrum of genetic, antigenic and pathogenic differences will ever be 
mapped.  
 
This is not to say that cap and the capsid protein are not significant in the 
pathogenesis  of  the  disease.  Mahe et  al. (2000) identified  capsid  epitopes 
unique to PCV1 and PCV2 and the presence of unique epitopes may occur 
with  BFDV  as  well  and  may  explain  the  variable  cross-reactivity  of  the 
cockatiel  isolates.  Considering  that  there  are  currently  no  cell-culture 
techniques or any in vitro methods to propagate BFDV, the identification of 
these  unique  epitopes  and  other  motifs  suspected  to  play  a  role  in 
pathogenesis will need to be carried out using such techniques as epitope 
mapping, infectivity studies using infectious clones and analysis of nucleotide 
sequence  polymorphisms.  Likewise,  infectivity  studies  with  various  BFDV 
isolates  or  mutant  BFDV  infectious  clones  and  a  wide  range  of  psittacine 
species may be the only way to investigate the extent to which the genotype 
of an isolate affects its infectivity and pathogenicity. Such studies have been 112 
 
applied to the porcine circoviruses (Hughes and Piontkivska, 2007, Lefebvre 
et al., 2008, Mahe et al., 2000, Meehan et al., 1998, Meerts et al., 2005a, 
Opriessnig et al., 2006d) and the VP2 protein of CAV (Wang et al., 2007a) 
and will no doubt be applicable to BFDV.  113 
 
Chapter 5. Development of a Monoclonal Antibody to a 
Recombinant Beak and Feather Disease Virus (BFDV) 
Capsid Protein; its Applications in Western Blotting, 
Immunohistochemistry, Haemagglutination-Inhibition and 
the Development of a Novel Blocking Enzyme-Linked 
Immunosorbent Assay (bELISA) 
 
 
5.1 Introduction and Aims 
5.1.1 Introduction 
The development of diagnostic assays for the detection of BFDV antigens and anti-
BFDV antibodies has traditionally been hampered by the difficulty associated with 
producing  suitable  reagents,  namely  purified  virus  and  polyclonal  antibodies.  At 
present, HA and HI assays (Raidal et al., 1993c, Ritchie et al., 1991b) are commonly 
used  for  the  detection  of  virus  excreted  from  feathers  or  faeces  and  anti-BFDV 
antibodies in psittacine sera, respectively. They require erythrocytes from suitable 
birds  and  virus  purified  from  the  feathers  of  infected  birds.  Polyclonal  antibody 
preparations  and  variations  in  these  reagents  make  consistency  between  tests 
difficult to achieve.  
 
Similarly, methods for the detection of the virus in formalin-fixed, paraffin-embedded 
tissue, or in western- or dot-blots have relied on polyclonal antibodies (Johne et al., 
2004, Latimer et al., 1990, Latimer et al., 1991, Raidal and Cross, 1995, Ritchie et 
al., 1990), making consistency between techniques difficult to achieve. Given that no 
cell  culture  system  has  been  found  to  grow  the  virus  successfully  in  vitro, 
recombinant proteins and monoclonal antibodies are the most attractive options for 
the  development  of  standardised  diagnostic  assays.  To  this  end,  a  recombinant 
BFDV capsid protein (Stewart et al., 2007) was used as the antigen source for the 114 
 
development of a monoclonal antibody (MAb) specific to the capsid protein of BFDV 
and  its  application  in  western  blotting,  immunohistochemistry,  ELISA  and  HI 
investigated. 
 
Surveys  using  PCR-based  assay  methods  have  found  virus  prevalence  rates  of 
between 8% (Bert et al., 2005) and 39% (Rahaus and Wolff, 2003). The reported 
seroprevalence  varies  between  16%  and  62%  (Khalesi  et  al.,  2005,  Raidal  and 
Cross,  1994a)  among  captive  flocks  and  between  41%  and  94%  in  wild  flocks 
(Raidal et al., 1993b). Currently, an HI assay (Raidal et al., 1993c, Ritchie et al., 
1991b) is the only method available for the detection of antibodies against BFDV in 
psittacine sera. This assay is useful since it detects both IgM and IgG antibodies 
from  a  wide  range  of  species  of  psittacine birds.  However  it  may  suffer  from  an 
appreciable amount of inter-test variation due to variability in quality and quantity 
between virus preparations and the sensitivity to the virus of the erythrocytes used in 
the  test.  To  overcome  these  limitations,  the  baculovirus-expressed  recombinant 
BFDV capsid protein (Stewart et al., 2007) and monoclonal antibody raised against 
this  protein  (Shearer  et  al.,  2008b)  were  used  to  develop  a  novel  blocking  (or 
competitive)  ELISA  (bELISA)  for  the  detection  of  anti-BFDV  antibodies.  Blocking 
ELISAs have also been developed to detect aetiological agents (Hochel et al., 2004, 
Rauer and Conrad, 2001, Shurley et al., 2005) and the suitability of the bELISA for 





This  principal aim  of  this experiment  was  to  investigate  the immune  response  to 
experimental BFDV infection in vaccinated and non-vaccinated psittacine birds using 
an assay which had a lower limit of detection and was  more consistent than the 
existing HI assay. This necessitated production of a suitable antigen and antibody for 
use in the assay. Thus, the secondary aims of this experiment were to produce a 
recombinant BFDV capsid protein and monoclonal antibody against this protein and 
to describe their respective characteristics and applications. 
 
5.2 Materials and Methods 
5.2.1 Experimental design 
During protein production, quantitation and characterisation, protein amount was the 
independent variable and pixel density and HA titre were the dependent variables. 
During monoclonal antibody production, quantitation and characterisation, mouse ID 
and MAb dilution factor were the independent variables and antibody responses (HI 
titre, ELISA titre and intensity of western blot and IHC intensity) were the dependent 
variables.  When  testing  the  birds  using  the  bELISA,  time  was  the  independent 
variable and HI titre was the dependent variable. When determining the variability of 
the bELISA and comparing the bELISA and HI assays, replicate number, dilution 
factor and HI titre were the independent variables and deviation from mean PI and 
bELISA PI were the dependent variables. The experimental design of the vaccination 
trial is described in Section 3.2.1. 
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5.2.2 Production and purification of recombinant BFDV capsid protein 
5.2.2.1 Protein production 
A  full-length,  baculovirus-expressed  BFDV  capsid  protein  was  expressed  and 
purified as described by Stewart et al. (2007). Stored P5 (passage 5) virus stocks of 
known infectivity (>10
7 pfu/mL) (Stewart et al., 2007) were used to infect Sf9 insect 
cells at an MOI (multiplicity of infection) of 0.2 in a 100 mL volume of insect cell 
culture at a density of 2x10
6 cells/mL. Infected cells were then grown for 5 days at 
28ºC to express the recombinant capsid protein. After the growth period, the cell 
cultures were centrifuged at 1,700 rpm for 10 minutes at 4ºC to pellet the cells. Cell 
pellets were stored at -80ºC if the protein was not immediately purified. 
 
5.2.2.2 Protein purification using Ni-NTA resin 
Pellets  of  insect  cells,  produced  as  described  above  were  lysed  by  adding  lysis 
buffer (25 mM Tris-HCl, pH 8.5, 2.5 mM β-mercaptoethanol, 12.5 mM KCl, 0.5 mM 
PMSF, 0.5 U/mL DnaseI) and the cell pellet and lysis buffer solution mixed for 30 
minutes at 4ºC. The mixture was then sonicated on ice for 1 minute, 3 times in total, 
with a 1 minute interval between each sonication. Efficient lysis was checked using a 
haemocytometer,  then  cell  debris  was  removed  from  the  lysed  cell  mixture  by 
ultracentrifugation at 10,000 g for 10 minutes at 4ºC. 
 
The supernatant, containing soluble protein, was then added to 1 mL of Ni-NTA resin 
(Qiagen)  which  had  been  pre-equilibrated  with  lysis  buffer.  The  proteins  were 
allowed to bind to the resin overnight at 4ºC, whilst being mixed constantly. After 
binding, the liquid was allowed to flow through the column and was collected. The 
resin was then washed three times by inverting end-over-end for 20 minutes at 4ºC 
with wash buffer (25 mM NaH2PO4, 250 mM NaCl, 5 mM Imidazole) and the liquid 117 
 
collected after each wash. After washing, the protein was eluted by passing four 500 
µL aliquots of elution buffer (25 mM NaH2PO4, 250 mM NaCl, 300 mM Imidazole) 
over the resin and collecting the liquid. The 2 mL of elution buffer was then re-added 
to the resin and the mixture allowed to stand at 4ºC overnight. The liquid was then 
collected and a further 2 elutions were made. The collected fractions were stored at 
4ºC for short-term use or -20ºC/-80ºC for long-term storage, before being analysed 
as described below. All fractions were then analysed by SDS-PAGE electrophoresis 
and concentrations determined by densitometer analysis, in comparison with bovine 
serum albumin (BSA) and lysozyme standards. 
 
5.2.2.3 Protein purification using ultracentrifugation 
Insect  cells  were  produced  and  lysed  as  described  above.  Cell  pellets  were 
resuspended in 4 mL PBS, then added to 750 µL of a 40% (w/v in PBS) sucrose 
cushion and centrifuged in an ultracentrifuge (Beckman Coulter) in an SW55Ti rotor 
at  28,  000 rpm  for  2  hours  at  4ºC.  Cell lysates, in  4  mL  aliquots,  were  similarly 
treated, then the supernatants discarded and the cell pellets resuspended in 2 mL 
PBS and sonicated on ice for 10 seconds. Three millilitres of CsCl solution (3.8 M in 
distilled  H20)  was  then  added  to  the  resuspended  cell  pellet  and  the  solution 
centrifuged in an ultracentrifuge (Beckman Coulter) in an SW55Ti rotor at 29, 000 
rpm for 2 hours at 4ºC. Fractions were collected in 500 µL aliquots and then dialysed 
overnight in PBS at 4ºC. The collected fractions were then stored at 4ºC for short-
term use or -20ºC/-80ºC for long-term storage, before being analysed as described 
below. Dialysed fractions were then analysed and quantified as described above. 
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5.2.2.4 Concentration of protein stocks 
After dialysis, fractions containing the purified recombinant protein were dialysed in a 
5-20% (w/v) solution of polyethylene glycol, MW 20,000 kDa (PEG 20K). Once the 
solution had decreased to the desired volume, the solution was removed, the dialysis 
tubing  rinsed  thoroughly  in  deionised  water  and  the  solution  was  collected  and 
stored at 4ºC for short-term use or -20ºC/-80ºC for long-term storage. 
 
5.2.3 Detection and analysis of baculovirus-expressed recombinant 
BFDV capsid protein 
Purified  recombinant  proteins  were  analysed  by  SDS-PAGE,  western  blotting, 
haemagglutination assay, haemagglutination inhibition assay, transmission electron 
microscopy and protein sequencing. 
 
5.2.3.1 SDS-PAGE 
Protein samples were loaded onto a 12.5% (w/v) resolving gel containing 0.1% (w/v) 
SDS and subjected to electrophoresis at 200 V for 45-60 minutes. Gels were then 
stained with a solution of 45% (v/v) methanol, 5% (v/v) glacial acetic acid and 0.1% 
(w/v) Coomassie Brilliant blue (Bio-Rad) for at least 4 hours at room temperature 
with gentle rocking. Gels were then de-stained with a solution of 40% (v/v) methanol 
and 5% (v/v) glacial acetic acid for at least 4 hours at room temperature with gentle 
rocking, then dried and stored. Coomassie staining was not carried out on gels used 




5.2.3.2 Western blotting 
An  aliquot  of  the  recombinant  protein  was  run  on  a 12.5%  SDS-PAGE  gel,  then 
transferred to a nitrocellulose membrane using a semi-dry transfer apparatus (Bio-
Rad). The membrane was then blocked with a solution of tris-buffered saline with 
0.05% (v/v) Tween 20 (TBST) plus 5% (w/v) skim milk (Diploma) for 1 hour at room 
temperature with gentle rocking, or overnight at 4ºC. The blocking buffer was then 
poured off and the primary antibody solution applied for 1 hour at room temperature. 
Mouse anti-his (Serotec), diluted 1:2,000 in blocking buffer was used as a positive 
control. When screening multiple samples, a Bio-Rad Mini-PROTEAN II multiscreen 
apparatus was used and samples added to individual lanes. The membrane  was 
then washed three times in TBST, for 5 minutes each wash at room temperature, 
with gentle rocking. A solution of alkaline phosphatase conjugated goat anti-mouse 
IgG (Sigma), diluted 1:5,000 in blocking buffer was then added and the membrane 
incubated for 1 hour at room temperature with gentle rocking. The membrane was 
then washed as before. Western Blue colour development solution (Promega) was 
applied and the colour allowed to develop at room temperature. Colour development 
was stopped by rinsing the membrane in excess deionised water and the membrane 
allowed to dry. 
 
5.2.3.3 Haemagglutination assay and correlation of protein amount to HA titre 
A modified haemagglutination assay was performed as described by Raidal et al. 
(1993c), using both serial and non-serial dilutions of a 360 ng/µL stock solution of 
purified recombinant protein. The negative control consisted of PBS only and the 
positive control was a 50 µL suspension of virus purified from feathers and organs of 
a BFDV-infected sulphur-crested cockatoo, diluted to give a HA titre of 4-8 HAU/50 
µL.  The  amount  of  protein in  the  first  well of  each  row  was  calculated  using the 120 
 
dilution  factor  and  HA  titres  were  plotted  against  the  calculated  protein  amounts 
(Figure 5.2). 
 
5.2.3.4 Haemagglutination-inhibition assay 
Haemagglutination-inhibition assays were carried out as described in Section 4.2.6, 
except that recombinant protein, diluted to 4-8 HAU/50 µL, was used as antigen. 
 
5.2.3.5 Transmission electron microscopy 
An  aliquot of  purified  and  concentrated recombinant  protein  solution  was  spotted 
onto copper 400 mesh Formvar carbon-coated grids and left to stand for 1min at 
room temperature. The protein solution was then blotted off with Whatmann filter 
paper and the sample stained with phosphotungstic acid (PTA) by adding a drop of 
PTA and leaving the grid to stand for 1 minute at room temperature. The PTA was 
then  blotted  off  and  the  grid  viewed  in  a  Philips  CM100  transmission  electron 
microscope. 
 
5.2.3.6 Protein sequencing 
Protein  sequencing  was  carried  out  by  Proteomics  International  (Perth,  Western 
Australia). After SDS-PAGE analysis, samples of protein were cut out of the gels and 
extracted by trypsin digestion (Casey et al., 2005) followed by MALDI-TOF mass 
spectrometry using a 4800 Proteomics Analyser (Applied Biosystems). Spectra were 
analysed using Mascot sequence matching software (Matrix Science) and compared 
to entries in the NCBI MSDB database. 
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5.2.4 Production of monoclonal antibodies 
5.2.4.1 Immunisation and screening of mice 
A mixture of 50 µg of protein mixed with Freund’s Incomplete adjuvant was injected 
into the peritoneal cavity of each of 4 BALB/c mice. Mice were injected twice at four-
weekly intervals, then serum collected four weeks after the second injection. The 
sera of the vaccinated mice were screened by HI and western blot as described 
above and by ELISA. For western blotting, sera were diluted 1:100 in blocking buffer. 
After screening the sera, one mouse was selected and boosted by injection with a 
further 50 µg of protein and its spleen harvested 2 weeks later. 
 
5.2.4.2 Indirect enzyme-linked immunosorbent assay 
The  recombinant  protein  was  diluted  to  5  µg/mL  in  0.1  M  carbonate/bicarbonate 
buffer, pH 9.6 and added to all wells of a 96-well ELISA plate (Costar), then the plate 
incubated at  4ºC  overnight.  The  plate  was  then  washed  3 times  with  PBST  plus 
0.05% Tween 20 (PBST). A blocking solution, 5% BSA in PBST, was added to all 
wells and the plate incubated for 1 hour at room temperature. The plate was washed 
again and 50 µL of 5% BSA in PBS (PBS-BSA) added to all wells. When screening 
mice vaccinated with the recombinant protein, 50 µL of serum, diluted 1:100 in PBS-
BSA, were added to the first well of each row and serially diluted across the plate. 
The plate was then incubated at room temperature for 1 hour, after which the sera 
were removed. The plate was washed 3 times as before, then 50 µL of horseradish 
peroxidase (HRP)-conjugated goat anti-mouse IgG (Sigma), diluted 1:5, 000 in PBS-
BSA were added to all wells and the plate incubated for 1 hour at room temperature. 
The solution was removed and the plate washed as before, with a final wash with 
deionised  water.  Colour  development  was  carried  out  by  adding  a  developing 
solution  containing  2,  2'-azino-bis  (3-ethylbenzthiazoline-6-sulphonic  acid)  (ABTS) 122 
 
and 10% (v/v) citric acid pH 4.2, then incubating at room temperature for 15 minutes. 
Absorbances were read at 405 nm using a DTX 880 spectrophotometer (Beckman 
Coulter). 
 
Hybridoma supernatants were screened as above, except that 50 µL of hybridoma 
supernatant were added to the corresponding individual well of the ELISA plate. On 
a separate ELISA plate, known positive mouse serum (processed as above) was 
used  as  a  positive  control  and  negative  mouse  serum  and  PBS  were  used  as 
negative controls. 
 
5.2.4.3 Production and screening of hybridomas 
Sp2/0  mouse  myeloma  cells  were  grown  and  maintained  in  Dulbecco’s  modified 
Eagle’s medium (DMEM) (Gibco) supplemented with 1% foetal calf serum (FCS) and 
antibiotics (penicillin and streptomycin), at 37ºC in a 5% CO2-in-air environment. Cell 
culture medium was changed every 2-3 days and cells were split between 1:2 to 1:5 
(depending on the rate of growth) once they were 75% confluent or more. 
 
The  spleen  from  mouse  BB01  was  harvested  aseptically,  the  connective  tissue 
removed  with  forceps,  the  pulp  passed  through  a  fine  mesh  filter  and  the  cells 
collected into DMEM. The cell suspension was then centrifuged at 1, 500 rpm for 5 
minutes and the media decanted. Sp2/0 myeloma cells were also harvested. The 
spleen  cells  were  resuspended  in  a  small  volume  of  DMEM  and  mixed  with  the 
myeloma cells. More DMEM was added to the cell suspension, the cells pelleted by 
centrifugation and the media decanted. One millilitre of PEG 1500 was then added 
slowly to the cells with gentle mixing, then 2 mL DMEM was added slowly with gentle 123 
 
mixing. The cell suspension was then divided into two equal volumes and DMEM 
added  to  both aliquots,  to  a  final  volume  of  40  mL.  A  200  µL  aliquot  of  the  cell 
suspension  added  to  all  wells  of  four  96-well  culture  plates.  The  plates  were 
incubated for 3 days, after which time the culture media was changed to Hybridoma 
serum-free medium (SFM) (Gibco), supplemented with 1% FCS, antibiotics and IL-6 
(composition not supplied). Media changes were performed every 2-3 days for 14 
days, after which the hybridoma supernatants were screened by ELISA. 
 
ELISA-positive hybridomas were transferred to a 48-well culture plate and 1 mL of 
Hybridoma-SFM  (plus  FCS,  antibiotics  and  IL-6)  added.  The  hybridomas  were 
placed in an incubator and allowed to grow overnight, then re-screened by ELISA the 
following day  to  confirm  that  hybridomas  were  continuing  to  produce  the  desired 
antibodies. To determine the class of antibodies, a second ELISA was performed, 
using  a  BioRad  Typer  isotyping  kit  as  per  the  manufacturer’s  instructions.  Any 
hybridomas positive for IgM were excluded from the study. 
 
IgG-secreting hybridomas were then screened thrice by haemagglutination-inhibition 
assay and once by western blot. The first haemagglutination-inhibition assay was 
performed as previously described, using the supernatant of the hybridoma culture 
media. The second and third assays were similar except that the second time the 
samples were only adsorbed with galah erythrocytes and the third time the samples 
were  not  adsorbed  with  either  kaolin  or  galah  erythrocytes. Western  blotting  was 
carried out as described above, with the hybridoma supernatants diluted 1:2 in TBS 
and serum from mouse BB01 diluted 1:100 in TBST used as the positive control. 
One hybridoma, which had a high ELISA titre and detected only the recombinant 
protein by western blot was selected and cloned by limiting dilution. The cells of the 124 
 
selected hybridoma were resuspended gently in situ and a small aliquot taken to 
perform a viable cell count. The cells were then diluted to a final concentration of 45 
viable cells per 10 mL culture medium and 100 µL of the cell suspension were added 
to all wells of a 96-well culture plate. After 14 days the supernatants were screened 
by ELISA as described above. 
 
Clones that were positive by ELISA were expanded in 6 well culture plates and re-
screened  by  ELISA  and  western  blot.  Western  blotting  was  performed  with 
supernatants  tested  against  both  the  recombinant  BFDV  capsid  protein  and  a 
polyhistidine-tagged recombinant baculovirus-expressed PCV2 capsid protein. 
 
Electrophoretic mobility shift assays were also conducted in an attempt to determine 
the affinity of the antibodies for the NLS. Initial assays were conducted as described 
by Heath et al. (2006), using polyclonal chicken anti-BFDV in order to assess the 
suitability  of  the  assay  for  screening  monoclonal  antibodies.  A  total  of  10  ng 
recombinant capsid protein was mixed in DNA binding buffer (100 mM Tris-HCl, pH 
8,  300  mM  KCl,  25  mM  MgCl2,  20%  glycerol,  500  µg/ml  BSA)  in  a  0.5  mL 
microcentrifuge tube (Eppendorf) to a volume of 20 µL. To this, 25 µL of chicken 
anti-BFDV polyclonal antisera, with an HI titre of 4-8 HIU/50 µL, were added and the 
mixture incubated for 1 hour at 37ºC. One hundred nanograms of pUC 18 plasmid 
DNA (Invitrogen) were then added to make a total volume of 50 µL and the solution 
incubated again for 1 hour at 37ºC. Two control reactions, one without protein and 
another  without  protein  or  antibodies  were  prepared  in  separate  microcentrifuge 
tubes. Reaction products were visualised on a 1% agarose gel with the addition of 
0.001%  ethidium  bromide,  run  at  90  V  for  30  minutes.  The  polyclonal  antibody 
solution  was  also  purified  by  ammonium  sulphate  precipitation  as  described  by 125 
 
Nilson et al. (1993). Briefly, 100 µL of saturated ammonium chloride solution was 
added to an equal volume of chicken anti-BFDV polyclonal antisera and the solution 
incubated at 4ºC for 18 hours. The solution was then centrifuged at 10,000 rpm for 
15 minutes, the supernatant removed and the pellet resuspended in 100 µL PBS. 
The  purified  antibodies  were  tested  by  HI  assay  to  confirm  the  success  of  the 
purification, then used in another electrophoretic mobility shift assay. 
 
5.2.4.4 Production and purification of monoclonal antibodies 
The selected hybridoma was grown in Hybridoma-SFM (Gibco) plus FCS, antibiotics 
and  IL-6  and  expanded  to  a  total  volume  of  one  litre.  Before  purification  of  the 
monoclonal antibody, hybridoma cells were pelleted by centrifugation at 1, 500 rpm 
for  5  minutes.  The  supernatant  was  collected  and  passed  over  protein  A-coated 
sephadex beads (BioRad) in a BioRad HPLC pump at 4ºC. The bound antibodies 
were washed once with excess PBS and then eluted with 50 mM glycine buffer (pH 
2.7), into Tris buffer (1 M Tris-HCl, pH 8). Purified antibodies were then dialysed in 
PBS overnight at 4ºC. The subclass of the antibody was determined using a Pierce 
mouse isotyping kit (Pierce), with the assay performed in triplicate. 
 
5.2.5 Applications of the monoclonal antibody 
5.2.5.1 Haemagglutination inhibition 
Fifty  microlitres  of  undiluted  purified  monoclonal  antibody  were  tested  by  HI  as 




5.2.5.2 Optimisation of the indirect enzyme-linked immunosorbent assay 
The recombinant protein was diluted to 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0 and 2.5 
µg/mL  in  0.05  M  carbonate/bicarbonate  buffer,  applied  to  duplicate  rows  of  two 
Microlon 600 ELISA plates (Greiner BioOne) and allowed to coat at 4ºC overnight. 
The following morning, the plate was washed with wash buffer (PBS, 0.05% (v/v) 
Tween 20), then blocking buffer (PBS, 0.05% (v/v) Tween 20, 5% (w/v) skim milk 
powder) added to all wells and the plate incubated for 1 hour at room temperature. 
Two solutions of the monoclonal antibody were prepared; a 1:25 and a 1:30 dilution 
in blocking buffer. After washing the protein coated plates again, 50 µL of blocking 
buffer were added to all wells, a 1:25 dilution of the monoclonal antibody was added 
to the first well of the first row of each protein dilution and a 1:30 dilution added to the 
first well of the second row. The mixtures from the first well of each row were then 
serially  diluted  across  the  plates  and  the  plates  incubated  for  1  hour  at  room 
temperature. After washing again, HRP-conjugated goat anti-mouse IgG (Sigma), at 
the manufacturer’s recommended dilution in blocking buffer, was added to all wells 
of both plates and the plates incubated for 1 hour at room temperature. The plates 
were washed again, then 50 µL/well of a solution containing ABTS (BioRad) were 
added and colour allowed to develop for 15 minutes at room temperature. The colour 
development  reaction  was  stopped  by  the  addition  of  2%  (w/v)  oxalic  acid  and 
absorbance at 405nm measured using a spectrophotometer. 
 
5.2.5.3 Optimisation of western immunoblotting 
A  nitrocellulose  membrane  containing  the  recombinant  protein  was  prepared  and 
western blotting was carried out as described above. The monoclonal antibody was 
diluted 1:50 and 1:62.5 in TBS, then serial 1:2 dilutions were made of each solution. 
One  hundred  and  fifty  microlitres  of  each  consecutive  dilution  were  added  to 127 
 
individual lanes of a Bio-Rad Mini-PROTEAN II multiscreen apparatus and incubated 
at room temperature for 1 hour. Colour development was carried out as previously 
described. 
 
5.2.5.4 Optimisation of indirect immunohistochemistry 
Three different dilutions of the monoclonal antibody (1:50, 1:200 and 1:500) were 
used in an indirect IHC procedure to optimise the amount of antibody. Five-micron 
sections of formalin-fixed and paraffin embedded liver tissue, from a rainbow lorikeet 
known  to  be  infected  with  BFDV,  were  cut  using  a  microtome  (Leica  RM  2135), 
placed onto glass slides, de-waxed 3 times in xylene for 3 minutes and re-hydrated 
using decreasing ethanol concentrations and a final wash in Tris buffer for 3 minutes. 
Seven  tissue  sections  were  prepared;  one  negative  control  (no  monoclonal 
antibody),  then  duplicate  sections  for  each  dilution  tested.  Of  these  duplicate 
sections, one of each was treated for antigen retrieval by microwaving three times for 
three minutes each time in citrate buffer pH 9. Endogenous peroxidase activity was 
quenched by the addition of 0.3% (v/v) hydrogen peroxide for 5 minutes and then the 
sections were washed with deionised water. 
 
Each  of  the  dilutions  of  monoclonal  antibody  was  then  applied  to  the  duplicate 
sections  for  10  minutes  at  room  temperature,  with  TBS  applied  to  the  negative 
control  section. The  sections  were  then  washed  twice  with  TBS  and  tapped  dry. 
EnVision  anti-mouse  HRP  (Dako)  was  then  added  and  the  sections  incubated  at 
room temperature for 30 minutes, after which the sections were washed twice with 
TBS. Antigen-antibody complexes were visualised by the addition of the chromogen 
diaminobenzidine  (DAKO
®  DAB  chromogen)  and  the  sections  incubated  at  room 128 
 
temperature for 3 minutes, then rinsed in deionised water. The sections were then 
dehydrated  in  increasing  concentrations  of  ethanol,  counterstained  with 
haematoxylin  and  mounted.  Imaging  was  performed  using  an  Olympus  BX  13 
microscope and digital camera accessory. 
 
5.2.6 Development of a blocking enzyme-linked immunosorbent assay 
Insofar as was practical, the bELISA was developed and validated in accordance 
with guidelines established by the Office International des Epizooites (O.I.E.) for the 




Samples of blood, collected on filter paper and air-dried and serum or plasma from 5 
species  of  psittacine  birds  (including  sulphur-crested  cockatoos,  galahs,  rainbow 
lorikeets,  eclectus  parrots  and  gang-gang  cockatoos  known  to  have  antibodies 
against BFDV were used to optimise the Ab-bELISA. These were selected to include 
a  range  of  HI  antibody  titres.  Normal  chicken  serum  was  included  as  a  known 
negative  control  and  a  sample  of  serum  from  a  chicken  inoculated  with  a  DNA 
vaccine protective for BFDV (Section 6.2.6) was included as a sample which had an 
antibody titre bellow the limit of detection of the HI assay. 
 
To  validate  the  bELISA,  166  samples  from  the  vaccine trial  described in  Section 
3.2.3 were tested using the optimised bELISA. Samples included both dried blood on 
filter paper and plasma. 
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For blood collected onto filter paper, two spots of blood on filter paper were excised 
using  either  scissors  or  a  hole  punch  and  placed  into  a  microcentrifuge  tube 
(Eppendorf). One hundred microlitres of ELISA blocking buffer (PBS, 0.05% (v/v) 
Tween 20, 5% (w/v) skim milk powder (Diploma)) were then added in order to make 
a 1:5 (w/v) suspension and serum eluted from the paper by incubating the mixture 
for  1  hour  at  room  temperature.  Serum  or  plasma  samples  were  diluted  1:5  in 
blocking buffer. 
 
Feathers  from  birds  which  had  previously  tested  positive  for  BFDV  by 
haemagglutination  assay  were  used  in  the  development  of  the  antigen  blocking 
ELISA (Ag-bELISA). Samples were selected to include a range of HA antigen titres 
and were prepared as for haemagglutination assays as described by Raidal et al. 
(1993c).  Feathers  were  incubated  with  100  µL  PBS  at  60ºC  for  1  hour  in  a 
microcentrifuge tube (Eppendorf) and the suspension centrifuged briefly. 
 
5.2.6.2 Optimisation of the blocking enzyme-linked immunosorbent assay for 
the detection of specific antibodies 
Recombinant baculovirus-expressed BFDV capsid protein was diluted to 2.5 µg/mL 
in 0.05 M carbonate/bicarbonate buffer, added to all wells of a Microlon 600 ELISA 
plate (Greiner BioOne) and allowed to coat at 4ºC overnight. The plate was then 
washed with wash buffer, blocking buffer added to all wells and the plate incubated 
for 1 hour at room temperature. After another wash step, 50 µL of blocking buffer 
were added to all wells of the ELISA plate and 50 µL sera, eluted as above, were 
added to the first well of each row and serially diluted across the plate. The plate was 
then incubated for 1 hour at room temperature. After removing the sera, the plate 
was washed again and 50 µL/well of a monoclonal antibody against the recombinant 130 
 
BFDV capsid protein (Section 5.2.4), diluted 1:400 in blocking buffer, were added 
and the plate incubated for 1 hour at room temperature. After washing, 50 µL of 
polyclonal anti-mouse IgG (Sigma), at the manufacturer’s recommended dilution in 
blocking buffer, were added to each well and the plate incubated for 1 hour at room 
temperature. After washing, 50 µL/well of a solution containing ABTS (BioRad) were 
added and colour allowed to develop for 15 minutes at room temperature. The colour 
development  reaction  was  stopped  by  the  addition  of  2%  (w/v)  oxalic  acid  and 
absorbance  at  405  nm  measured  using  a  spectrophotometer.  The  percentage 
inhibition (PI) of the test sera samples and negative cut-off value (based on the PI of 
the known negative samples) were then calculated. 
 
5.2.6.3 Optimisation of the blocking enzyme-linked immunosorbent assay for 
the detection of antigen (antigen-bELISA) 
Microtitre  plates  were  coated  overnight  with  recombinant  protein,  washed,  and 
blocked as described above. At the same time, 50 µL blocking buffer were added to 
a separate, non-coated microtitre plate and 50 µL of the supernatants from individual 
feather preparation were added to the first well of each column. Serial dilutions were 
made by removing 50 µL of the solution from the first well, mixing with 50 µL PBS in 
the next well and repeating the process down the column of the microtitre plate. Fifty 
microlitres of the monoclonal antibody, diluted 1:400 in blocking buffer, were added 
to each well. Negative and positive controls lanes were included for each microtitre 
plate;  negative (no  inhibition)  controls used blocking  buffer  instead  of  the  feather 
preparation and positive (complete inhibition) controls used blocking buffer instead of 
the antibody solution. The plates were then incubated as described above, then the 
protein-coated plate washed and the feather eluate/antibody mixture transferred from 131 
 
the non-coated plate to the coated plate. The plate was incubated and washed, then 
colour development and calculation of PI values carried out as described above.  
 
Further optimisation was conducted by testing the monoclonal antibody at dilutions 
of 1:400, 1:1,500, 1:3,000, 1:5,000, 1:10,000, 1:20,000 in blocking buffer and using 
serial dilutions of a 10% feather suspension from sulphur-crested cockatoo with a 
strong positive HA titre of >40 960HAU/50 µL. Each antibody dilution was tested in 
parallel using blocking buffer with 5% skim milk, blocking buffer with 1% skim milk 
and plain PBS as the diluent. 
 
5.2.7 Validation of the Ab-bELISA for the detection of specific antibodies 
To validate the bELISA, 166 samples from eastern long-billed corellas vaccinated 
with a recombinant BFDV capsid protein (Bonne et al., 2008b, Stewart et al., 2007) 
and  challenged  with live  virus  were  tested using  the  optimised  bELISA.  Samples 
included  both  dried  blood  on  filter  paper  and  plasma.  After  testing,  the  PI of  the 
samples were compared to the corresponding HI titres. In addition, 82 samples from 
cockatiels  that  had  been  assessed  as  negative  by  HI  (Section  4.3.1)  as  well  as 
samples from a cockatiel known to be BFDV-positive and its cage mate were also 
tested.  Both  of  these  birds  had  also  previously  tested  negative  by  HI.  For  blood 
collected onto filter paper one spot of blood on filter paper was cut out using scissors 
or a hole punch and collected into a microcentrifuge tube (Eppendorf). 100 µL of 
ELISA  blocking  buffer  were  then  added  (to  make  a  1:10  (w/v)  suspension)  and 
serum  eluted  from  the  paper  by  incubating  the  mixture  for  1  hour  at  room 
temperature. Serum or plasma samples were diluted 1:10 in blocking buffer. 
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Tests to evaluate the precision, repeatability and accuracy of the assay were also 
conducted;  however  it  was  not  practical  to  evaluate  reproducibility  between 
laboratories.  Repeatability  assays  were  conducted  using  pooled  sera  from  10 
vaccinated  birds.  The  intra-assay  coefficient  of  variation  was  determined  by 
performing 10 replicates of pooled sera and the inter-assay coefficient of variation 
was determined by repeating this group of replicates 10 times. Data from the test of 
intra-assay repeatability was plotted to determine the assay’s precision. The linearity 
of the assay was also investigated using 10 replicates of the pooled sera that were 
serially diluted 1:2 and the PI values plotted against the log2 of the dilution factor.  
 
5.2.8 Statistical analysis 
Calculation of the line of best fit and correlation coefficient of the graph of protein 
amount  against  HA  titre,  the  PI  values  of  vaccinated  and  non-vaccinated  birds 
against  time,  the  correlation  between  HI  values  and  bELISA  PI  values  were 
performed using CoPlot (CoHort Software, 2005). Descriptive statistics for bELISA PI 
values from the vaccine trial, sensitivity, specificity, positive and negative predictive 
values and coefficients of variation were calculated using Microsoft Excel. 
 
5.3 Results 
5.3.1 The recombinant protein has HA activity and forms virus-like 
particles 
The recombinant protein  was  successfully  expressed  in  Sf9 insect  cells and  was 
purified  using  both  Ni-NTA  resin  chromatography  and  sucrose/CsCl 
ultracentrifugation.  Purification  using  Ni-NTA  resin  was  incomplete,  however,  with 
much of the protein remaining in the insoluble and unbound fractions (Figure 5.1a). 
Sucrose/CsCl ultracentrifugation successfully purified the protein from both of these 133 
 
fractions and was also used successfully to purify the protein from crude insect cell 
lysates (Figure 5.1b). Dialysis in PEG 20K could successfully concentrate the protein 
more than 100-fold overnight. 
 
SDS-PAGE showed that the protein was approximately 32 kDa in size (Figure 5.1a) 
and  was  not  present  in  the  control  Sf9  cells  (not  shown).  Western  blotting  with 




Figure 5.1: Purification of the recombinant protein by Nickel-NTA resin and caesium chloride (CsCl) 
ultracentrifugation.  A:  SDS-PAGE  analysis  of  the  expressed  and  purified  protein  (arrow).  MW: 
molecular weight markers; Ins: the insoluble proteins, collected after clarification of the lysed cells; 
Unb: the unbound fraction (proteins which did not bind to the Ni-NTA resin); W1 – 3: wash fractions 1 
to 3; E1 – 4: elution fractions 1 to 4. Note that the protein is present in the first elution fraction, as it 
should be, but a large amount of protein is still present in both the insoluble and unbound fractions. B: 
Sucrose/CsCl purification of the recombinant protein. A distinct band containing the protein can be 
seen (open arrow). 
 
 
The recombinant protein demonstrated haemagglutination activity with Type A galah 
erythrocytes (Figure 5.2a, b) and protein concentration was logarithmically related to 
the HA titre (log2HA = 1.65ln(protein) + 2.25, R






Figure 5.2: Correlation of protein amount with haemagglutination (HA) titre. A: Serial dilutions of the 
recombinant  protein.  B:  non-serial  dilutions  of  the  recombinant  protein.  C:  Relationship  between 
protein amount (ng/well) and log2HA titre. 
 
 
Sera from naturally immune psittacine birds successfully inhibited agglutination of 
galah  erythrocytes,  as  did the polyclonal  chicken  anti-BFDV  used as  the  positive 
control. The expected HI titre of each bird’s serum was achieved for all samples. 
Sera  from  naïve  chickens  and  psittacine  birds  did not inhibit agglutination  by  the 









Figure  5.3:  Haemagglutination  inhibition  (HI)  assay  using  the  recombinant  protein  as  the  antigen 
source and sera from inoculated chickens and naturally immune psittacine birds. The first row is a 
back titration of native Beak and Feather Disease Virus and the second row a back titration of the 
recombinant protein. The sera from naturally immune psittacine birds (rows 3-8) attained the expected 
HI titres. A positive HI titre was indicated by the sedimentation of the erythrocytes within the well of 
the microtitre plate, whereas a negative HI result was indicated by the suspension of the erythrocytes 
in the well.  
 
 
Transmission  electron  microscopy  showed  that  the  protein  self-assembled  into 
spherical, 18-20 nm diameter VLPs that appeared identical to wild-type BFDV virions 
(Figure  5.4).  Protein  sequencing  by  MALDI-TOF  mass  spectrometry  showed  the 





Figure 5.4: Transmission electron micrograph of phosphotungstic acid-stained baculovirus-expressed 
recombinant Beak and Feather Disease Virus capsid protein. The protein has self-assembled into 
spherical virus-like particles (VLPs) approximately 18-20 nm in diameter. 
 
 
5.3.2 A monoclonal antibody to a recombinant BFDV capsid protein 
All mice developed an antibody response to the recombinant protein detectable by 
western blotting and the polyclonal anti-recombinant BFDV Cap serum from all mice 
recognised native BFDV in an HI assay (Figure 5.5b). The spleen cells from mouse 
BB1  were  fused  with  Sp2/0  myeloma  cells  and  about  60%  of  the  resultant 






Figure 5.5: Screening of mice vaccinated with the recombinant protein. A: Western blot assay. The 
sera detected the recombinant protein (solid arrow) as well as some other proteins (hollow arrows) 
present in the protein solution. Lane 1: MW markers, Lane 2: no serum, Lane 3: mouse anti-his, 
Lanes 4-7: mice BB1-BB4. B: Haemagglutination inhibition assay using the same sera. The sera of all 
four mice recognise native Beak and Feather Disease Virus and have high (log210-11) antibody titres. 
 
 
ELISA assays showed that most (>70%) hybridomas were producing antibody that 
recognised the recombinant protein (Figure 5.6b), so the 29 hybridomas  with the 
strongest  ELISA  result  were  selected,  then  expanded  and  re-screened  and  their 
antibody isotype determined. All 29 hybridomas were still producing antibodies after 
expansion and isotyping showed that 28 of the 29 hybridomas produced IgG. These 
28  hybridomas  were  screened  3  times  by  HI  assay  as  described  above.  No  HI 
activity was detectable in any of the supernatants, regardless of whether or not they 
were  treated  prior  to  testing.  When  samples  were  not  adsorbed  with  kaolin  (i.e. 
haemadsorption only or no treatment), non-specific HA activity was present in the 
samples (Figure 5.6c). Haemadsorption prior to testing reduced this non-specific HA 
activity by  a  factor of log22  and  both  kaolin  and  haemadsorption  eliminated  non-
specific HA (Figure 5.6d). 
 
Electrophoretic mobility shift assay revealed that proteins in the antiserum solution 
also bind DNA. The control assay containing antiserum but not protein inhibited DNA 
movement  as  much  as  the  assay  containing  protein  only.  The  antiserum  was 
successfully  purified  by  ammonium  sulphate  precipitation,  as  the purified  solution 138 
 
had  the  same  HI  titre  as  the  non-purified  solution.  The  control  assay  containing 
purified antibodies but not protein did not inhibit DNA movement. However, the test 
assay containing protein and purified antibodies did not prevent the inhibition of DNA 
movement by the recombinant protein. Thus it was concluded that larger quantities 
of  antibody  than  were  available  are  likely  required  to  inhibit  the  binding  of  the 




Figure 5.6: Screening of hybridomas by ELISA and haemagglutination-inhibition (HI). A: ELISA control 
plate, control samples were tested in duplicate. Rows 1-2: polyclonal mouse anti-recombinant Beak 
and Feather Disease Virus (BFDV) Cap; rows 3-4: normal mouse serum; rows 5-6: PBS. B: ELISA 
screening of hybridomas. Individual wells represent corresponding hybridomas. C: HI screening of 
hybridomas without kaolin adsorption or haemadsorption. Row 1: A back titration of BFDV; row 2: 
chicken  anti-BFDV;  rows  3-8:  hybridomas.  Note  the  non-specific  haemagglutination  (HA)  activity, 
indicated by sludging of the erythrocytes. D: HI screening of hybridomas after kaolin adsorption and 
haemadsorption. Non-specific HA activity has been removed but no HI activity is detectable. 
 
 
Western  blotting  of  hybridoma  supernatants  showed  that  most  hybridomas  were 
secreting  a  polyclonal  array  of  antibodies  and  only  some  of  these  successfully 
detected the recombinant protein (Figure 5.7a). Hybridoma 3F8 was selected as it 
reacted strongly in both the ELISA and western blot and it appeared that almost all of 139 
 
the antibody it produced was specific to the recombinant protein (Figure 5.7a, arrow). 
Hybridoma  3F8  was  cloned  by limiting  dilution  and  screened  by  both  ELISA  and 
western blot. Three clones were determined to be positive by ELISA and all clones 
detected  only  the  recombinant  protein  and  not  the  PCV2  capsid  protein  or 
polyhistidine  tag  by  western  blot  (Figure  5.7b).  Clone  3F8-1  had  the  strongest 
reaction by ELISA and western blot and was chosen for expansion and production of 
monoclonal antibodies. After purification, the subclass of the monoclonal antibody 




Figure 5.7: A: Western blotting of IgG-secreting, ELISA-positive hybridomas. Hybridoma 3F8 (arrow) 
reacted  strongly  with  the  recombinant  protein.  M:  molecular  weight  markers;  Lane  1:  polyclonal 
mouse  anti-recombinant  Beak  and  Feather  Disease  Virus  Cap;  Lanes  2-14:  tested  hybridoma 
supernatants. Note hybridoma 3F8 (lane 5, arrow). B: western blotting of limiting-dilution clones of 
hybridoma  3F8  against  the  recombinant  BFDV  capsid  protein  (lanes  1-4)  and  a  his-tagged 
recombinant Porcine Circovirus 2 capsid protein (lanes 5-8). M: molecular weight markers; Lanes 1, 




5.3.3 The monoclonal antibody has HI activity and is useful in multiple 
applications 
5.3.3.1 Haemagglutination inhibition 
Hybridoma 3F8-1, when untreated by either kaolin or haemadsorption, had an HI 





Figure 5.8: Haemagglutination Inhibition (HI) assay using monoclonal antibody 3F8-1. When the virus 
was used at low concentrations, the monoclonal antibody had HI activity of up to log22 HIU/50µL. Row 
1: a back titration of Beak and Feather Disease Virus (BFDV) (open arrow); Row 2: polyclonal chicken 
anti-BFDV; Row 3: monoclonal antibody 3F8-1 used as a test sample (closed arrow). 
 
 
5.3.3.2 Indirect enzyme-linked immunosorbent assay 
The optimal amount of protein used in the indirect ELISA was determined to be 250 
ng/well  and  the  optimal  dilution  of  monoclonal  antibody  was  1:400.  The  indirect 
ELISA  performed  well  at  many  other  combinations  of  protein  and  monoclonal 
antibody dilution, but the above protein amount and antibody dilution were selected 
as they had a good positive absorbance value and a useful dynamic range. 
 
5.3.3.3 Western immunoblotting and indirect immunohistochemistry 
The optimal dilution of monoclonal antibody for use in both western immunoblotting 
and indirect IHC was determined to be 1:500. When used in western immunoblotting, 
the  monoclonal  antibody  detected  the  recombinant  protein  at  all  dilutions  up  to 









Figure 5.9: Optimisation of a western blotting protocol using monoclonal antibody 3F8-1. M: molecular 
weight markers. The monoclonal antibody reacts strongly with the recombinant protein at all dilutions 
up to 1:500 (arrow). Detectable reactions could still be observed at dilutions between 1:1,000 and 
1:4,000 (dashed line). 
 
 
The  monoclonal  antibody  detected  BFDV  antigen  in  formalin  fixed,  paraffin 
embedded tissues at all dilutions tested. Background staining and edge effect were 
significant when the monoclonal antibody was used at 1:50 and 1:200 (Figure 5.10b, 
d) and made evaluation of the results more difficult. Antigen retrieval decreased the 
endogenous  peroxidase  activity  of  erythrocytes,  but  increased  non-specific 
background staining and decreased the amount of specific positive staining at all 




Figure 5.10: Indirect immunohistochemistry using monoclonal antibody 3F8-1 on a section of liver 
from a lorikeet infected with Beak and Feather Disease Virus. A: negative (no monoclonal antibody) 
control; B, D, F: the monoclonal antibody used at 1:50, 1:200 and 1:500, respectively, without antigen 
retrieval;  C,  E,  G:  the  monoclonal  antibody  used  at  the  same  respective  dilutions,  with  antigen 
retrieval. Note the increased edge-effect around erythrocytes with the higher antibody concentration 
(image B) and the decrease in endogenous peroxidase activity, background staining but also specific 
staining after antigen retrieval (image C, E, G). Bar equals 50 µm. 143 
 
5.3.4 A novel blocking ELISA for the detection of antibodies to BFDV 
The optimal dilution of serum for use in the Ab-bELISA was determined to be 1:10. 
This gave a useful dynamic range and a lower limit of detection (greater analytical 
sensitivity) than the HI test. 
 
The corellas vaccinated with the recombinant protein had peak mean PI levels of 
between 6.01% and 44.26% at challenge (after the second vaccination) and between 




Figure  5.11:  Blocking  ELISA  (bELISA)  mean  percentage  inhibition  values  of  vaccinated  (○)  and 
control (●) birds after vaccination. Vaccinations are indicated by an arrow (↑) and challenge with a 
triangle (∆). Bars indicate standard error. 
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Control  birds  had  peak  antibody  levels  of  between  55.25%  and  83.26%  after 
challenge with live virus. When antibody levels measured by bELISA were compared 
with HI titres, the correlation coefficient was very high (r
2 = 0.8156, p<0.05) (Figure 
5.12). After repeating the cockatiel sero-survey using the Ab-bELISA, no antibodies 
were  detected  in  the  serum  of  any  of  the  birds.  Furthermore,  both  the  cockatiel 








Based  on  the  results  of  the  vaccine  trial  samples,  sensitivity  was  99.09%  and 
specificity was 71.43% when compared to the HI assay, with a positive and negative 
predictive value of 87.2% and 97.56% respectively. Using the results of the cockatiel 145 
 
sero-survey, the bELISA was 100% specific and combining these results with the 
results of the vaccine trial gave the same sensitivity and increased the specificity to 
88.41%  and  the  negative  predictive  value  to  99.19%.  The  mean  PI  value  of  the 
pooled sera was 64.28% and almost all repeated samples fell within ± 2 standard 
deviations of the mean value (Figure 5.13a). The intra- and inter-assay coefficients 
of variation were 3.61% and 6.94%, respectively and the bELISA was determined to 
be linear within the working range of the samples tested (Figure 5.13b). This working 
range did not include the entire biological range exhibited by samples from birds in 




Figure 5.13: A: Blocking ELISA (bELISA) precision. B: bELISA linearity assay using sera pooled from 
10 vaccinated birds. The percentage inhibition values are linear within the dynamic range of the test. 
Bars indicate standard error. 
 
 
The Ag-bELISA was not useful for the detection of BFDV antigen, since the binding 
of the monoclonal antibody to the recombinant protein on the microtitre plate was not 
inhibited by naturally occurring amounts of soluble antigen at a dilution of 1:10,000 or 
less.  At  dilutions  greater  than  1:10,000,  spectrophotometer  measurements  were 




Given the high rates of BFDV infection in psittacine birds worldwide, sensitive and 
specific detection methods which are readily standardised, making comparison of 
results between different laboratories feasible, are highly desirable. Since the BFDV 
capsid protein is the major antigenic determinant of the virus (Stewart et al., 2007), 
the  capsid  protein  and  a  specific  antibody  to  it  are  the  two  most  important 
components of any diagnostic assay for BFDV. Recombinant BFDV capsid proteins 
(Heath et al., 2006, Johne et al., 2004, Stewart et al., 2007) can be produced in large 
quantities and quantified reasonably accurately and may be substituted for whole 
BFDV virus, which cannot be easily produced. The monoclonal antibody to the BFDV 
capsid protein described in this study also has the advantage that it can be produced 
in  the  laboratory  in  large  quantities  and  accurately  quantified.  This  antibody,  in 
combination with the recombinant BFDV capsid protein, should enable the further 
development of standardised diagnostic tests. 
 
Like other recombinant viral proteins (Noad and Roy, 2003, Tegerstedt et al., 2005, 
Ulrich et al., 1998), the full-length recombinant BFDV capsid protein self assembled 
into  VLPs.  Importantly,  the  VLPs  behaved like  native  BFDV  in  that  they had  HA 
activity  and  were  recognised  by  naturally  occurring  anti-BFDV  sera.  Other 
recombinant BFDV capsid proteins have been developed (Heath et al., 2006, Johne 
et al., 2004) and have been shown to have merit for use in serological assays, but 
the morphology and haemagglutination behaviour of the proteins were not assessed. 
The formation of VLPs is an important consideration in the development of vaccines 
for BFDV, as VLPs are processed in a similar way to native virus (Noad and Roy, 
2003, Tegerstedt et al., 2005, Ulrich et al., 1998) and induce potent T-cell responses 
(Noad and Roy, 2003). The variable size and shape of some of the VLPs is probably 147 
 
a result of incomplete or improper assembly (Crowther et al., 2003, Wong et al., 
1994). A criticism of HA and HI tests is that the variation in sensitivities of donor 
erythrocytes to the virus, which may induce differences in results when the same 
amount  of  virus  or  antibody  is  used,  makes  them  difficult  to  standardise.  The 
experiment  performed  in  this  chapter  to  correlate  the  amount  of  protein  with  the 
resultant HA titre allows a  measure of standardisation of HI assays as well as a 
means of assessing the efficiency of the various steps of the purification process. 
Obviously the HA titre of a protein sample will differ when erythrocytes from different 
hosts are used. The sensitivity of a single donor’s erythrocytes varies over time, but 
the precise measurement of protein quantity allows this variation to be accounted for 
and mitigated to a certain extent. 
 
There has been only one other report on the development of monoclonal antibodies 
to BFDV (Ritchie et al., 1992). This monoclonal antibody was developed using whole 
virus prepared from the feathers of infected birds and was optimised for use in an 
indirect  ELISA  and  immunohistochemistry.  Unfortunately,  there  have  been  no 
subsequent reports  on  the  use  of  this  monoclonal  antibody in  other  applications. 
Ritchie et al. (1992) reported that the monoclonal antibody they developed was not 
able to inhibit haemagglutination by BFDV. However, the current study demonstrates 
that this may simply have been due to the amount of monoclonal antibody used in 
the  HI  test,  as  the  supernatant  of  hybridoma  3F8-1  also  did  not  inhibit 
haemagglutination until it was purified and concentrated. The amount of virus that 
the  authors  used  may  have  affected  the  inhibition  of  haemagglutination  by  the 
monoclonal antibody, as the HI assay was described as using virus with an HA titre 
of  64  HAU  (Ritchie et  al., 1991b). Why  the  authors  used  this  amount  of  virus is 
unclear. The monoclonal antibody described in this study will no doubt be suitable for 148 
 
ongoing use in the western blotting and immunohistochemistry as described above 
and will enable standardisation of these applications. 
 
The monoclonal antibody detected virus from a cockatoo and a lorikeet (this study) 
and a cockatiel (Section 4.3.2). Ongoing testing using virus from as many species of 
psittacine birds as possible is still necessary. Cross-reactivity work using sera from 
rainbow  lorikeets,  short-billed  corellas  (Cacatua  sanguinea),  a  sulphur-crested 
cockatoo, a red lory (Eos bornea) and a galah-corella hybrid and virus from rainbow 
lorikeets,  a  red  lory,  two  swift  parrots  (Lathamus  discolor),  a  sulphur-crested 
cockatoo and a scarlet-chested parrot (Neophema splendida) failed to find evidence 
of  antigenic  serotypes  (Khalesi  et  al.,  2005).  However,  the  results  of  the  similar 
experiment  described  in  Section  4.3.1  suggest  that  the  cockatiel  isolate  may  be 
sufficiently  different  antigenically  to  be  considered  a  separate  serotype.  Given, 
though, that the antibody detects virus from cockatiels, it should have widespread 
application for the detection of most, if not all other BFDV isolates. 
 
Interestingly,  the  optimal  dilution  of  the  antibody  is  the  same  when  used  in  both 
western blotting and immunohistochemistry. Often the formalin-induced cross-links 
within and between proteins require the use of antigen retrieval techniques (Rait et 
al.,  2004)  and/or  a  more  concentrated  primary  antibody  solution.  According  to 
Sompuram et al. (2006), the epitope detected by the monoclonal antibody described 
in  this  study  is  most  likely  linear,  with  a  high  concentration  of  proline,  tyrosine, 





The monoclonal antibody potentially has widespread application in both diagnostic 
and research work. Its use in western immunoblotting and HI assays will likely be 
limited to research, since western blotting is not practical for the routine detection of 
viral  antigen  and  large  amounts  of  the  antibody  are  needed  to  inhibit 
haemagglutination. The initial results of IHC testing, presented in the current study, 
are promising and the antibody should have widespread diagnostic application after 
its efficacy has been tested with a suitable range of virus isolates. 
 
At present, HI and HA assays are the best available assays for the detection of anti-
BFDV  antibodies  and  shed  virus,  respectively.  However,  given  the  amount  of 
variation inherent in both the HI and HA assays, novel diagnostic tests for both the 
virus  and  the  presence  of  anti-BFDV  antibodies  in  serum  are  highly  desirable. 
Presented here are the methods used to develop a novel blocking ELISA for the 
detection  of anti-BFDV  antibodies in  psittacine  sera.  Blocking  ELISAs  have  been 
developed  for  the  detection  of  antibodies  to  other  avian  viruses,  such  as  avian 
metapneumovirus  Type-C  (Turpin  et  al.,  2003),  avian  polyomavirus  (Khan  et  al., 
2000), chicken anaemia virus (Tannock et al., 2003, Todd et al., 1999) and turkey 
coronavirus  (Guy  et  al., 2002).  These bELISAs  have  the  distinct  advantage  over 
indirect ELISAs, in that secondary antibodies specific to the immunoglobulins of the 
species being tested are not required. For current large-scale screening and sero-
surveillance,  blocking  ELISAs  have  largely  replaced  indirect  ELISAs  (Gorham, 
2004). 
 
The  sensitivity  and  specificity  of  the  blocking  ELISA  developed  here  were  within 
values defined as acceptable by the OIE (Jacobson, 2004) and should prove to be a 
useful diagnostic test for BFDV. The monoclonal antibody used in the assay has a 150 
 
high analytical specificity (Section 5.3.2) and the analytical sensitivity was greater 
than the HI test, as it detected antibodies in vaccinated birds that were HI negative. 
Because  of  this,  however,  the  analytical  sensitivity  could  not  be  determined 
precisely.  The  comparative  diagnostic  sensitivity  and  specificity  was  good,  but 
because of the greater analytical sensitivity of the bELISA, the absolute diagnostic 
sensitivity  and  specificity  is  likely  to  be  higher.  Given  the  calculated  diagnostic 
sensitivity, 166 samples is adequate to validate the assay with 95% confidence of an 
accurate  result  (Jacobson,  1998).  However,  assuming  the  highest  calculated 
diagnostic specificity of 88%, the number of known negative animals required is 1 
014. The actual number of known negative animals required is likely to be much 
less, since the actual diagnostic specificity is likely to be higher. Since it is so difficult 
to find psittacine birds that have not been exposed to the virus, ongoing testing with 
birds of known antibody status is desirable. 
 
The precision, repeatability and accuracy of the assay were within values accepted 
by the OIE (Jacobson, 1998). Reproducibility could not be assessed since testing in 
other laboratories was impractical. The cut-off value was determined from a 95% 
confidence interval of the negative control wells (Coligan et al., 2001) since it was 
almost impossible to find a group of birds known to be truly seronegative. Assuming, 
though, that the cockatiels were truly seronegative, the cut-off value calculated from 
a 95% confidence interval of the mean PI of those 82 samples was similar to that 
calculated using the negative control wells only. As more samples are tested using 
this assay over time, the methods of calculating a cut-off value can be compared 
with receiver-operator curves to see which method is more appropriate. The positive 
and  negative  predictive  values  were  good  and  given  the  high  seroprevalence  of 
BFDV, should translate well to samples from naturally infected birds. 151 
 
 
The  correlation  coefficient  between  bELISA  values  and  HI  titres  from  a  group  of 
corellas vaccinated with a recombinant BFDV capsid protein and challenged with live 
virus (Bonne et al., 2008b) was high. This is somewhat surprising given the differing 
nature of the two tests. The HI assay gives a defined cut-off, with the difference 
between the last positive well and the first negative well being a 1:2 dilution of the 
sample. The bELISA, on the other hand, would allow more precise characterisation 
of antibody levels, as it allows for continuous readings of PI values for samples with 
antibody  levels  which  fall  in  between  HI  end-points.  The  intra-  and  inter-assay 
coefficients of variation were good and in line with OIE assay validation guidelines 
(Jacobson, 2004). Absorbance values fell within the linear range of the assay for the 
samples tested; however evaluation of the assay’s behaviour for samples with PI 
values greater than 64.28% was not possible. 
 
Only one other ELISA has been developed to test for the presence of anti-BFDV 
antibodies  in  psittacine  sera  (Johne  et  al.,  2004).  This  was  an  indirect  ELISA, 
utilising  a  truncated  recombinant  BFDV  capsid  protein  and  a  secondary  antibody 
directed against psittacine IgY. This ELISA tested 11 serum samples from 7 different 
psittacine species and thus has yet to be validated with a large number of samples of 
birds with known antibody status. Additionally, no studies have yet been conducted 
investigating the cross-reactivity of psittacine IgY and given that there are 78 genera 
and 332 species within the Psittacidae, such studies may be prohibitively difficult. 
This means, though, that a sample from a rare species of psittacine bird which tested 
negative  by  indirect  ELISA  could  not  be  guaranteed  to  be  truly  negative. 
Consequently, we believe that a blocking ELISA, as described here, is likely to be a 
more reliable diagnostic test. The blocking ELISA also has the advantage that serum 152 
 
containing both IgM and IgY can be reliably tested using the one assay, as it does 
not rely on secondary antibodies directed against either class of immunoglobulin. 
 
Although the ELISA described here has been validated with 166 samples, further 
testing is necessary to ensure that the assay performs well with sera from as many 
psittacine species as possible. Any potential problems with consistency of the test 
between  species  would  theoretically  be  the  result  of  differing  cross-reactivities 
between the test serum and the recombinant protein. Stewart et al. (2007) failed to 
find  any  differences  in  cross  reactivity  between  the  recombinant  protein  and  a 
number of psittacine anti-BFDV antisera in both western blotting and HI, but further 
testing and validation should be an ongoing process. The fact that the monoclonal 
antibody  described  in  this  chapter  recognised  BFDV  from  a  sulphur-crested 
cockatoo,  rainbow  lorikeet  and  a  cockatiel  indicates  that  there  is  some  antigenic 
homology between isolates. 
 
The sero-survey of 88 cockatiels described in Chapter 4 failed to find any birds with 
detectable  HI  titres.  As  such,  the  sero-survey  was  repeated  using  the  newly 
developed bELISA and included serum from a cockatiel known to be BFDV-positive 
and its cage mate in an attempt to elucidate the reason for the apparent universal 
negative results. The apparent lack of sero-positive birds may be due to one of three 
possibilities.  Firstly,  the  birds  may  have  had  antibody  levels  below  the  limit  of 
detection of the HI test. Secondly, antibodies in cockatiel sera may not cross-react 
with the virus used in the HI tests or the recombinant protein, or finally, cockatiels 
may be resistant to BFDV infection to the extent that they rarely become infected 
and  hence  do  not  develop  antibodies.  Unfortunately,  no  definite  answer  can  be 
deduced after repeating all of these samples, given that the cage mate of a known 153 
 
BFDV-positive bird tested negative by HI using virus prepared from both cockatoo 
and cockatiel feathers and also tested negative by bELISA. A definitive answer to 
this problem may only be discovered by conducting HI assays using sera from many 
cockatiels, tested against virus eluted from the feathers from a range of psittacine 
birds. 
 
The  bELISA  has  a  number  of  advantages  over  the  HI  test.  First  and  most 
importantly, the bELISA is much more easily standardised as the amounts of both 
the  recombinant  protein  and  monoclonal  antibody  used  in  the  assay  can  be 
quantified  more  accurately.  Even  though  both  the  recombinant  protein  and 
monoclonal antibody are initially expensive to develop and produce, they are a much 
more  reliable  and  consistent  source  of  reagents  than  the  virus  preparation, 
polyclonal antibodies and erythrocytes used in HI assays. Virus used in the HI assay 
must be purified from the feathers from persistently infected birds. This process is 
expensive, ethically questionable, time consuming, results in low yields of virus and 
the extraction procedure can be contaminated with host proteins. The HI assay also 
requires a flock of suitable birds to be kept in order to use their erythrocytes for 
haemadsorption and testing. 
 
Within  this  flock,  the  sensitivity  of  erythrocytes  to  BFDV  may  vary  between 
individuals within a species (Sanada and Sanada, 2000) and the sensitivity of an 
individual bird’s erythrocytes may also vary over time. Variation in the amount of 
virus  between  preparations  and  decreased  HA  activity  of  the  virus  over  time 
compounds  this  problem.  Even  though  this  variation  may  be  standardised  to  an 
extent  by  titrating  virus  and  antibody  activity  against  each  other  and  against  the 
erythrocytes  from  multiple  birds  prior  to  testing,  HI  assays  are  still  prone  to  an 154 
 
appreciable  amount  of  inter-test  variation.  Another  factor  to  consider  is  that  the 
amount of antibodies present in a sample as measured by ELISA may not correlate 
directly with neutralisation of the virus. Studies on PCV2 have shown that variations 
in the length and composition of the capsid protein can cause disparities between 
ELISA  and  serum  neutralisation  titres  (Fan  et  al.,  2008).  This  should  not  be  a 
problem with the bELISA described here, as it uses a full-length capsid protein as 
the antigen and correlates well with the HI assay. 
 
Another advantage of the bELISA over the HI assay is the amount of time taken to 
perform  the  assay.  Even  though  there  are  four  1-hour  incubation  steps  in  the 
bELISA, sample preparation time is much reduced as samples are eluted directly 
into the ELISA blocking buffer. The time taken to run the bELISA could be shortened 
further by pre-coating and blocking the plates in bulk and storing them for future use 
(KPL, 2006), or by directly conjugating the monoclonal antibody to HRP. The total 
incubation time would therefore be reduced to 2 hours. However, the performance of 
the  protein-coated  plates  after  storage  and  the  effect  of  the  directly  conjugated 
monoclonal antibody on peak absorbance values would need to be assessed. 
 
Overall, the b  ELISA described here should be a useful tool for the sero-diagnosis of 
BFDV infection. It is more readily standardised, simpler to perform, more repeatable 
and has a greater analytical sensitivity than the HI assay. In the future it should also 
provide valuable information in subsequent studies on the pathophysiology of the 
virus, such as the fluctuations in antibody levels at various stages of disease and the 
transfer  of  maternal  antibodies and  their  effect  on infection  and immunity.  In  this 
experiment  it  was  able  to  provide  the  valuable  information  that  the  vaccinated 
corellas  had  developed  antibodies  against  the  recombinant  protein  after  the  first 155 
 
vaccination and it should also prove to be very useful in the further optimisation of 
BFDV vaccination protocols. 
 
It is unfortunate that the bELISA could not be adapted for the detection of antigen as 
well. Since the monoclonal antibody has been shown to bind to soluble antigen in 
solution in an HI assay, the most likely explanation for the lack of success of the Ag-
bELISA is that the dilution of monoclonal antibody required for it to be the limiting 
reagent was too great. A 1:400 dilution was appropriate for the Ab-bELISA, since the 
amount  of  recombinant  protein  was  the  limiting  factor  and  a  greater  amount  of 
monoclonal antibody could be used in order to amplify the signal. It is unlikely that 
the Ag-bELISA was not successful due to the monoclonal antibody having a greater 
affinity for the recombinant protein than native virus, since it has been shown that the 
optimal  dilution  of  monoclonal  antibody  is  the  same  for  recombinant  protein,  in 
western blotting and for virus in IHC. 
 
An  antigen-capture  ELISA  will  almost  certainly  be  more  useful  for  the  antigen 
detection and such an assay could easily be developed using the components of the 
Ab-bELISA. In this assay, the monoclonal antibody would be bound to the microtitre 
plate,  virus  suspensions  added  and  then  the  same  monoclonal  antibody,  directly 
conjugated  to  an  enzyme  such  as  HRP  bound  to  the  captured  virus  and  colour 
developed  and  absorbances  measured.  Alternately,  given  the  large  number  of 
hybridomas  available  for  development,  a  second  monoclonal  antibody  could  be 
produced and used in the capture ELISA, with the antibody of greatest affinity bound 
to the microtitre plate. If epitope mapping experiments are carried out with different 
BFDV isolates and antigenic differences are revealed, antigen capture ELISAs could 
potentially be developed to discriminate between isolates.  156 
 
Chapter 6. Development of Two Novel DNA Vaccines as a 
Potential Strategy for the Control of Psittacine Beak and 
Feather Disease (PBFD) 
 
 
6.1 Introduction and Aims 
6.1.1 Introduction 
Psittacine Beak and Feather Disease (PBFD) is the most common viral infection of 
psittacine birds and causes both a chronic debilitating feather disease in adult birds 
(Albertyn et al., 2004, Pass and Perry, 1985, Rahaus and Wolff, 2003, Ritchie et al., 
1989b) and a severe, acute disease syndrome in nestlings and African grey parrots 
(Doneley, 2003, Raidal and Cross, 1995, Schoemaker et al., 2000). The causative 
agent, BFDV, is a circovirus with a single stranded DNA genome, approximately 1.7-
2.0 kb in length (Bassami et al., 2001, Ritchie et al., 1989b). The genome of BFDV 
and other circoviruses is ambisense and encodes at least two major open reading 
frames (ORFs) (Bassami et al., 1998, Hattermann et al., 2003, Khalesi et al., 2005, 
Todd et al., 2001a, b). The ORF present on the viral strand of the double-stranded 
DNA  replicative  form  (Hanley-Bowdoin  et  al.,  1999)  encodes  the  replication-
associated  protein,  responsible  for  initiation  of  rolling  circle  replication  (Hanley-
Bowdoin et al., 1999, Steinfeldt et al., 2001, Steinfeldt et al., 2006). The ORF present 
on  the  complementary  strand  encodes  the  capsid  protein  and  studies  using 
recombinant proteins have demonstrated that Cap is the major antigenic determinant 
of BFDV (Stewart et al., 2007).  
 
As no cell culture system has been developed to successfully grow the virus in vitro, 
recombinant  techniques  hold  the  most  promise  for  the  development  of  effective 
vaccines that may be produced on a large scale (Bonne, 2004, Heath et al., 2006, 157 
 
Johne  et  al.,  2004,  Stewart  et  al.,  2007).  A  killed  whole-virus  vaccine  has  been 
developed  previously  (Raidal  and  Cross,  1994a,  Raidal  et  al.,  1993a),  but  the 
antigen was purified from the feathers of persistently infected birds. This process is 
expensive, ethically questionable, time consuming, results in low yields of virus and 
the  extraction  procedure  can  be  contaminated  with  host  proteins.  Incomplete 
inactivation of the virus may also result in clinical disease when administered (Raidal 
et al., 1993a, Wylie and Pass, 1987).  
 
DNA  vaccines  have  been  developed  against  many  aetiological  agents  including 
viruses (Cheung et al., 2004, Li et al., 2004, Wang et al., 2006, Yang et al., 2004), 
bacteria (Ko et al., 2005) and parasites (Lillehoj et al., 2005, Nagata et al., 1999, Wu 
et al., 2004). In order to explore the potential of DNA vaccines for the control of 
BFDV, two similar vaccines based on the nucleotide sequence of the capsid-coding 
gene of BFDV were constructed and their expression both in vitro and in vivo and the 
subsequent  antibody  response  incited  in  the  latter  were  examined.  To  test  the 
hypothesis that removal of the NLS would result in improved expression (Heath et 
al.,  2006)  and  consequently  an  increased  host  immune  response,  DNA  vaccines 
encoding both the full-length and NLS-truncated capsid sequence were assessed. 
  
6.1.2 Aims 
The principal aim of this experiment was to determine whether a DNA vaccine based 
on  the  capsid  sequence  of  BFDV  would  incite  the  development  of  antibodies  in 
vaccinated birds. Secondary aims were to determine whether there was a difference 
in  antibody  levels  between  groups  of  birds  administered  either  the  full-length  or 
truncated  vaccine  and  whether  peak  antibody  levels  might  be  protective  against 
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6.2 Materials and Methods 
6.2.1 Experimental design 
Vaccine type (full-length or truncated) was the independent variable when assessing 
the performance of the vaccines both in vitro and in vivo. When assessing in vitro 
performance, the dependent variable was the subcellular location of the expressed 
proteins.  When  assessing  in  vivo  performance,  the  dependent  variable  was  the 
antibody level in vaccinated birds, assessed by bELISA. The vaccination experiment 
consisted of two treatments (vaccine type), with three replicates per treatment group 
and was a balanced design. Each treatment was performed twice and samples were 
collected  before  treatment,  at  the  time  of  each  treatment  and  3  times  after  the 
second treatment. 
 
6.2.2 Insert generation by PCR 
Viral DNA was extracted from the feather of a sulphur-crested cockatoo which had 
previously tested PCR positive for BFDV using the methods described by Ypelaar et 
al. (1999) (Section 3.2.4). 
 
Primers CapFullF1 and CapR (Table 6.1) were designed to generate a PCR product 
coding for the full-length 747 nt capsid-coding region of BFDV; primers Cap-nlsF3 
(Table 6.1) and CapR were used to generate an NLS-truncated variant, which was 











Table 6.1: Primers used for the amplification and screening of capsid-coding inserts for use in the 
DNA vaccine* 
 
Primer ID  Sequence  Position 
CapFullF1  5’ GAT TAT GGG AGG CAC CTC TAA C 3’  1961-1975 
(after 
Kozac) 
Cap-nlsF3  5’ GAC CAT GGG CCA ATT CAA ATT C 3’  1798-1812 
(after 
Kozac) 
CapR  5’ TTA AGT GCT GGG ATT GTT AGG GGC  3’  1235-1257 
T7 forward  5’ TAA TAC GAC TCA CTA TAG GG 3’   
*Type in red indicates a Kozac sequence 
 
 
PCR reactions consisted of 2.5 mM MgCl2, 2.5 µL of 10x polymerisation buffer, 25 
pmol of each primer, 0.1 mM of each dNTP, 0.12 U of Taq DNA polymerase plus 
ultrapure  water  to  a  final  volume  of  23  µL  (all  reagents  Fischer  Biotec).  Two 
microlitres  of  DNA  were  added  and  reactions  carried  out  in  an  Eppendorf 
Mastercycler Gradient thermocycler (Eppendorf). Cycling conditions are outlined in 
Table 6.2. After the PCR reaction, a small aliquot of the PCR products was loaded 
on a 1% agarose gel containing ethidium bromide, subjected to electrophoresis at 90 
V for 1 hour and viewed on a transilluminator. The rest of the PCR product was 




Table 6.2: Cycling conditions used for the amplification of capsid-coding inserts for use in the DNA 
vaccine 
 
Step  Temperature (ºC)  Time (s)  Cycles 
1  95  5 min   
2  95  30   
3  50  30  40 
4  72  60   
5  72  10 min   




6.2.3  Construction  and  production  of  plasmids  pVAX1BFDVC1  and 
pVAX1BFDVC1-nls 
Plasmid pVAX1 (Invitrogen) was subjected to restriction digestion with EcoRV, to 
give blunt ends. The reaction mixture consisted of 1 µg of pVAX1, 3 µL of EcoRV 
10x reaction buffer, 3 µg BSA and 5 U EcoRV, plus sterile deionised water to a total 
volume of 25 µL (all reagents Fischer Biotec). The reaction was incubated for at least 
1 hour at 37ºC, then purified using an Axyprep PCR product purification kit. 
 
After purification, 5’ T-overhangs were added by incubating the digested and purified 
plasmid  with  2.5  mM  MgCl2,  5  U  of  Taq  DNA  polymerase,  10  µL  of  10x  Taq 
amplification buffer, 1 mM dTTP and ultrapure water to a total volume of 100 µL. The 
reaction mixture was incubated for 2 hours at 75ºC, then purified using an Axyprep 
PCR product purification kit. 
 
Before the ligation reaction was performed, the amounts of vector and insert DNA 
were  measured  using  a  Nanodrop  ND-100  spectrophotometer.  The  volumes  of 
vector and insert DNA required was calculated using the formula: 
 
x (ng PCR product) = (Y bp PCR product)(50 ng pVAX1) 
           (size in bp of pVAX1: ~3, 000 bp) 
 
The vector and insert DNA were then mixed together along with 1 µL of 10x ligation 
buffer and 1 µL of T4 DNA ligase (all reagents Invitrogen), then made up to 10 µL 




Chemically  competent  TOP10F’  E.  coli  (Invitrogen)  were  transformed  with  the 
plasmids  pVAX1BFDVC1  and  pVAX1BFDVC1-nls.  Two  microlitres  of  each 
transformation  reaction  were  added  to  50  µL  of  competent  cells  and  the  mixture 
incubated on ice for 30 minutes. The cells were then heat-shocked by incubation at 
42ºC for 30 seconds in a water bath and then placed on ice. Two hundred and fifty 
microlitres of SOC medium (2.0% [w/v] tryptone, 0.5% [w/v] yeast extract, 10 mM 
NaCl, 2.5 mM KCl, 10 mM MgCl2.6H20, 20 mM glucose; Invitrogen) were added and 
the mixture incubated for 1 hour at 37ºC on a horizontal shaker (Certomat
®; R.B. 
Braun) at 225 rpm. Aliquots of 25 and 50 µL of each transformation mixture were 
plated onto 2xYT agar plates (16 g/L tryptone peptone, 10 g/L yeast extract, 5 g/L 
NaCl, 15 g/L agar (Becton Dickinson) 50 µg/mL kanamycin). Plates were incubated 
at 37ºC overnight. 
 
6.2.4 Screening of E. coli and plasmids for the inserted capsid sequence 
6.2.4.1 Growth of selected colonies 
Colonies  of  cells  transformed  with  both  pVAX1BFDVC1  and  pVAX1BFDVC1-nls 
were  screened  in  the  same  way.  Fifteen  colonies  each  were  selected  and  each 
colony inoculated both onto a new 2xYT agar plate marked with a grid and into 10 
mL of 2xYT broth (16 g/L tryptone peptone, 10 g/L yeast extract, 5 g/L NaCl, Becton 
Dickinson) with 50 µg/mL kanamycin added. The inocula on plates were incubated 
overnight  at  37ºC.  Broth  was  likewise  incubated,  but  on  a  horizontal  shaker  as 
described above. The following morning, plates were wrapped in clear plastic film 
and stored at 4ºC and colonies in broth were centrifuged at 14,000 rpm to pellet the 
cells, then stored at -80ºC. 
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6.2.4.2 PCR screening of the selected colonies 
Pelleted cells were screened by PCR using a toothpick miniprep procedure (Maniatis 
et al., 1982). A small amount of cells was picked up with a wire loop and dipped in 
ultrapure water (Fischer Biotech) and the suspension boiled for 10 minutes. Plasmid 
pVAX1  contains  binding  sites  for  the  primer  T7  forward  within  the  T7  promoter 
region. Primers T7 forward (Table 6.1) and CapR were used to determine whether 
the capsid sequences were present and in the correct orientation, as only correctly 
oriented inserts would amplify. 
 
PCR reactions consisted of 2.5 mM MgCl2, 2.5 µL of 10x polymerisation buffer, 25 
pmol of each primer, 0.1 mM of each dNTP, 0.12 U of Taq DNA polymerase plus 
ultrapure  water  to  a  final  volume  of  23  µL  (all  reagents  Fischer  Biotec).  Two 
microlitres of the boiled toothpick miniprep were added and reactions carried out in 
an  Eppendorf  Mastercycler  Gradient  thermocycler  (Eppendorf).  PCR  and 
subsequent agarose gel electrophoresis was carried out as described above, except 
that the annealing temperature was decreased to 45ºC.  
 
6.2.4.3 Sequencing of PCR-positive colonies 
Plasmid  DNA  was  purified  from  the  selected  colonies  using  a  HiPure  Plasmid 
miniprep  kit  (Invitrogen).  Dideoxynucleotide  sequencing  was  carried  out  using 
primers T7 forward and CapR in an ABI Prism Dye Terminator Cycle Sequencing Kit 
(Applied Biosystems) according to the manufacturer’s instructions, except that the 
reaction  volume  was  reduced  to  10  µL  and  the  temperature  reduced  to  50ºC. 
Sequencing  reactions  consisted  of  2  µL  of  reaction  buffer  (containing  Tris-HCl, 
MgCl2, fluorescently-labelled dNTPs and AmpliTaq DNA polymerase, concentrations 
not supplied; Perkin Elmer), 1 µL of 5x sequencing buffer (composition not supplied, 163 
 
Perkin Elmer), 150-200 ng of plasmid, then made up to a total of 10 µL with ultrapure 
water (Fischer Biotec).  
 
DNA sequences were determined using an Applied Biosystems 3730 DNA Analyser 
and edited using Sequence Scanner v1.0 (Applied Biosystems) and GeneTool Lite 
(BTI Software). Edited sequences were analysed using MEGA 3.1 (Kumar et al., 
2004). Inserts were sequenced at least twice in each direction and edited sequences 
compared to known BFDV capsid sequences using the programs BLASTn (Altschul 
et al., 1997) and MEGA 3.1 (Kumar et al., 2004). 
 
6.2.5 Confirmation of protein expression in vitro 
6.2.5.1 Cells and media 
COS-7 cells (transformed African green monkey kidney cell line, ATCC CCL-1651) 
were grown in 25 cm
3 tissue culture flasks (Falcon) in DMEM (Gibco) supplemented 
with 1% new born calf serum and antibiotics (penicillin and streptomycin), at 37ºC in 
a 5% CO2-in-air environment. Cell culture medium was changed every 2-3 days and 
cells  were  passaged  once  they  were  75%  or  more  confluent.  When  cells  were 
passaged, the media was first aspirated then the cells washed with PBS. The PBS 
was then removed, 0.5 mL ATV (NaCl 80 g/L, KCl 4 g/L, glucose 10 g/L, NaHCO3 6 
g/L, trypsin [1:250 of a 5 g/L solution], EDTA 2 g/L, 1% phenol red 4 mL/L) added 
and the cells incubated at 37ºC for at least 5 mins until the cells had detached. Cells 
were resuspended in an appropriate volume of growth media and dispensed into cell 
culture flasks for further growth. 
 164 
 
6.2.5.2 Transfection of COS-7 cells 
The  day  before  transfection,  cells  were  split  1:5  into  6-well  tissue  culture  flasks 
(Nunc) and grown overnight as above. The following day, 20 µg of each plasmid was 
mixed with 2 mL of calcium phosphate transfection buffer (0.25 M CaCl2, 25 mM 
N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid (Sigma), 140 mM NaCl, 0.75 M 
Na2PO4, pH 6.95) and 50 µL of the mixture added drop wise to the relevant wells of 
the culture flask. Transfection buffer without plasmid was also added to two wells as 
negative transfection controls. The culture plates were incubated overnight as above 
and the following day the cells were washed twice with fresh culture media, then 
fresh media was added once again and the cells incubated for 2 days as above. 
After this final incubation, the cells were washed twice with PBS then fixed in -20ºC 
methanol for 20 minutes. 
 
6.2.5.3 Analysis of COS-7 cells for transient protein expression 
Cells  were  assayed  for  transient  protein  expression  via  an  indirect 
immunocytochemistry assay, using a monoclonal antibody (Section 5.3.2) developed 
against a recombinant BFDV capsid protein(Section 5.3.1). Fixed cells were washed 
twice with PBS, then a 1:500 dilution of the primary monoclonal antibody in PBS 
added and the cells incubated for 1 hour at room temperature. Unbound antibody 
was  then  removed  by  duplicate  washes  in  PBS  before  incubating  with  HRP 
conjugated EnVision anti-mouse (Dako) at room temperature for 1 hour. The slide 
was  washed  as  before  and  then  antigen-antibody  complexes  visualised  with  the 
chromogen diaminobenzidine (DAKO
® DAB chromogen). After colour development, 
cells  were  counterstained  briefly  with  haematoxylin  and  imaging  was  performed 
using an Olympus BX 13 microscope and digital camera accessory. 
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6.2.6  Vaccination  of  chickens  with  plasmids  pVAX1BFDVC1  and 
pVAX1BFDVC1-nls 
6.2.6.1 Birds 
Chickens were used as an experimental bird because the species is not known to be 
naturally  susceptible  to  BFDV  and  this  avoided  any  possibility  of  stimulating  an 
anamnestic response. Six Isabrown chickens were housed at the Murdoch University 
Animal House, each of the two DNA vaccines was administered to each of three 
chickens.  Five  days before  vaccination  with  the  DNA  vaccine  plasmids,  chickens 
were  injected  with  0.3  mL  bupivicaine into  the  pectoral  muscle  to  induce  muscle 
regeneration.  Chickens  were  injected  twice  with  300  µg  of  the  DNA  vaccine-
containing  plasmids  at  14  day  intervals  and  blood  collected  by  venepuncture  of 
jugular or cutaneous ulnar veins at each vaccination, then at fortnightly intervals after 
the second vaccination. Blood was spotted onto filter paper (Whatmann Grade No. 
3),  then  allowed  to  air  dry  at  room  temperature  as  described  by  Riddoch  et  al. 
(1996).  Serum  from  the  chickens  was  tested  for  the  presence  of  anti-BFDV 
antibodies by HI assay and the Ab-bELISA described in Section 5.2.6.2. 
 
6.2.6.2 Haemagglutination-inhibition (HI) assay 
Haemagglutination-inhibition assays were carried out as described in Section 4.2.6, 
except that the antigen preparation consisted of virus purified from the feathers of a 







6.2.6.3 Antibody-blocking ELISA 
Antibody  was  also  detected  using  a  bELISA  which  utilised  the  recombinant 
baculovirus-expressed BFDV capsid protein-coated described in Section 5.3.1 and 
the BFDV-specific monoclonal antibody described in Section 5.3.2. The bELISA was 
performed  as  described  in  Section  5.2.6.2,  with  serum  samples  diluted  1:10  in 
blocking buffer. 
 
6.2.7 Statistical analysis 
Descriptive statistics and paired t-tests, between pre- and post-vaccination bELISA 
PI values, were performed using Microsoft Excel. Repeated measures ANOVA was 
performed using SPSS version 15.0. 
 
6.3 Results 
6.3.1 Generation of DNA vaccines for BFDV 
Full-length  and  NLS-truncated  capsid-coding  sequences  were  successfully 
generated  by  PCR  and  cloned into  vector pVAX1  (Invitrogen)  to  create plasmids 
pVAX1BFDVC1  and  pVAX1BFDVC1-nls.  PCR  screening  identified  plasmids  that 
contained the insert in the correct orientation (Figure 6.1) and sequencing of these 
products confirmed the inserts to be in the correct orientation and in-frame with the 
Kozac  sequences  and  stop  codons.  These  sequences  had  a  high  degree  of 





Figure 6.1: Amplification of inserts and screening of transformed plasmids by PCR. A: amplification of 
capsid coding sequences. Lane 1, 100bp molecular weight markers; lane 2, full-length capsid-coding 
sequence; lane 3, negative control; lane 4, Nuclear localisation signal (NLS)-truncated capsid-coding 
sequence.  B:  screening  of  colonies  producing  plasmid  pVAX1BFDVC1  by  PCR  of  toothpick 
minipreps. Lane 1, 100bp molecular weight markers; lanes 2-8, colonies screened by PCR. Plasmids 
2, 3 and 7 contain the insert in the correct orientation. C: screening of colonies producing plasmid 
pVAX1BFDVC1-nls by PCR of toothpick minipreps. Lane 1, 100bp molecular weight markers; lanes 
2-7, colonies screened by PCR. Plasmids 2, 3, 4 and 6 contain the insert in the correct orientation. 
 
 
6.3.2 The DNA vaccines are successfully expressed in vitro 
After indirect immunocytochemistry, both variants of the capsid protein were visible 
within transfected COS-7 cells as aggregates of brown pigment (Figure 6.2). The 
subcellular localisation of the protein within mammalian cells was in agreement with 
the  findings  of  Heath  et  al.  (2006),  who  examined  the  location  of  the  expressed 
protein in insect cells. In COS-7 cells, the full-length capsid protein was present in 
the nuclei of transfected cells, whereas the NLS-truncated protein was present in the 
cytoplasm.  Visualisation  of  the  protein  within  nuclei  was  easier  before 
counterstaining,  after  which  cells  expressing  the  full-length  capsid  protein  were 






Figure 6.2: Expression of the DNA vaccine constructs in COS-7 cells. A: negative transfection control 
cells. B: cells transfected with the plasmid pVAX1BFDVC1, protein can be seen as dark aggregates of 
pigment within nuclei (arrowheads). C: cells transfected with the plasmid pVAX1BFDVC1-nls, protein 
can be seen as dark aggregates of pigment within the cytoplasm (arrowheads). Bar = 100 µm 
 
 
6.3.3  The  DNA  vaccines  are  expressed  in  vivo  and  vaccinated  birds 
produce antibodies against BFDV 
HI  assays  were  confounded  by  the  presence  of  non-specific  agglutinins,  present 
despite  adsorption  with  kaolin  and  normal  galah  erythrocytes.  Consequently,  no 
results were obtained from HI testing. The Ab-bELISA demonstrated the presence of 
anti-BFDV antibodies (Figure 6.3). Except for bird 5, peak antibody titres of between 
8.57% and 14.08% PI occurred between 2 and 4 weeks after the second inoculation 
(Figure 6.3). Bird 5 had a peak antibody titre of 20.42% at the second vaccination. 
These antibody levels, whilst low compared to levels found in experimentally infected 
birds, were all above the calculated negative cut-off value of 7% PI. Birds injected 
with the vaccine based on the truncated capsid sequence developed peak antibody 
levels at 2 weeks, 4 weeks earlier than birds which received the full-length vaccine. 
Repeated measures ANOVA found that the combined effect of vaccine type and time 
was  significant  (p<0.05).  Paired  t-tests  between  pre-vaccination  samples  and 
samples  at  each  time  point  found  that  ELISA  antibody  levels  were  significantly 
different  (p<0.05)  at 4  and  6  weeks  post-vaccination  for  the  full-length  and  NLS-






Figure 6.3: Blocking ELISA (bELISA) mean percentage inhibition values of chickens vaccinated with 
the  DNA  vaccine  constructs  pVAX1BFDVC1  (●)  and    pVAX1BFDVC1-nls  (○).  Vaccinations  are 




Presented here is the first report of the preliminary assessment of a DNA vaccine for 
BFDV.  Due  to  the  difficulty  and  expense  associated  with  procuring  BFDV-free 
psittacine birds, this study was only a small pilot trial, intended to assess whether the 
DNA vaccine constructs were expressed in vivo and resulted in seroconversion. Both 
the full-length and NLS-truncated DNA vaccines described above were successfully 
expressed  and  incited  antibody  development  by  vaccinated  chickens.  Although 
further  work  is  required  to  optimise  these  DNA  vaccines  and  information  on  the 
relative  efficacy  of  each  vaccine  variant  is  limited,  both  DNA  vaccines  may  be 
potentially useful candidates for the prevention of BFDV in psittacine birds. Because 170 
 
of the debilitating course of PBFD, an effective vaccine against the virus is highly 
desirable and will significantly aid in the prevention and control of the disease. A 
killed whole-virus vaccine has been developed previously (Raidal and Cross, 1994a, 
Raidal et al., 1993a), but no cell culture method has been discovered to enable in 
vitro propagation of antigen or the development of  infectivity assays. The antigen 
had to be purified from the feathers from persistently infected birds which produces a 
risk of incomplete inactivation of the virus (Raidal et al., 1993a, Wylie and Pass, 
1987)  as  well  as  possibility  of  host  protein  contamination  which  could  induce 
immune-mediated reactions. 
 
Recombinant BFDV capsid proteins have recently been the focus of much research, 
as they can be produced in vitro in large quantities. Various research groups have 
developed and produced both full-length (Bonne, 2004, Heath et al., 2006, Stewart 
et  al.,  2007)  and  truncated  (Heath  et  al.,  2006,  Johne  et  al.,  2004)  recombinant 
BFDV capsid protein and described their use as potential vaccine candidates and in 
serological assays.  
 
DNA vaccines have the advantage over recombinant protein-based vaccines in that 
they are easier and cheaper to produce and plasmids encoding exogenous markers 
for the serological differentiation of vaccinated from naturally infected animals can be 
easily  included.  However,  unless  techniques  of  plasmid  construction,  vaccine 
preparation and injection are optimised, they may suffer from low levels of detectable 
antibody production after expression in vivo (Johnson et al., 2000) and may be less 
effective than recombinant protein vaccines (Blanchard et al., 2003). The presence 
of  non-specific  agglutinins  in  the  sera  of  vaccinated  chickens  precluded 
measurement of antibody levels by HI and it is possible that some of the samples 171 
 
with high bELISA antibody levels would have a detectable HI titre had these non-
specific agglutinins not been present. Several studies have shown that a positive HI 
titre correlates strongly with freedom from disease (Khalesi et al., 2005, Raidal et al., 
1993b) and the bELISA used to evaluate the chickens’ antibody levels has been 
shown to be both sensitive and specific and to correlate strongly with the HI test 
(Section 5.3.4). Therefore, it is likely that if similar antibody levels were induced in 
psittacine  birds  after  vaccination  with  these  DNA  vaccines,  that  they  would  be 
protected from infection. 
 
This  study  evaluated  the  development  and  efficacy  of  two  relatively  simple  DNA 
vaccine constructs. There are a number of measures that can be used to improve 
the efficacy of DNA vaccines in vivo, including gene electrotransfer (Dupuis et al., 
2000,  Gao  et  al.,  2007,  Hojman  et  al.,  2007,  Mehier-Humbert  and  Guya,  2005), 
codon  optimisation  (Garmory  et  al.,  2003,  Wang  et  al.,  2006),  inclusion  of 
immunostimulatory  CpG  motifs  in  the  target  sequence  or  backbone  plasmid 
(Garmory et al., 2003, Sato et al., 1996), encouraging muscle regeneration at the 
injection site prior to vaccination (Davis and Whalen, 2004, Vitadello et al., 1994, 
Whalen, 2004), administration of osmotic agents at the time of vaccination (Suarez 
and Schultz-Cherry, 2000, Wu et al., 2004), and administration of adjuvants such as 
interferons and interleukins (Li et al., 2004, Lillehoj et al., 2005). Any successful DNA 
vaccination strategy will no doubt employ a combination of the above techniques. 
 
The  inclusion  of  extra  immunostimulatory  CpG  motifs  was  not  attempted  in  this 
experiment because the capsid sequence of BFDV contains high proportions of CpG 
motifs (Section 4.3.3.1). However, since CpG motifs can be both immunostimulatory 
or immunosuppressive (Hasslung et al., 2003, Stevenson et al., 2006), identification 172 
 
of the type of CpG motifs present in the BFDV capsid sequence and alteration of 
these  (if  necessary)  to  immunostimulatory  sequences  could  improve  the  host 
response  to  the  vaccine.  If  codon  optimisation  were  to  be  attempted  for  a  DNA 
vaccine  for  BFDV,  though,  one  would  need  to  optimise  against  the  genome 
sequence of the chicken, as the genome sequence of any psittacine birds has not 
been described. Since the proportion of codons conserved between chickens and 
psittacine birds is unknown, evaluation of the relative efficacy of optimised and non-
optimised  DNA  vaccines  would  require  concurrent  vaccination  with  each  type  of 
plasmid and subsequent measurement of antibody levels and response to live-virus 
challenge. 
 
In this study, we attempted to improve the efficacy of the vaccines by preparing the 
muscle with bupivicaine (Davis and Whalen, 2004, Vitadello et al., 1994, Whalen, 
2004).  The  peak  antibody  titre  of  bird  5  at  the  time  of  the  second  vaccination 
probably indicates that this was successful at this time in this one bird only and the 
peak  is  consistent  with  an  initial  IgM  antibody  response.  Given  the  lower  peak 
antibody  titres  of  the  other  birds,  muscle  preparation  was  probably  unsuccessful. 
Injection  of  the  DNA  vaccine  in  the  exact  place  in  the  pectoral  muscle  that  the 
bupivicaine was injected is very difficult; perhaps a more suitable site would be a 
smaller muscle such as the biceps brachii, triceps brachii, flexor carpi ulnaris or other 
suitable muscle of the wing. 
 
Even  though  both  vaccine  variants  resulted  in  the  development  of  anti-BFDV 
antibodies, further evaluation and even modification of the constructs is desirable. 
Such  work  could  include  the  assessment  of  the  effect  of  NLS-truncation  on  the 
structure and function of the expressed protein (Birnbaum and Nassal, 1990, Heath 173 
 
et al., 2006), inclusion of a secretory tag to enhance the availability of the expressed 
protein  (Fan  et  al.,  2008)  and  comparison  between  the  DNA  vaccines  and 
recombinant proteins of the effects on cell-mediated immunity (Donnelly et al., 1997, 
Johnson et al., 2000, Toussaint et al., 2005). The effect of prior infection should also 
be assessed, as it has been shown that PCV2 infection can decrease the efficacy of 
vaccines (Opriessnig et al., 2006c). 
 
In the field of vaccine research, the concept of heterologous vaccination, whereby 
different  types  of  vaccines  (modified live,  killed,  recombinant  subunit  and/or  DNA 
vaccines)  against  multiple  strains  or  serotypes  are  employed  in  order  to  incite 
concomitant humoral and cell-mediated responses, is becoming increasingly popular 
(Griebel  et al.,  2006,  Toussaint et  al.,  2006,  Toussaint et  al.,  2005, Wood  et  al., 
2006). Co-administration of the full-length recombinant capsid protein may improve 
the expression of either of the DNA vaccine constructs described here, due to the 
ability of circovirus capsid proteins to bind DNA, enter antigen presenting cells and 
aid in its transport to the nucleus (Birnbaum and Nassal, 1990, Esko, 1999, Heath et 
al., 2006, Liu et al., 2001, Misinzo et al., 2006). Use of the full-length capsid protein 
in an heterologous vaccination strategy would also improve the immune response as 
a result of the immunostimulatory effect of virus-like particles (VLPs) (Noad and Roy, 
2003,  Tegerstedt  et  al.,  2005,  Ulrich  et  al.,  1998).  Whether  or  not  the  proteins 
produced in cells transfected with the DNA vaccines form VLPs and are processed 
as  such  would  merit  investigation,  as  would  investigation  of  the  difference  in 




As BFDV is so genetically diverse, vaccines utilising the capsid sequence of multiple 
isolates would certainly be advantageous. DNA vaccination is an easier means of 
accomplishing this than producing multiple recombinant proteins. However given the 
number  of  species  within  the  Psittaciformes,  production  of  a  truly  heterologous 
vaccine would probably not be feasible. A combination of a few isolates, such as 
cockatoo,  lorikeet,  lovebird  and  budgerigar  would  likely  be  adequate  and  any 
heterologous  BFDV  vaccine  should  include  the  capsid  sequence  of  the  newly 
described cockatiel strain (Shearer et al., 2008a) which may be sufficiently different 
antigenically to qualify as a separate strain. 
 
Other methods being investigated for their applications in both vaccination and gene 
therapy are replication-incompetent viral vectors (Ju et al., 2005, Minke et al., 2007, 
Pardoa et al., 2007, Poulet et al., 2003, Wang et al., 2007b), recombinant subunit 
vaccines produced in plants (Ma et al., 2005, Ma et al., 2003, Rigano and Walmsley, 
2005) and artificially constructed viruses. These systems all have potential merit for 
use in vaccination strategies for both domestic and wild psittacine birds, but many 
aspects of function, protein expression, large scale production and efficacy still need 
to be addressed (Davis et al., 1993, Floss et al., 2007, Mastrobattista et al., 2005, 
Mastrobattista et al., 2006). Such systems could possibly be employed to vaccinate 
wild birds against BFDV, supplied in food and water at feeding stations, for example. 
However,  testing  and  quality  control  would necessarily  need  to  be  extraordinarily 
strict  and  thorough  to  ensure,  for  example,  that  the  replication-incompetent  virus 
could not revert to virulence by recombining with a wild-type virus. In addition, there 
would  need  to  be  no  negative  effects  on  either  target  or  non-target  species, 
especially given the adverse effects identified in some human clinical trials (Check, 
2003, Marshall, 1999). 175 
 
 
Since there is no cell culture system available for BFDV, recombinant technologies 
likely  hold  the  key  to  effective  treatment  and  prevention  options  for  the  virus.  In 
developing  two  novel  DNA  vaccines  against  BFDV,  this  study  demonstrated  that 
DNA vaccination is a potentially useful method of producing an effective vaccine. 
Effective vaccination strategies will likely include both recombinant proteins and DNA 
vaccines and should take advantage such of new developments in immunology as 
the inclusion of avian-derived cytokines as both adjuvants and therapeutic agents.176 
 
Chapter 7. General Discussion 
 
Despite the increasing volume of research on BFDV in recent years, many 
gaps remain in the knowledge of its mode of replication and its clinical and 
molecular pathogenesis. Efforts to develop diagnostic tests and vaccines for 
the  detection  of  BFDV  antigens  and  anti-BFDV  antibodies  that  can  be 
standardised and produced in bulk have been hampered by the lack of a cell 
culture system to grow the virus in vitro. As such, investigations have largely 
focussed on the molecular (genetic and phylogenetic) characteristics of the 
virus and similarly detection has relied on PCR-based methods.  
 
As previously discussed, detection of excreted virus and anti-BFDV antibodies 
requires the use of HA and HI assays, respectively. Because of the difficulties 
associated with implementing these tests (keeping a suitable flock of birds 
and preparing their blood) and ensuring consistency in their performance (due 
to  differences  in  polyclonal  antibody  preparations  and  haemagglutination 
activity of donor erythrocytes), there are only a limited number of studies that 
have utilised them for investigation of the pathogenesis and epidemiology of 
BFDV  (Khalesi  et  al.,  2005,  Raidal  and  Cross,  1994a,  Raidal  and  Cross, 
1995,  Raidal  et  al.,  1993a,  Raidal  et  al.,  1993b).  Other  laboratories  have 
reported the development of these tests (Kondiah et al., 2005, Ritchie et al., 
1991b,  Sanada  and  Sanada,  2000,  Soares  et  al.,  1998)  with  similar  or 
modified reagents, but have not reported their use in applied studies. Ongoing 
BFDV research requires consistent, high quality assays capable of detecting 
and  quantifying  viral  nucleic  acid,  antigen  and  anti-BFDV  antibodies  in  a 
range of samples. Molecular detection methods, whilst they only detect viral 177 
 
nucleic acid and not viral antigen, are still extremely useful as they are based 
on reagents and equipment that are widely available and easily standardised. 
 
As an antigen source, Cap is the most suitable as it has been shown to be the 
sole  antigenic  determinant  (Stewart  et  al.,  2007).  Standard  antibody 
preparations  based  on  Cap  will  likewise  have  the  most  value  for  the 
development  of  diagnostic  tests.  However,  it  is  suspected  that  antigenic 
differences exist between isolates and the research presented in Chapter 4 
supports  this  theory.  Any  standard  antibody  preparations  used in  universal 
diagnostic  tests  should  be  tested  against  virus  preparations  from  as  many 
psittacine species as possible on an ongoing basis. There has only been 1 
study to date investigating the possibility of the existence of BFDV serotypes 
(Khalesi  et  al.,  2005)  and  while  the  authors  could  not  find  evidence  of 
serotypes, antigenic mapping is necessary to definitively identify any antigenic 
variations between isolates. 
 
For assays detecting viral nucleic acid, rep is theoretically the gene of choice 
as it is the most conserved part of the viral genome apart from the stem-loop, 
NLS  and  octanucleotide  motif  (Bassami  et  al.,  2001,  Khalesi  et  al.,  2005, 
Raue et al., 2004). Assays for the detection of nucleic acid based on cap have 
been developed and seem to perform well (Albertyn et al., 2004, Ogawa et al., 
2005,  Raue et  al.,  2004).  Theoretically  the performance  of  each  molecular 
assay  will  depend  on  the  variation  of  the  section  of  the  genome  that  they 
amplify.  Still,  since  none  of  these  assays  have  been  validated  with  a 
sufficiently large number of samples and their diagnostic performance has not 178 
 
been compared with assays based on rep, they are less desirable choices for 
diagnostic assays.  
 
The  quantitative,  real-time  PCR  assay  described  in  Chapter  3  should  be 
useful  for  the  quantitation  of  viral  DNA  in  blood  samples  from  a  range  of 
psittacine species. It is based on a highly conserved section of rep, is able to 
detect virus from a range of psittacine species and has a greater analytical 
sensitivity than the standard PCR assay described by Ypelaar et al. (1999). 
Ensuring  consistency  in  the  quantitation  standards,  inclusion  of  reference 
genes into the assay for data normalisation and validation of the assay with 
other sample types, such as fresh and preserved tissues and swabs, should 
be pursued for the test to have as great an application as possible in both 
research and clinical diagnosis. A key finding of the experiment was evidence 
that vaccination does not prevent viral replication. The assay demonstrated 
that the viral load in both vaccinated and control birds increased for the first 4 
weeks after challenge despite the fact that vaccinated birds had anti-BFDV 
antibodies  before  being  challenged  (Bonne  et  al.,  2008b,  Shearer  et  al., 
2009). 
 
Even though the assay measures viral DNA and not antigen, if studies are 
conducted to determine the infectivity of a given sample of virus (Coombs et 
al.,  1993,  Rusert  et  al.,  2004)  and  correlated  with  the  number  of  genome 
copies present, then the infectious load can be interpolated from the qPCR 
assay measurements. Even without this information, the assay could be used 
to fill in important gaps in the knowledge. For example, the kinetics of BFDV 179 
 
infection  and  their  correlation  with  the  development  and  progression  of 
antigen excretion, anti-BFDV antibodies and clinical signs in recently infected, 
chronically infected and apparently recovered birds. 
 
Because Cap is the most suitable protein for the development of standard 
BFDV antigen and antibody preparations, a recombinant BFDV capsid protein 
and  monoclonal  antibody  were  produced  as  described  in  Chapter  5.  Like 
other  recombinant  viral  proteins  (Noad  and  Roy,  2003,  Tegerstedt  et  al., 
2005, Ulrich et al., 1998), the full-length recombinant BFDV capsid protein self 
assembled into VLPs and importantly behaved like native BFDV in that it had 
HA activity and was recognised by naturally occurring anti-BFDV sera. Other 
recombinant BFDV capsid proteins have been developed (Heath et al., 2006, 
Johne et al., 2004) and have been shown to have merit for use in serological 
assays, but the morphology and haemagglutination behaviour of the proteins 
were not assessed. 
 
Even though there have been no serotypes of BFDV described, there is still a 
possibility  that  monoclonal  antibodies  developed  against  the  virus,  or 
recombinant  capsid proteins,  may  not  detect  all  BFDV isolates  because  of 
variations  in  amino  acid  sequences  between  isolates.  The  monoclonal 
antibody  developed  in  Chapter  5  detected  viral  antigen  isolated  from  a 
cockatoo, a lorikeet and a cockatiel. Given that the cockatiel isolate has been 
shown to have some antigenic differences to other BFDV isolates, the fact 
that detection by the monoclonal antibody occurred indicates that the epitope 
it targets is likely to be conserved across virus isolates. Of course, ongoing 180 
 
testing  with  as  many  virus  isolates  as  possible  and  characterisation  of 
epitopes present on the BFDV capsid protein is highly desirable. The other 
important  property  of  the  monoclonal  antibody  is  the  ability  to  inhibit 
haemagglutination. This means that the monoclonal antibody may be useful in 
the performance of HI assays. In addition, because the monoclonal antibody 
and recombinant protein can be quantified reasonably accurately, they could 
be  used  to  measure  and  compensate  for  variations  in  erythrocyte 
haemagglutination sensitivity. The monoclonal antibody was also assessed to 
be useful in western blot and immunohistochemistry assays and should make 
these applications more user-friendly and more easily standardised. 
 
Haemagglutination-inhibition assays are useful for the serological detection of 
exposure to BFDV and estimation of the amount of antibodies present in a 
sample. Antibody measurements are reasonably precise if attention is paid to 
minimising inter-assay variation by titrating virus and antibody activity against 
each other and against the erythrocytes from multiple birds prior to testing. 
Even  so,  HI  assays  are  still  prone  to  an  appreciable  amount  of  inter-test 
variation, especially if performed infrequently or  without standard reference 
antigen and sera. Because of the lack of an easily standardised and widely 
applicable sero-diagnostic test, the Ab-bELISA developed in Chapter 5 should 
find  wide  application  in  both  epidemiological  surveys  and  routine  sero-
diagnosis. The Ab-bELISA is sensitive and specific, correlates well with the HI 
assay  but  has  a  greater  analytical  sensitivity.  Like  the  HI  assay,  the  Ab-
bELISA is able to detect both IgM and IgY because the assay does not utilise 
a  secondary  anti-psittacine  IgM/IgY  antibody.  Furthermore,  since  the 181 
 
performance of the assay depends on the affinity of the sample antibody for 
the capsid protein, the type of animal from which the serum is collected does 
not matter and so the assay should be useful with sera from experimentally 
inoculated animals (e.g. mice, sheep or chickens). 
 
The key advantage of the bELISA over an indirect ELISA is that it does not 
need a secondary antibody to psittacine IgY. Two studies have reported the 
use of anti-psittacine IgY in western blot (Heath et al., 2006, Johne et al., 
2004) assays and one in an indirect ELISA assay (Johne et al., 2004). The 
antibody  preparation described  by  Johne  et  al (2004)  detected  IgY  from  7 
diverse species of psittacine birds. Even so, the cross-reactivity of psittacine 
anti-IgY  preparations  has  not  been  assessed  and  potential  differences  in 
affinity  between  samples  could  affect  the  result  of  tests  using  them. 
Additionally,  the  indirect  ELISA  reported  by  Johne  et  al  (2004)  was  not 
validated with a sufficiently large number of samples, whereas the bELISA 
described  in  Chapter  5  has  been  validated  with  an  acceptable  number  of 
samples (Jacobson, 1998). The bELISA was unfortunately not applicable to 
the detection of viral antigen, but the use of the same reagents in an antigen-
capture ELISA, for example, should be easily accomplished and the resulting 
assay should be extremely useful. 
 
As well as the need for new reagents and assays, there is the need to fill in 
the large gaps in knowledge concerning the genetic and antigenic spectrum of 
virus isolates, the interaction of the virus with a range of psittacine hosts and 
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proposed the presence of “strains” of the virus, based on the species from 
which they were isolated, the characteristics of disease in those hosts and 
their geographical location (Bassami et al., 2001, Heath et al., 2004, Kondiah 
et al., 2006, Raue et al., 2004, Ritchie et al., 2003). While it is certainly likely 
that modifications to the virus will occur as a result of host-virus interactions, 
no genetic, antigenic or serological differences between these isolates have 
been identified or characterised. 
 
The question of whether virus “strains” exist partly motivated the investigation 
described  in  Chapter  4.  The  discovery  of  BFDV  infection  in  cockatiels  is 
significant as infection had not been previously described in this species. The 
proposal  that  virus  strains  exist  is  partially  supported  by  the  fact  that 
phylogenetic analysis grouped the cockatiel BFDV isolates separately to other 
isolates. Analysis of CpG content also suggests distinct differences in virus 
isolates,  but  the  consistency  of  these  differences  within  “strains”  and  their 
significance  is  yet  to  be  investigated.  Cross  reactivity  work  demonstrated 
antigenic differences between the virus isolated from the cockatiels and other 
isolates,  but  the  precise  differences  are  unknown.  Thus,  questions  of  the 
existence  of  a  novel  BFDV  serotype  remain  unanswered.  Thorough 
investigation of the differences in pathogenicity of BFDV isolates and whether 
distinct  strains  exist  will  require  epitope  mapping,  analysis  of  nucleotide 
sequence polymorphisms and recombination events and studies of infectivity 
using infectious clones on as wide a range of BFDV isolates and hosts as is 
possible, similar to experiments accomplished with the porcine circoviruses 
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et  al.,  2000,  Meehan  et  al.,  1998,  Meerts  et  al.,  2005a,  Opriessnig  et  al., 
2006d) and the VP2 protein of CAV (Wang et al., 2007a). 
 
The  existence  of  antigenic  and  nucleotide  sequence  differences  between 
isolates  is  highly  likely  given  the  effects  of  random  mutations  (Nei,  2007), 
recombination (Biagini et al., 2001, He et al., 2007, Heath et al., 2004, Ma et 
al., 2007, Olvera et al., 2007, Worobey, 2000) and purifying selection (Hughes 
and Piontkivska, 2007). However, any suspected differences will need to be 
confirmed experimentally. Given the combined effects of these processes, the 
emergence of strains or even serotypes is possible (He et al., 2007, Heath et 
al., 2004, Hughes and Piontkivska, 2007, Nei, 2007, Olvera et al., 2007). This 
is  especially  likely  considering  the  amount  of  substitutions  that  have 
accumulated in CAV (Nogueira et al., 2007) and PCV genomes (Olvera et al., 
2007)  and  that  PCV  and  CAV  strains  with  different  pathogenicity  and  cell 
tropisms have developed (Lucio et al., 1990, Meerts et al., 2005a, Nogueira et 
al., 2007,  Opriessnig  et  al.,  2006d).  As  such,  the  full  spectrum  of  genetic, 
antigenic and pathogenic differences is unlikely to ever be fully described and 
characterised. 
 
The  reagents  and  tests  developed  as  part  of  this  research  will  have 
application in the investigation of the issues previously discussed and many 
other similar questions. For example, immunoblotting using the monoclonal 
antibody  (and  other  monoclonal  antibodies)  may  elucidate  some  antigenic 
differences  between  virus isolates,  or  could  investigate  the  mechanisms  of 
immunosuppression  by  detecting  viral  antigen  in  immunological  cells  and 184 
 
tissues. The qPCR assay could be used to determine the viral load within 
various  tissues  and  a  modified  qPCR  assay  could  be  used  to  measure 
cytokine mRNA expression in naïve and infected birds. The bELISA will be 
useful  for  sero-epidemiological  studies.  These  types  of  studies  should  be 
more  easily  accomplished  using  the  reagents  and  tests  described  in  this 
study. 
 
Some studies, however, will still require the use of preparations of infectious 
virus and live birds kept for long periods of time. Such key areas of knowledge 
include the cross-infectivity and pathogenicity of different virus isolates, the 
long-term progression of viral infection induced at various ages in different 
psittacine species, the individual variation in susceptibility to a given isolate 
and the effect of other diseases. These studies can be accomplished using 
the techniques already available, however their execution would benefit from 
the  extra  information  available  as  a  result  of  the  new  reagents  and  tests 
described in this study. 
 
Investigations  into  the  mode  of  replication,  transcription  patterns  and 
infectivity of BFDV would be greatly enhanced by development of a system to 
culture the virus in vitro. To date, such efforts have been unrewarding, but the 
use of PHA and LPS to enable replication of TTV in cultured PBMCs (Desai et 
al., 2005, Mariscal et al., 2002) and IFN-γ to enhance PCV2 replication in PK-
15 and monocytic cells (Meerts et al., 2005b) may indicate that such a system 
can  be  developed.  Of  course,  recombinant  technologies  would  still  be  the 
methods of choice for the production of vaccines and reagents for diagnostic 185 
 
tests,  but  an  in  vitro  culture  system  would  make  the  isolation  and 
characterisation of BFDV isolates much easier. 
 
The usefulness of new highly sensitive and specific assays is limited unless 
the  tests  are  applied  properly and  their  results interpreted in  a  meaningful 
way.  Any  test,  no  matter  how  sensitive  and  specific, is  vulnerable  to  false 
positive  and  negative  results.  Low  disease prevalence  and  less  than  ideal 
methods  for  the  prevention  of  cross  contamination  can  result  in  false 
positives. BFDV testing is particularly susceptible to the occurrence of false 
positives as the virus is excreted in large quantities in feather dander which is 
easily aerosolised and manually transferred during handling. Our laboratory 
has seen instances of false positive PCR results occurring when clinicians 
have taken samples from a bird excreting BFDV in the feather dander and 
then  taken  samples  from  BFDV-negative  birds.  The  small  amount  of  virus 
transferred  on  the  fingers  is  enough  to  give  a  positive  reaction  in  the 
conventional PCR assay for at least 2 birds handled after the BFDV-positive 
bird (Sharp, 2007, pers comm). 
 
Even widely used methods for sample collection and storage are susceptible 
to contamination. Bonne et al. (2008a) demonstrated that BFDV DNA can be 
transferred by hole-punch, with DNA detectable by conventional PCR in up to 
5  pieces  of  filter  paper  processed  after  the  original  positive  sample.  False 
negative results are less affected by biological variables than false positives 
(Jacobson, 1998), so their occurrence is usually related to inhibitory effects or 
pipetting errors (Belak and Thoren, 2004). Nonetheless, if these errors occur, 186 
 
they will affect the performance and validity of the assay and protocols should 
be in place to minimise the chance of their occurrence. 
 
Worldwide, most laboratories rely on PCR methods for the diagnosis of BFDV 
infection because of the difficulty and expense associated with developing, 
maintaining  and  standardising  HA  and  HI  assays.  This  presents  three 
problems, all with significant clinical implications. Firstly, as outlined above, 
improper sample collection and handling can give false results. Secondly, the 
detection of nucleic acid alone does not confirm active infection, merely the 
presence of the DNA of the organism. Furthermore, active infection does not 
necessarily result in clinical disease. Thirdly, a single test at a single point in 
time contributes little useful information on the complete clinical status and 
progression  of  the  infection.  Add  to  this  the  paucity  of  knowledge  on  the 
pathophysiology and progression of the disease and the results of a single 
test can be of limited value. 
 
Even serological tests on their own tell us little about the patient’s infection 
status,  merely  whether  the  patient  has  been  previously  exposed  to  the 
infectious agent. Flock testing is a little better, but PCR testing alone will only 
show how many birds have virus present in the sample taken at that point in 
time. In comparison, serosurveys will at least indicate whether the flock has 
had  recent  exposure  (low  seroprevalence)  or  is  endemically  infected  (high 
seroprevalence). With high prevalences worldwide and no easy and effective 
method of control, the best course of action is to conduct multiple tests (viral 
DNA, antigen and antibody) so that as complete a clinical picture as possible 187 
 
is  obtained.  Tests  such as  the  bELISA  described in  Chapter  5  and  others 
based  on  similar  standard  reagents  should  make  this  much  easier  to 
accomplish.  Ultimately,  using  a  single  test  for  an  infectious  agent  is  only 
warranted when the presence of the agent is cause for immediate action. This 
scenario occurs only when the prevalence of the agent is low as a result of 
effective, well planned and widely applied prevention strategies (vaccination 
and disinfection). For example, a parvovirus antigen test in a puppy with signs 
of gastrointestinal disease. 
 
Effective  control  of  BFDV  will  be  greatly  assisted  by  the  availability  of  an 
effective vaccine. The lack of a system to grow the virus in cell culture means 
that recombinant technologies are the best way of producing such a vaccine. 
Chapter 6 details the methods used to construct two DNA vaccines based on 
cap. Both vaccines were expressed in vitro and elicited detectable antibody 
responses in chickens inoculated with the constructs, so they are attractive 
potential vaccine candidates. DNA vaccines are much cheaper and easier to 
produce  than  vaccines  based  on  recombinant  proteins  or  killed  whole 
organisms  and  result  in  more  potent  cell-mediated  immune  responses 
(Johnson et al., 2000). However, unless they are administered using methods 
to improve their transfection efficiency and boost the immune response of the 





To  date,  only  two  studies  have  outlined  efforts  to  characterise  vaccines 
against BFDV and their protection of vaccinated birds from challenge with live 
virus. The first of these utilised a whole killed virus vaccine prepared from 
feathers and organs of PBFD-affected birds and whilst effective, the vaccine 
was too difficult and expensive to produce (Raidal et al., 1993a). Even though 
there  have  been  a  number  of  reports  of  the  development  of  recombinant 
proteins as candidate vaccines (Bonne, 2004, Heath et al., 2006, Johne et al., 
2004, Stewart et al., 2007), the difficulty associated with procuring and raising 
a  flock  of  BFDV-free  birds  has  meant  that  only  one  study  thus  far  has 
evaluated the efficacy of a recombinant protein-based vaccine (Bonne et al., 
2008b). 
 
Both full-length and NLS-truncated proteins show promise in the development 
of  effective  vaccines,  however  recombinant  protein  vaccines  utilising  full-
length capsid proteins are probably better candidates because the NLS will 
theoretically  enhance  the  entry  of  the  protein  into  antigen  presenting  cells 
(Esko, 1999) and its subsequent processing and presentation. Recombinant 
HBV proteins require only the first 144 amino acids for accurate self-assembly 
into  VLPs  (Birnbaum  and  Nassal,  1990),  so  NLS-truncated  BFDV  capsid 
proteins  should  behave  similarly  and  should  still  confer  protection  from 
challenge with live virus, provided that antibodies to the NLS are not required 
for full protection. However, the contribution of the BFDV NLS to protection of 
vaccinated  birds  needs  to  be  evaluated,  as  even  though  parvovirus  B19 
requires only the VP2 protein for formation of VLPs (Wong et al., 1994), the 
VP1 protein is required for the development of an effective immune response 189 
 
(Kajigaya et al., 1991). The in vitro expression of NLS-truncated BFDV capsid 
proteins has  also  been  shown  to  be  greater  than  that of  full-length capsid 
proteins (Heath et al., 2006). The inclusion of a secretory tag in DNA vaccines 
utilising  an  NLS-truncated  capsid  gene  of  PCV2  has  also  been  shown  to 
significantly increase levels of protective antibodies (Fan et al., 2008). The 
effect these modifications have on the uptake, processing of and response to 
the various recombinant vaccines for BFDV remains to be investigated and it 
is  likely  that  successful  vaccination  strategies  will  utilise  a  combination  of 
approaches. 
 
Further studies using vaccinated birds will be highly desirable to assess the 
length of protection conferred, whether birds are still protected after repeated 
challenge,  how  long  maternal  antibodies  are  protective  against  clinical 
disease in chicks and whether the progeny of vaccinated birds can still be 
vertically infected, as is the case with CAV (Brentano et al., 2005). The effect 
of pre-infection on vaccination should also be assessed, as PCV has been 
shown to decrease the efficacy of vaccines (Opriessnig et al., 2006c). The 
effect  of  circoviruses  on  vaccine  efficacy  is  also  likely  to  be  economically 
significant in  birds  such  as  pigeons,  geese and  ducks,  which are routinely 
vaccinated for other diseases. Should vaccines for other psittacine diseases 
be  produced  and  implemented,  the  effects  of  BFDV  infection  on  these 
vaccines will likely be significant. Evaluation of other vaccination strategies, 




Evaluation of the serological response to vaccines has previously required the 
use of the HI assay. Thus the bELISA described in Chapter 5, validated with 
samples from the vaccine trial (Bonne et al., 2008b), should prove to be an 
effective tool for the evaluation of future vaccines. The design of vaccines and 
related diagnostic tests should also ideally include strategies to differentiate 
infected  from  vaccinated  animals  (DIVA).  Such  strategies  may  include  the 
development of a test to detect a viral protein not in the vaccine preparation 
(e.g. Rep for recombinant subunit or DNA vaccines), or a novel substance 
present only in the vaccine preparation (James et al., 2007). The production 
of  recombinant  infectious,  but  non-pathogenic,  clones  carrying  genetic 
markers may also show promise for the development of vaccines with an in-
built DIVA mechanism (Liu et al., 2007a). Thorough evaluation of the tests 
detecting viral proteins not present in vaccines is necessary in order to ensure 
that  these  tests  are  still  valid  if  the  bird  is  infected  after  vaccination.  The 
prevalence of antibodies to the chosen viral protein or novel substance should 
be low or absent within non-vaccinated populations in order to prevent false 
positives and would also need to be evaluated thoroughly. 
 
The availability of an effective vaccine will contribute immensely to the control 
of BFDV in both individual birds and avicultural collections. Administration of 
vaccines  must  be  conducted  in  concert  with  appropriate  quarantine  and 
disinfection procedures for prevention and control programs to be effective. 
Based on studies with other non-enveloped viruses, peroxide compounds are 
theoretically the only products that can neutralise BFDV (Cross, 2006). Their 
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cleaning of aviaries and the properties of the chemicals themselves. These 
products must be allowed to work on surfaces that are free of organic material 
and must be in contact with the surfaces for at least 10 minutes. Removing all 
virus-containing organic material and ensuring adequate contact time is very 
difficult  and  prolonged  contact  with  peroxide  compounds  may  damage 
stainless  steel.  The  cleaning  action  associated  with  the  use  of  many 
household bleach or ammonia compounds and specialised disinfectants (F10) 
will be useful for reducing the amount of virus present, but the compounds will 
not neutralise non-enveloped viruses. In Australia, exposure of captive birds 
to endemically infected wild psittacine flocks makes effective quarantine and 
disinfection especially difficult. 
 
Effective quarantine to prevent the introduction or spread of BFDV is also very 
difficult given the lack of precise knowledge on the pathophysiology of the 
virus.  It  is  strongly  suspected  that  the  virus  is  transmitted  vertically,  that 
recovered birds, especially lorikeets, eclectus parrots and king parrots, may 
revert  to  virus  excretion  despite  the  presence  of  circulating  antibodies.  In 
addition, BFDV isolates are probably infectious to all other psittacine species, 
but  this  is  yet  to  be  confirmed.  Answering  other  questions  of  the 
pathophysiology of the virus will better inform the requirements for prevention 
and  control.  Such  questions  include  the  pre-patent  period  of  the  virus, 
whether birds only develop disease after being infected during the age-related 
window of susceptibility (Wylie and Pass, 1987) or whether birds infected as 
adults can also develop disease, whether birds that develop an appropriate 
antibody  response  can  still  develop  clinical disease  and  whether  particular 192 
 
isolates  cause  different  forms  of  clinical  disease.  Ongoing  education 
campaigns  are  still  required  to  reinforce  the  basics  of  quarantine  to  bird 
owners, breeders, traders and veterinarians, such as avoiding mixing large 
numbers  of  birds  (e.g.  at  bird  shows  or  pet  shops)  and  preventing  the 
premature  introduction  of  new  birds  to  the  home  or  flock.  Because  of  the 
ubiquitous and highly infectious nature of the virus, effective prevention and 
control  strategies  will  require  a  combination  of  vaccination,  thorough 
disinfection and strict quarantine, backed up by appropriate testing regimes 
and ongoing education. 
 
Similar reasoning  applies  to  the  diagnosis, prevention  and  control  of  other 
diseases  of  companion  birds.  At  present  there  are  few  routinely  available 
assays for the diagnosis of common diseases. Where tests are available, they 
are  mostly  molecular-based  methods  and if  serological  tests  are available, 
their  interpretation  can  be  confusing  given  that  these  diseases  are  often 
prevalent in the population. Most canine and feline infectious diseases benefit 
from years of research and prevention programs, so most veterinarians and 
owners are aware of the best ways to test for and prevent them. The gold 
standard  tests  for  these  diseases  are  chosen  as  such  because  they  have 
usually  been  thoroughly  tested  and  proven,  whereas  the  owners  and 
clinicians of avian patients often must choose a test because it is either the 
only one available or the best known. As research into BFDV and other avian 
diseases progresses, the manufacturers of such tests have a responsibility to 
ensure that the test or combination of tests provides the most useful clinical 
information  possible,  backed  up  by  high  quality  research.  Since  the  avian 193 
 
market is relatively small, the danger exists that a well marketed test of poor 
quality would be better used than a less well marketed test of high quality, 
resulting in a disservice to all in the industry. 
 
Treatment  options  are  necessarily  aimed  at  reducing  viral  replication  or 
boosting the host’s immune response to the virus. RNA interference aims to 
do the former, whilst interferon therapy aims to do the latter. Only cytokine 
treatments have been trialled for BFDV infections and whilst promising, need 
to be evaluated more fully. Proper assessment of the success or failure of 
treatment  trials  will  also  depend  on  a  more  thorough  knowledge  of  the 
pathophysiology  of  the  virus  as  outlined  above.  Also  important  is  the 
recognition  that  viruses  are  extremely  adept  at  evading  or  modulating  the 
immune system and as such any vaccination or treatment method is unlikely 
to completely eliminate the virus. 
 
As  has  been  demonstrated,  vaccination  does  not  prevent  replication  so 
logically  virus  may  also  persist  after  treatment.  At  least  some  of  the 
immunosuppressive effects of the viral genome are probably independent of 
infectivity and interactions between viral and host proteins are unlikely to be 
disturbed if infectivity is lost (Kekarainen et al., 2008, Vincent et al., 2007). 
Therefore,  clinical  disease  or  secondary  infections  may  still  occur  despite 
vaccination  and/or  treatment,  especially  after  prolonged  subclinical  or 
repeated  infections.  Disruption  of  the  IL-10  mediated  immunosuppression 
may aid in recovery and viral clearance and is another option worth exploring. 
This  could  be  accomplished  through  RNAi,  specific  anti-IL-10  monoclonal 194 
 
antibody therapy or gene therapy (expressing a non-functional IL-10 mutant to 
compete  with  endogenous  IL-10).  As  an  aside,  circoviruses  also  have 
potential as gene therapy vectors for the treatment of other diseases, since 
VLPs  are  easily  produced  and  efficiently  transported  to  the  cell’s  nucleus 
(Noad and Roy, 2003, Tegerstedt et al., 2005, Whittaker and Helenius, 1998). 
 
There  has  been  a  need  for  widely  available,  efficacious  and  cost-effective 
vaccines  and  diagnostic  tests  for  avian  diseases  for  many  years  and  the 
mainstream use and acceptance of recombinant technologies brings them a 
step closer. Equally important is the need to fill in key gaps in the information 
concerning  the  pathophysiology  of  BFDV  and  other  avian  diseases.  The 
prototype diagnostic tests and vaccines described in this thesis will hopefully 
be  of  use  in  the  development  of  cheap,  commercially  available  tests  and 
vaccines. 
 
Turning the work described in this thesis into products available to the wider 
community will require much additional time, effort and money to scale up, 
validate and package them but this work should be rewarding and of great 
benefit. These products will be of use in research, pet bird health and the 
wider  environment  by  assisting  investigations  into  clinical  and  academic 
aspects of disease, maintenance of healthy pet birds and use in conservation 
programs, for example. The availability of these products will, in turn, work to 
promote further avian species’ status as companion animals. Just as vaccines 
for infectious diseases of dogs and cats help to control common diseases and 
involve owners in their care, vaccines for avian diseases will do the same for 195 
 
birds. As these technologies and products are applied and accepted, owners’ 
and veterinarians’ involvement with birds will increase, as will their knowledge 
of and care for them and they should be a valuable tool for the promotion of 
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Appendix 1. Sequences used for phylogenetic analysis 
Code  Accession 
Number 
Host species (common name)  Region used 
(entire or partial 
sequence) 
BB-AUS  AF311295  Psephotus haematogaster (blue bonnet parrot)  Entire 
LB-AUS  AF311296  Agapornis roseicollis (peach-faced lovebird)  Entire 
ELBC-AUS  AF311297  Cacatua tenuirostris (long-billed corella)  Entire 
ER-AUS  AF311298  Eolophus roseicapillus (galah)  Entire 
TH-AUS  AF311299  Trichoglossus haematodus (rainbow lorikeet)  Entire 
MMC-AUS  AF311300  Cactua leadbeateri (Major Mitchell’s cockatoo)  Entire 
SCC1-AUS  AF311301  Cacatua galerita (sulphur-crested cockatoo)  Entire 
SCC2-AUS  AF311302  Cacatua galerita (sulphur-crested cockatoo)  Entire 
SCC3-AUS  AF080560  Cacatua galerita (sulphur-crested cockatoo)  Entire 
BFDV-USA  AF071878  Pooled virus  Entire 
PK1-USA  AY521234  Psittacula krameri (Indian ringneck)  Entire 
LB-UK  AY521235  Agapornis roseicollis (peach-faced lovebird)  Entire 
AGP-UK  AY521238  Psittacus erithacus (African grey parrot)  Entire 
AGP-GER  AY521237  Psittacus erithacus (African grey parrot)  Entire 
LB-SAF  AY450442  Agapornis nigrigenis (black-cheeked lovebird)  Entire 
PG-SAF  AY450441  Poicephalus gulielmi (Jardine’s parrot)  Entire 
WBC-SAF  AY450434  Pionites leucogaster (white-bellied caique)  Entire 
PE-SAF  AY450435  Psittacus erithacus (African grey parrot)  Entire 
WC-SAF  AY450436  Cactua alba (umbrella cockatoo)  Entire 
PR1-SAF  AY450437  Poicephalus robustus (Cape parrot)  Entire 
PR2-SAF  AY450438  Poicephalus robustus (Cape parrot)  Entire 
PR3-SAF  AY450439  Poicephalus ruppellii (Ruppell’s parrot)  Entire 
PEP01  AY521236  Psittacus erithacus (African grey parrot)  Entire 
AFG5-ZA  DQ397817  Psittacus erithacus (African grey parrot)  ORFV1 
HHP1-ZA  DQ397816    ORF V1 (Partial) 
UFS6  DQ384626  Poicephalus gulielmi massaicus (Cape parrot)*  ORF V1 (Partial) 
UFS5  DQ384625  Melopsittacus undulatus (Budgerigar)  ORF V1 (Partial) 
UFS4  DQ384624  Melopsittacus undulatus (Budgerigar)  ORF V1 (Partial) 
UFS3  DQ384623  Melopsittacus undulatus (Budgerigar)  ORF V1 (Partial) 
UFS2  DQ384622  Psittacula krameri (Indian ringneck)  ORF V1 (Partial) 
UFS1  DQ384621  Psittacula krameri (Indian ringneck)  ORF V1 (Partial) 
TW04-13  DQ304756  Melopsittacus undulatus (Budgerigar)  ORF V1 (Partial) 
TW04-14  DQ304757  Melopsittacus undulatus (Budgerigar)  ORF V1 (Partial) 
TW04-11  DQ304754  Amazona auropalliata (yellow-naped parrot)  ORF V1 (Partial) 
TW04-08  DQ304753  Eclectus roratus (Eclectus parrot)  ORF V1 (Partial) 
TW04-07  DQ304752  Cacatua galerita (Sulphur-crested cockatoo)  ORF V1 (Partial) 
TW04-04  DQ304750  Eclectus roratus (Eclectus parrot)  ORF V1 (Partial) 
TW04-06  DQ304751  Cacatua galerita (Sulphur-crested cockatoo)  ORF V1 (Partial) 
TW04-01  DQ304749  Eclectus roratus (Eclectus parrot)  ORF V1 (Partial) 
TW03-13  DQ304748  Forpus coelestis (Pacific parrotlet)  ORF V1 (Partial) 
TW03-11  DQ304746  Psephotus haematonotus (red-rumped parrot)  ORF V1 (Partial) 
TW03-10  DQ304745  Psittacus erithacus (African grey parrot)  ORF V1 (Partial) 
TW03-07  DQ304744  Amazona auropalliata (yellow-naped parrot)  ORF V1 (Partial) 
TW03-05  DQ304742  Ara ararauna (blue and gold macaw)  ORF V1 (Partial) 
TW02-05  DQ304739  Eos reticulate (blue-streaked lory)  ORF V1 (Partial) 
TW02-01  DQ304738  Eos reticulate (blue-streaked lory)  ORF V1 (Partial) 
SCC1-NZ  AY148285  Cacatua galerita (sulphur-crested cockatoo)  ORF V1 (Partial) 
SCC2-NZ  AY148286  Cacatua galerita (sulphur-crested cockatoo)  ORF V1 (Partial) 
SCC3-NZ  AY148287  Cacatua galerita (sulphur-crested cockatoo)  ORF V1 (Partial) 
SCC4-NZ  AY148288  Cacatua galerita (sulphur-crested cockatoo)  ORF V1 (Partial) 
SCC5-NZ  AY148290  Cacatua galerita (sulphur-crested cockatoo)  ORF V1 (Partial) 
LC1-NZ  AY148289  Cacatua tenuirostris (long-billed corella)  ORF V1 (Partial) 
RCL-NZ  AY148291  Trichoglossus  haematodus  rubritorquis  (red-
collared lorikeet) 
ORF V1 (Partial) 
YBL-NZ  AY148292  Lorius chlorocercus (yellow-bibbed lory)  ORF V1 (Partial) 
RL1-NZ  AY148293  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
RL2-NZ  AY148294  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
RL3-NZ  AY148295  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
BSL1-NZ  AY148296  Eos reticulata (blue-streaked lory)  ORF V1 (Partial)   233 
Code  Accession 
Number 
Host species (common name)  Region used 
(entire or partial 
sequence) 
SL2-NZ  AY148297  Eos reticulata (blue-streaked lory)  ORF V1 (Partial) 
GL-NZ  AY148298  Psitteuteles goldiei (Goldie’s lorikeet)  ORF V1 (Partial) 
YBL2  AY148299  Lorius chlorocercus (yellow-bibbed lory)  ORF V1 (Partial) 
RL2-NZ  AY148300  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
BG1-NZ  AY148301  Melopsittacus undulatus (budgerigar)  ORF V1 (Partial) 
BG2-NZ  AJ605577  Melopsittacus undulatus (budgerigar)  ORF V1 (Partial) 
RL-NSW  DQ016388  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
RL-NSW  DQ016389  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
SP-TAS  DQ016390  Swift parrot (Lathamus discolor)  ORF V1 (Partial) 
SP-TAS  DQ016391  Swift parrot (Lathamus discolor)  ORF V1 (Partial) 
RL-VIC  DQ016392  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
ML-WA  DQ016393  Musk lorikeet (Glossopsitta concinna)  ORF V1 (Partial) 
RL-WA  DQ016394  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
RCL-WA  DQ016395  Trichoglossus  haematodus  rubritorquis  (red-
collared lorikeet) 
ORF V1 (Partial) 
RL-NSW  DQ016396  Trichoglossus haematodus (rainbow lorikeet)  ORF V1 (Partial) 
CV clone1  AY518932  Coracopsis vasa (greater vasa parrot)   ORFC1 (Partial) 
AM clone1  AY518931  Ara militaris (military macaw)  ORFC1 (Partial) 
ER clone1  AY518930  Eolophus roseicapillus (galah)  ORFC1 (Partial) 
PK2  AY518929  Psittacula krameri (Indian ringneck)  ORFC1 (Partial) 
PE3 clone6  AY518938  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PEPR clone1  AY518926  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PS clone1  AY518925  Poicephalus senegalensis (senegal parrot)  ORFC1 (Partial) 
AA clone1  AY518924  Amazona autumnalis (red-lored amazon)  ORFC1 (Partial) 
CM clone1  AY518923  Cacatua moluccensis (moluccan cockatoo)  ORFC1 (Partial) 
CL clone1  AY518922  Cacatua leadbeateri (Major mithchell’s cockatoo)  ORFC1 (Partial) 
CH clone1  AY518921  Cacatua haematuropygia (Philippine cockatoo)  ORFC1 (Partial) 
PE clone1  AY518920  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
AR clone3  AY518919    ORFC1 (Partial) 
AR clone5  AY518918    ORFC1 (Partial) 
ER clone1  AY518917  Eolophus roseicapillus (galah)  ORFC1 (Partial) 
AS clone1  AY518916    ORFC1 (Partial) 
PE7 clone4  AY518915  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PE7 clone3  AY518914  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
TH clone1  AY518913    ORFC1 (Partial) 
PEP clone11  AY518912  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
AA clone102  AY518911    ORFC1 (Partial) 
PEP clone16  AY518910  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
AR2 clone2  AY518909  Agapornis roseicollis (peach-faced lovebird)  ORFC1 (Partial) 
AR7 clone2  AY518908  Agapornis roseicollis (peach-faced lovebird)  ORFC1 (Partial) 
AR8 clone2  AY518907  Agapornis roseicollis (peach-faced lovebird)  ORFC1 (Partial) 
PEI clone1  AY518906  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PEJ clone1  AY518905  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PEU clone1  AY518904  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PE7 clone1  AY518902  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PEP clone1  AY518901  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
PK1 clone1  AY518900  Psittacula krameri (Indian ringneck)  ORFC1 (Partial) 
PE1 clone1  AY518899  Psittacus erithacus (African grey parrot)  ORFC1 (Partial) 
ARB1-ZA  AY450452    ORFC1 (Partial) 
SM1-ZA  AY450451    ORFC1 (Partial) 
UC2-ZA  AY450450    ORFC1 (Partial) 
ARB3-ZA  AY450449    ORFC1 (Partial) 
ARB2-ZA  AY450448    ORFC1 (Partial) 
GJP2-ZA  AY450447    ORFC1 (Partial) 
LJP1-ZA  AY450446    ORFC1 (Partial) 
BWJ1-ZA  AY450445    ORFC1 (Partial) 
LJP2-ZA  AY450444    ORFC1 (Partial) 
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Psittacine beak and feather disease is known to occur in awide range of psittacine species; however, there are
no scientific or credible anecdotal reports of psittacine beak and feather disease occurring in the cockatiel
(Nymphicus hollandicus) despite it being one of the world’s most commonly kept companion bird species.
Consequently, this has resulted in speculation that the species may have some innate resistance to beak and
feather disease virus (BFDV) infection. To investigate this hypothesis we conducted a survey of cockatiels
(n 88) at commercial aviaries to investigate whether BFDV infection occurs in cockatiels, and found that all
birds were virus-free by polymerase chain reaction and haemagglutination assay and had no detectable
antibody titre by haemagglutination-inhibition assay. In addition to this, we sequenced the genome of two
BFDV isolates obtained from diseased cockatiel feathers and performed cross-reactivity assays using virus
eluted from these feathers and sera from naturally immune psittacine birds. Serological cross-reactivity
results and phylogenetic analysis of the nucleotide sequences indicated that the cockatiel virus isolates were
serologically and genetically different to other BFDV isolates. This is the first paper to report evidence of an
antigenically distinct BFDV in psittacine birds.
Introduction
Beak and feather disease virus (BFDV) is the most
common viral infection of psittacine birds, and the
chronic debilitating feather disease that it causes has
been confirmed in more than 60 psittacine species; it is
highly probable that all are susceptible (Pass & Perry,
1985; Ritchie et al., 1989; Rahaus & Wolff, 2003;
Albertyn et al., 2004). Surveys have been carried out in
both wild and captive psittacine populations and re-
ported virus prevalence rates vary between 10% and
94%, depending on the method of detection (McOrist et
al., 1984; Raidal et al., 1993a; Rahaus & Wolff, 2003;
Khalesi et al., 2005). Given the wide range of Psittaci-
forme species reported to be susceptible, it is curious that
the cockatiel (Nymphicus hollandicus) is greatly under-
represented in both the scientific and lay literature.
Indeed we know of no published reports of psittacine
beak and feather disease (PBFD) in cockatiels even
though the species is one of the most commonly kept
companion bird species worldwide. It seems the only
evidence of BFDV infection occurring in the cockatiel
was a diagnosis made by polymerase chain reaction
(PCR) in our own laboratory (Khalesi et al., 2005).
In order to investigate the apparently low rate of
BFDV infection in cockatiels we decided to survey
cockatiels at three commercial aviaries in Perth, Western
Australia using PCR, as well as haemagglutination (HA)
assay and haemagglutination-inhibition (HI) assay. In
addition, BFDV DNA samples from the feathers of two
cockatiels submitted to us for BFDV diagnostic testing
were amplified by PCR, sequenced and analysed.
Materials and Methods
Samples. Feathers from two cockatiels (isolates 05-106 and 05-726) with
characteristic skin lesions consistent with PBFD that had tested BFDV-
positive by PCR and HA assay were used for subsequent PCR analysis
and DNA sequencing as described below. A formalin-fixed feather
follicle skin biopsy, submitted along with the feather of isolate 05-106,
was also processed by routine histology methods, stained with
haematoxylin and eosin, and examined by light microscopy for the
presence of characteristic inclusion bodies (Figure 1a). BFDV infection
was confirmed by immunohistochemistry (Figure 1b) as described
below.
A survey of cockatiels in commercial aviaries was also conducted.
Blood and feathers from 88 cockatiels at three commercial aviaries that
had a laboratory-confirmed history of housing PBFD-affected psitta-
cine birds were taken for testing. Blood was collected by venepuncture
of the jugular or cutaneous ulnar vein and spotted onto filter paper
(Whatmann, No. 3), then allowed to air dry at room temperature as
described by Riddoch et al. (1996). Feathers were plucked and placed
into clean 1.5-ml microcentrifuge tubes or zip-lock bags. PCR and HI
assay was performed on blood, and feathers were used for HA testing.
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9Immunohistochemical staining. Immunohistochemical staining using
primary monoclonal antibodies to recombinant BFDV capsid protein
(Stewart et al., 2007 and a horseradish-peroxidase-conjugated secon-
dary antibody were performed on tissue sections from case 05-106.
Briefly, 5 mm sections of formalin-fixed and paraffin-embedded feather
tissue were cut using a Leica RM 2135 microtome, placed onto glass
slides, de-waxed three times in xylene for 3 min and re-hydrated using
decreasing ethanol concentrations and a final wash in Tris buffer for 3
min. Endogenous peroxides were quenched using 0.3% (v/v) H2O2 in
methanol for 5 min and then washed in Tris buffer. Slides were
incubated with a 1:500 dilution of the primary monoclonal antibody
in Tris buffer for 10 min at room temperature, and unbound antibody
was then removed by triplicate washes each for 3 min in Tris buffer
before incubating with horseradish-peroxidase-conjugated EnVision
anti-mouse (Dako) at room temperature for 30 min. The slide was
washed as before and then antigen antibody complexes were visualized
with the chromagen diaminobenzidine (DAKO† DAB Chromagen).
Imaging was performed using an Olympus BX 13 microscope and a
digital camera accessory.
Extraction of DNA from feathers. Viral DNA was extracted from
feathers of the two cockatiels 05-106 and 05-726 using the methods
described by Ypelaar et al. (1999). Five millimetres of the feather
calamus was cut on a sterile surface and placed into a microcentrifuge
tube (Eppendorf). To this, 200 ml of 70% (v/v) ethanol was added and
the tube vortexed briefly, and then the ethanol was removed and 200 ml
sterile distilled water was added and the tube vortexed again. The sterile
water was removed and 500 ml lysis buffer [50 mM KCl, 10 mM Tris 
HCl (pH 8.0), 2.5 mM MgCl2, 0.5% (v/v) Tween 20, 0.5% (v/v) Nonidet
P40], containing 250 mg/ml proteinase K (Qiagen) was added. The
feather in lysis buffer was incubated at 378C for 1 to 2 h, before being
heated to 958C for 10 min. The solution was centrifuged and DNA was
extracted from the supernatant with the Qiagen blood mini kit
(Qiagen), using the blood and body fluid spin protocol.
Polymerase chain reaction. The PCR was carried out using methods
similar to those described by Ypelaar et al. (1999). Primers P2 (5?-AAC
CCT ACA GAC GGC GAG-3?) and P4 (5?-GTC ACA GTC CTC CTT
GTA CC-3?) amplify a 717 base pair (bp) fragment of open reading
frame ORFV1 of BFDV DNA, and were used to test the surveyed
cockatiels. Cockatiels 05-106 and 05-726 had previously tested positive
for BFDV DNA using these two primers. Primers SeqP5 (5?-CTG CGA
CCG TTA CCC ACA TA-3?) and SeqP10 (5?-TCG CCC TTT TCC
CGT CCA AC-3?) were designed to amplify a 1479 bp fragment, the
ends of which overlapped with the fragment generated by primers P2
and P4. Cockatiels 05-106 and 05-726 were tested using both primer
sets; the two overlapping amplicons included the entire BFDV genome
and were used in subsequent sequencing reactions. The PCR reaction
consisted of 2 mM MgCl2,5ml of 5x polymerization buffer containing
dNTPs, 12.8 pmol each primer and 0.1 U Tth-Plus DNA polymerase,
made to a total volume of 25 ml using ultrapure water (all reagents
Fischer Biotec). Reactions were carried out in an Eppendorf Master-
cycler Gradient thermocycler (Eppendorf). The PCR reaction using
primers SeqP5 and SeqP10 was identical, except that 3 mM MgCl2 was
used and the annealing temperature was lowered to 488C. PCR
products were visualized on a 1% agarose gel with the addition of
0.001% ethidium bromide, run at 90 V for 30 min.
Haemagglutination assay. The HA assays were carried out as described
by Raidal et al. (1993b). Feathers were incubatedwith 100 ml phosphate-
buffered saline (PBS) at 608C for 1 h in a microcentrifuge tube
(Eppendorf). The suspension was centrifuged briefly after incubation
and 50 ml supernatant added to 50 ml PBS in a microtitre plate
(Eppendorf). Serial dilutions of the solution were made by removing
50 ml solution from the first well and mixing with 50 ml PBS in the next
well, and repeating the process across the row of the microtitre plate.
Negative and positive control lanes were included for each batch of
samples tested. The negative control consisted of PBS only, and the
positive control was a 50 ml suspension of virus purified from feathers
and organs of a BFDV-infected sulphur-crested cockatoo (Cacatua
galerita), diluted to give a HA titre of 40 to 80 HA units/50 ml. To each
well, 50 ml of a 0.75% to 0.85% (v/v) solution of type A galah
erythrocytes was then added, and the microtitre plate was incubated for
1ha t3 7 8C. A positive HA titre was indicated by the suspension of the
erythrocytes in the well of the microtitre plate, whereas a negative HA
result was indicated by the sedimentation of the erythrocytes within the
well.
Haemagglutination-inhibition assays. The HI assays were carried out as
described by Raidal et al. (1993b) using antigen purified from the
feathers of a cockatoo with PBFD, diluted to give a HA titre of 4 to
8 HA units/50 ml. Plasma, serum or dried blood spots on filter paper
were used for testing. Plasma or serum was first heat-inactivated at
578C for 30 min, then 100 ml serum was added to 1 ml of 5% (w/v) acid-
washed kaolin and the mixture incubated for 1 h at room temperature,
or overnight at 48C. Equal volumes of the supernatant was then
haemadsorbed against a 10% (v/v) suspension of normal (non-
haemagglutinating) galah erythrocytes for 18 h at 48C.
For blood collected onto filter paper, one 0.5-cm-diameter spot of
blood on filter paper was cut out using scissors or a hole punch and
collected into a microcentrifuge tube (Eppendorf). Then 100 mlo f5 %
(w/v) acid-washed kaolin was added and serum eluted from the paper
by incubating the mixture for 1 h at room temperature, or overnight at
48C. Then 50 ml supernatant was haemadsorbed against 50 ml of a 10%
(v/v) suspension of normal (non-haemagglutinating) galah erythrocytes
for 18 h at 48C.
For testing, 50 ml haemadsorbed serum was added to 50 ml PBS in a
microtitre plate well (Eppendorf). Serial dilutions of the solution were
made by removing 50 ml solution from the first well and mixing with
50 ml PBS in the next well, and repeating the process across the row of
the microtitre plate. Negative and positive control lanes were included
Figure 1. 1a: Histological section of a feather follicle from
cockatiel 05-106, showing characteristic basophilic inclusions
within macrophages in the feather pulp (arrow heads). Bar 0.5
mm 1b: Immunohistochemical stain of the same section showing
strong positive (brown) reaction to BFDVantigen throughout the
epidermis. Bar 0.5 mm.























































































9for each batch of samples tested. The negative control was a 50 ml
suspension of purified virus, diluted to give a HA titre of 4 to 8 HA
units/50 ml. The positive control was a serial dilution of 50 ml chicken
anti-BFDV polyclonal sera, processed as above. A positive HI titre was
indicated by the sedimentation of the erythrocytes within the well of the
microtitre plate, whereas a negative HI result was indicated by the
suspension of the erythrocytes in the well.
Cross-reactivity assays. An additional set of HI assays was performed to
investigate the possible existence of a cockatiel-specific BFDV serotype.
HI assays were performed as described above, except that the antigen
and negative control was virus eluted from the feather of a cockatiel
that had tested positive for BFDV by PCR and HA. Sera from seven
different psittacine bird species including two short-billed corellas
(Cacatua sanguinea), a sulphur-crested cockatoo, two rainbow lorikeets
(Trichoglossus haematodus), one long-billed corella (Cacatua tenuiros-
tris), one red lory (Eos bornea) and one galah corella hybrid with
known HI titres were reacted against virus eluted from cockatiels
05-106 and 05-726. Sera from all cockatiels sampled at the commercial
aviaries were also tested against BFDV eluted from the feather of
cockatiel 05-106.
Nucleotide sequence determination and analysis. PCR products were
purified using an Axyprep PCR cleanup kit (Axygen), according to the
manufacturer’s instructions. Dideoxynucleotide sequencing was carried
out using an ABI Prism Dye Terminator Cycle Sequencing Kit (Applied
Biosystems) according to the manufacturer’s instructions, except that
the reaction volume was reduced to 10 ml and the annealing temperature
used when sequencing the 1478 bp products was reduced to 508C.
Sequencing reactions consisted of 2 ml reaction buffer (containing Tris 
HCl, MgCl2, fluorescently labelled dNTPs and AmpliTaq DNA
polymerase, concentrations not supplied; Perkin Elmer), 1 mlo f5 x
sequencing buffer (composition not supplied; Perkin Elmer), 10 to 20 ng
of 717 bp PCR product or 20 to 40 ng of the 1479 bp PCR product,
then made up to a total of 10 ml with ultrapure water (Fischer Biotec).
DNA sequences were determined using an Applied Biosystems 3730
DNA Analyser and edited using Sequence Scanner v1.0 (Applied
Biosystems) and GeneTool Lite (BTI Software). Edited sequences were
analysed using MEGA 3.1 (Kumar et al., 2004). Neighbour-joining,
maximum parsimony and Bayesian trees were constructed with 1000
bootstrap cycles for the neighbour-joining and maximum parsimony
trees.
Results
Survey of cockatiels for evidence of BFDV and cross-
reactivity assays. Of the 88 cockatiels tested using
primers P2 and P4, none were positive for BFDV by
PCRor HA assay and none had detectable antibodies to
BFDV. None of the cockatiels surveyed had detectable
HI activity against BFDV eluted from a cockatiel
feather. Six of the eight known anti-BFDV HI-positive
sera tested inhibited HA eluted from the feather of
cockatiel 05-106, and similarly five of the eight sera
inhibited HA eluted from isolate 05-726. Polyclonal
chicken anti-BFDV antibody did not inhibit agglutina-
tion by either cockatiel virus isolate (Table 1).
Sequencing and analysis of PCR-positive samples from
cockatiels. Primer sets P2/P4 and SeqP5/SeqP10 ampli-
fied overlapping 717 bp and 1497 bp fragments of the
BFDV genome, respectively, from samples 05-106 and
05-726. Analysis of the sequences revealed that both
sequences were 1993 nucleotides long and had identical
features to other described circoviruses. A potential
stem-loop structure, formed between bases 1976 and
1993 and between 1 and 12, as well as a repeated
octanucleotide motif (GGGCACCG) were present im-
mediately downstream of the stem-loop. Potential poly-
adenation signals were present in both sequences at
identical positions: CATAAA between nucleotides 1019
and 1024 on the viral strand, and AATAAA on the
complementary strand between nucleotides 758 and 763
(nucleotides 1231 to 1236 of the viral strand). A TATA
box was also present, between nucleotides 86 and 89 of
the viral strand. The area of the complementary strand
between nucleotides 60 and 207, containing putative
nuclear localization signals as described by Heath et al.
(2004), was highly conserved across all sequences
analysed, including the two cockatiel sequences.
Comparison of full-length sequences. Pairwise distances
between cockatiel sequences and 26 other BFDV
sequences varied between 3.2% and 15.5% (isolate
05-106) and between 3.8% and 14.5% (isolate 05-726)
at the nucleotide level, and between 3.8% and 19%
(isolate 05-106) and between 5.2% and 19.2% (isolate
05-726) at the amino acid level. Neighbour-joining
phylogenetic analysis showed that both cockatiel se-
quences (isolates 05-106 and 05-726; GenBank accession
numbers EF457974 and EF457975, respectively) clus-
tered within cockatoo and galah isolates; however,
maximum parsimony (data not shown) and Bayesian
analysis grouped the cockatiel isolates distinctly sepa-
rately, with a high posterior probability (Figure 2).
Bayesian analysis also identified three distinct clades
within the sequences (Figure 2): the cockatiels comprised
clade number 1; the cockatoos and galahs plus three
African grey parrots (AY521236, AY450443 and
AY450435), a white-bellied caique (AY450434) and a
Cape parrot (AY450439) made up clade number 2; and
the remaining clade was made up of all Agapornis sp.
isolates, the remaining African grey parrot and Poice-
phalus sp. plus a single rainbow lorikeet and a single
Indian ringneck isolate.
Table 1. Haemagglutination-inhibition cross-reactivity of known positive anti-BFDV (cockatoo) psittacine sera against virus eluted
from the feathers of two cockatiels with PBFD
Antibody source Cockatoo BFDV Cockatiel 05-106 Cockatiel 05-726
Chicken anti-BFDV   Negative Negative
Red Lory   Negative Negative
Long-billed Corella    Negative
Galah/Corella hybrid    
Rainbow lorikeet    
Rainbow lorikeet    
Short billed corella   Negative Negative
Short billed corella    
Sulphur crested cockatoo    























































































9A plot of CpG islands within the cockatiel sequences
showedhighproportionsofCpGmotifsthroughoutmost
of the sequence. Gardiner-Garden & Frommer (1987)
defined a candidate CpG island as having Y0.6 on the
CpG plot and a GC content 50%. As such, the first 30
basesandthenbases420to600,640to1120,1150to1570
and 1575 to 1993 of the complementary strand contained
candidate CpG islands (Figure 3). Particular points of
interest are spikes in the CpG plot at nucleotides 30 to
360, 630, 1120 and 1330 to 1540 of the complementary
strand (Figure 3). The spikes at nucleotides 630, 1130 and
the first spike between nucleotides 30 and 360 are less
likely to be significant, however, as the GC content in
these regions is less than 50%.The whole sequence was
GC-rich, as the GC content was only less than 50%
between bases 60 and 400, 580 and 640, 1120 and 1145
and 1550 and 1600 of the complementary strand
(Figure 3). Analysis of the CpG and GC plots of the viral
strand revealed similar findings but in different locations.
Comparison of CpG plots derived from the cockatiel
isolates demonstrated subtle differences compared with
plots derived from published BFDV sequences from a
sulphur-crestedcockatoo(AF080560),a rainbowlorikeet
(AF311299) and a peach-faced lovebird (AF311296). GC
density plots for these isolates demonstrated minimal
variation between the four isolates.
ORFV1. Sequences of both cockatiel isolates had a start
codon of ATG located at position 131. The stop codon
for both isolates was TGA, located at nucleotide 997.
The predicted size of ORFV1 was 867 nucleotides.
Distances between cockatiel sequences and other
BFDV sequences varied between 2.5% and 11.9%
(isolate 05-106) and between 2.4% and 11.1% (isolate
05-726) at the nucleotide level, and between 2.2% and
11% (isolate 05-106) and between 1.1% and 10.4%
(isolate 05-726) at the amino acid level. Phylogenetic
analysis showed that both cockatiel sequences clustered
closest to, but separate from, the cockatoo and galah
isolates (Figure 2).
ORFC1. Sequences of both cockatiel isolates had a
putative start codon at nucleotide 16 (CTG) of the
complementary strand (or nucleotide 1978 of the viral
strand), as per Bassami et al. (2001). The stop codon for
both isolates was a TAA at nucleotide 757 of the
complementary strand (nucleotide 1235 of the viral
strand). Distances between cockatiel sequences and
other BFDV sequences varied between 2.0% and 18.9%
(isolate 05-106) and between 5.9% and 19.1% (isolate
05-726) at the nucleotide level, and between 6.0% and
28.5% (isolate 05-106) and between 6.8% and 27.4%
(isolate 05-726) at the amino acid level. Phylogenetic
Figure 2. Phylogram constructed using full-length BFDV sequences demonstrating the distance between cockatiel (N. hollandicus)
BFDV sequences (EF457974 and EF457975) in relationship to published BFDV sequences from other Psittacidae and Cacatuidae.
Numbers at the nodes indicate Bayesian posterior probability as a percentage.























































































9analysis showed that both cockatiel sequences clustered
within a clade of cockatoo and galah isolates. Alignment
of translated amino acid sequences showed that 121 of
260 amino acids were conserved across all the isolates
examined, and 133 of 260 were variable. The areas
between amino acids 68 to 83, 94 to 97 and 228 to 241
were especially variable, but the significance of this is
unknown.
Discussion
The data presented in this paper provide histological,
DNA sequence and serotyping evidence of BFDV
infection in cockatiels, thus confirming that the species
is susceptible to BFDV infection. Immunohistochemical
staining and DNA sequence data and CpG analysis
demonstrated antigenic and genetic relationships with
BFDV isolates obtained from other Psittaciformes.
However, maximum parsimony and Bayesian analysis
of the cockatiel isolates placed them into a clade
genetically distinct from other BFDV sequences, and
HI cross-reactivity analysis also demonstrated evidence
of antigenic variation in one of the cockatiel BFDV
isolates when it was used as the antigen against known
positive BFDV antisera.
BFDV is a genetically diverse virus and there have
been numerous phylogenetic studies on the now many
isolates that have had their complete nucleotide se-
quences determined. Broad genotype lineages aligned
to the major Families of psittacine birds*namely the
cockatoos, loriids and other parrots*have been demon-
strated but the biological significance of this clustering
has not been well understood. There have been few
papers that have investigated antigenic variation in the
virus, but BFDV isolates harvested from a diverse range
of psittacine genera were found to be antigenically
similar by Ritchie et al. (1990) and antigen derived
from the feathers of diseased cockatoos has, until now,
proven useful for detecting antibody to BFDV using HI
assay. Within the Cacatuidae there are six genera and 21
species, and within the Psittacidae there are 78 genera
and 332 species. Numerous papers have found the HI
assay suitable for detecting anti-BFDVantibodies in sera
from a large proportion of these 353 species (Raidal
et al., 1993a,b; Raidal & Cross, 1994a; Ritchie et al.,
1991; Riddoch et al., 1996; Khalesi et al., 2005). Khalesi
et al. (2005) demonstrated no evidence of any antigenic
serotypes by HI cross-reactivity studies using feather and
blood samples obtained from a range of psittacine bird
species and an identical technique to that described in
this present paper. The fact that HI antibodies against a
single antigen has been successfully used to detect BFDV
in a range of psittacine bird species is good evidence that
there is a considerable degree of cross-reactivity between
the different genotypes that infect cockatoos, lorikeets
and parrots.
The low reported incidence of BFDV infection in
cockatiels and our negative serological survey results are
somewhat puzzling for such a supposedly common and
infectious virus that all Psittaciformes are presumed to
be susceptible to. It is highly unlikely that the negative
PCR results of all birds surveyed represent a failure of
the test. Khalesi et al. (2005) reported only one false-
negative PCR result from a total of 623 samples tested.
The authors also showed that the PCR test is able to
detect the cockatiel BFDV isolate, and this has been
confirmed in the present study. It could be that all of the
cockatiels surveyed in this present paper were naı ¨ve to
infection, and were truly antibody negative. However,
they were from commercial aviaries that had a high
Figure 3. CpG and GC plots of the complementary strand of the cockatiel (N. hollandicus) 05-106 isolate, overlain on CpG plots of
BFDV isolates from a sulphur-crested cockatoo (C. galerita), a rainbow lorikeet (T. haematodus) and a peach-faced lovebird
(Agapornis roseicollis) demonstrating areas of variable CpG regions at nucleotide 250 in the complementary strand.























































































9turnover of a wide variety of psittacine bird species,
many of which we knew from clinical observations were
expressing clinical signs of PBFD. Typically the birds in
such establishments have a high incidence of BFDV
infection, PBFD and a high HI antibody prevalence,
with budgerigars (Melopsittacus undulatus) and lovebirds
(Agapornis spp.) having the highest rates of infection
(Khalesi et al., 2005).
According to published epidemiologic data, an ex-
pected seroprevalence of 30% to 40% would be a
conservative estimate (Raidal et al., 1993a; Raidal &
Cross, 1994b; Khalesi et al., 2005) of the expected
seroprevalence within the population of cockatiels that
we sampled and a sample size of 88 should have provided
a 95% level of confidence of the estimate of the
prevalence of infection (Thrushfield, 1986). Failure to
detect any evidence of antibody in such a sample size
provides strong evidence (95% confidence level) that the
seroprevalence in the population of cockatiels we
sampled was less than 5% (Thrushfield, 1986). This is a
very low figure in comparison with other Psittaciforme
species. The lack of documented cases of cockatiels with
PBFD in the literature along with the negative PCR and
serological results obtained in our survey could be
interpreted as evidence that cockatiels are somewhat
innately resistant to BFDV infection. However, the PCR
results in individual cockatiels reported here and by
Khalesi et al. (2005) along with the histological evidence
of BFDV infection (Figure 1) indicate that the species is
susceptible to BFDV. Furthermore, the PCR results,
DNA sequence analysis and HI cross-reactivity data
provide evidence of a cockatiel-adapted BFDV that may
be sufficiently different, genetically and antigenically,
from most other BFDV isolates to be considered a
separate strain of the virus. This is not surprising given
evidence that avian circoviruses have coevolved with
their host species (Ritchie et al., 2003; Stewart et al.,
2006). Psittaciforme mitochondrial DNA phylogeny has
placed the monotypic Nymphicus more closely related to
the black cockatoos (Calyptorynchus and Callocephalon),
and not the more distantly related white cockatoos
(Cacatua and Eolophus) as was once thought (Brown &
Toft, 1999), and the results presented in this present
paper provide further support to this hypothesis.
Given the data presented in this paper, there are some
aspects of BFDV evolution and epidemiology that are
difficult to explain. Based on the phylogenetic analysis
(Figure 2), the cockatiel BFDV sequences are genetically
distinct from those obtained from other psittacine
species. However, the same method of analysis and other
similar studies have also found similar distinct genetic
differences between BFDV isolates from lovebirds,
lorikeets and cockatoos. In addition, cross-reactivity
work using BFDV eluted from the feathers of two
rainbow lorikeets, a musk lorikeet (Glossopsitta con-
cinna), a red lory, two swift parrots (Lathamus discolor),
a sulphur-crested cockatoo and a scarlet chested parrot
(Neophema splendida) and anti-BFDV antibodies from
the same panel of birds as in this study has shown these
not to be serologically distinct (Khalesi et al., 2005), and
therefore it is difficult to clearly associate a specific
mutation or genetic variation in the cockatiel sequences
with any biological or antigenic characteristics.
Phylogenetic analysis of full-length sequences and V1
sequences grouped the cockatiels separately to other
isolates, but analysis of C1 sequences alone grouped the
cockatiel sequences appropriately within a cockatoo
clade (data not shown). Most studies thus far have
focused on the C1 gene as the main determinant of the
pathogenicity of the virus (Heath et al., 2004; Raue et al.,
2004), but the fact that the C1 gene grouped within a
known clade while the V1 gene and full sequences
grouped separately suggests three things: firstly, that
the V1 gene may have other functions than first thought;
second, that parts of the sequence other than the C1 and
V1 gene play a part in pathogenesis; and third that host
factors (such as the presence or absence of cell surface
receptors for virus attachment or MHC presentation)
play a significant role.
The second of these possibilities is supported by work
with porcine circovirus 2 (PCV2) showing that CpG
motifs play a role in the modulation of a-interferon
expression (Hasslung et al., 2003), and as such CpG
motifs may play a similar role in modulating cytokines
during the course of BFDV infection. Fenaux et al.
(2003); 2004, demonstrated that when the capsid-coding
region of PCV2 was cloned into the genomic backbone
of PCV1, the resultant chimeric virus was less patho-
genic than wild-type PCV2. This is not to say that the C1
gene and capsid protein are not significant in the
pathogenesis of the disease. Mahe et al. (2000) identified
capsid epitopes unique to PCV1 and PCV2, and the
presence of unique epitopes may occur with BFDV as
well and may explain the variable cross-reactivity of the
cockatiel isolates. Considering that there are currently no
cell-culture techniques or any in vitro methods to
propagate BFDV, the identification of these unique
epitopes and other motifs suspected to play a role in
pathogenesis will need to be carried out using such
techniques as epitope mapping and infectivity studies
using infectious clones. Likewise, infectivity studies with
various mutant BFDV infectious clones and a wide
range of psittacine species may be the only way to
investigate the extent to which the genotype of an isolate
affects its pathogenicity.
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PCR-based assays for the detection of BFDV DNA are in widespread use throughout the world. Quan-
titative real-time PCR assays are extremely sensitive and have the advantages over standard PCR
assays that they do not require post-reaction processing to visualise PCR products and can quan-
tify the amount of DNA present in a sample. This study describes a quantitative real-time PCR assay
for the detection of BFDV DNA, using primers designed to amplify a conserved 81bp fragment of
ORFV1 and SYTO9, a ﬂuorescent intercalating dye. A synthetic oligonucleotide was used to make
standard curves for the quantitation of viral load in blood and feather preparations. The assay was
very sensitive, with a detection limit of 50copies/L. The assay was developed using DNA extracts
from the feathers of 10 different species of birds which had tested BFDV-positive previously and
was validated with blood and feather samples from corellas vaccinated with an experimental BFDV
vaccine, then challenged with live virus. Viral DNA was detected consistently in the blood of all con-
trol (non-vaccinated) birds and in some vaccinated birds. Contamination of the environment with
feather dander from BFDV-infected birds meant that feather preparations used for the haemaggluti-
nation assay were unreliable for the detection and quantitation of viral excretion. Nonetheless, the
assay should prove to be a useful and sensitive test for the detection of viral DNA in a range of sam-
ples.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Psittacine beak and feather disease (PBFD) is the most common
viral disease of psittacine birds and causes either a chronic debil-
itating feather disease in adult birds (Albertyn et al., 2004; Pass
and Perry, 1985; Rahaus and Wolff, 2003; Ritchie et al., 1989b)o ra
severe, acute disease syndrome in nestlings and African Grey par-
rots (Psittacus e. erithacus)( Doneley, 2003; Raidal and Cross, 1995;
Schoemaker et al., 2000). The causative agent, beak and feather dis-
easevirus(BFDV),isacircoviruswithasinglestrandedDNAgenome,
approximately 1.7–2.0kb in length (Bassami et al., 2001; Ritchie
et al., 1989b) and is considered to have a worldwide distribution
(Albertynetal.,2004;Hsuetal.,2006;Kiatipattanasakul-Banlunara
et al., 2002; Kock et al., 1993; McOrist et al., 1984; Pass and Perry,
1985; Rahaus and Wolff, 2003; Ritchie et al., 1989a). BFDV aggluti-
nates the erythrocytes of many birds (Kondiah et al., 2005; Raidal
and Cross, 1994; Ritchie et al., 1991; Sanada and Sanada, 2000;
Sexton et al., 1994; Soares et al., 1998), which has allowed the
∗ Corresponding author. Tel.: +61 2 69334450; fax: +61 2 69332812.
E-mail address: shraidal@csu.edu.au (S.R. Raidal).
development of haemagglutination (HA) and haemagglutination-
inhibition (HI) assays for the detection of virus and anti-BFDV
antibodies, respectively (Raidal et al., 1993). The ambisense viral
genome contains two major coding regions: ORFV1, which encodes
the replication-associated protein and ORFC1, which encodes the
capsid protein. PCR assays based on the DNA sequence of both
the V1 and C1 ORFs have been developed (Albertyn et al., 2004;
de Kloet and de Kloet, 2004; Kondiah et al., 2006; Ogawa et
al., 2005; Ritchie et al., 2003; Ypelaar et al., 1999), as well as
nested (Kiatipattanasakul-Banlunara et al., 2002), duplex (Ogawa
et al., 2005) and real-time (Raue et al., 2004) PCR assays. Despite
the difﬁculties associated with performing and standardising HA
assays, there are no alternative tests available for the quantita-
tion of the virus. Quantitative, real-time PCR (qPCR) assays allow
the rapid and sensitive quantitation of genetic material and are
in widespread use in studies of gene expression and the detec-
tion of infectious agents (Mackay, 2004; Nolan et al., 2006; Wong
and Medrano, 2005). As such, a qPCR assay could be extremely
useful for the detection of virus and characterisation of infec-
tion and excretion kinetics. Presented in this study is a novel
qPCR assay for the detection and characterisation of BFDV infec-
tion.
0166-0934/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.jviromet.2009.03.009Author's personal copy
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2. Materials and methods
Insofaraswaspractical,theqPCRwasdevelopedandvalidatedin
accordance with guidelines established by the Ofﬁce International
des Epizooites (O.I.E.) for the development of PCR methods for the
diagnosis of infectious diseases (Belak and Thoren, 2004; Jacobson,
2004).
2.1. Samples
DNA extracts used for the development of the qPCR were
taken from the archive of samples tested previously in our labo-
ratory. Samples originated from the blood and feathers of many
psittacine species, including sulphur-crested cockatoos (Cacatua
galerita), galahs (Eolophus roseicapillus), rainbow lorikeets (Tri-
choglossus haematodus), purple crowned lorikeets (Glossopsitta
porphyrocephala), eclectus parrots (Eclectus roratus), budgerigar
(Melopsittacusundulatus),Indianringneck(Psittaculaeupatriaeupa-
tria), Jardine’s parrot (Poicephalus gulielmi), green-cheeked conure
(Pyrrhura molinae), sun conure (Aratinga solstitialis), yellow-tailed
black cockatoo (Calyptorynchus funereus) and cockatiel. After DNA
extraction as described below, samples were stored at −20 ◦Cf o r
up to 5 years.
To validate the qPCR, samples from eastern long-billed corel-
las (Cacatua tenuiostris) that were part of an experiment to assess
a recombinant BFDV capsid protein-based vaccine (Bonne et al.,
2008b; Stewart et al., 2007) were tested using the optimised qPCR
assay. Long-billed corellas received 1mL vaccine containing 10mg
recBFDVcapbyintramuscularinjectiononday0and0.4mLvaccine
containing 66.8mg recBFDVcap on day 11. All vaccinated corel-
las and ﬁve non-vaccinated control corellas were given 0.4ml
BFDVsuspension[titre=log2 12haemagglutinationunits(HAU)per
50L]intramuscularlyand0.1mLorally16daysafterboostervacci-
nation. Samples of blood and serum or plasma, as described above,
were taken from vaccinated (n=15) and non-vaccinated control
(n=5) birds on six separate occasions, including the time of vac-
cination and the time of challenge with live virus. Not all samples
were available at each collection, so in total 108 samples were thus
collected.Aspartofthevaccinationtrial(Bonneetal.,2008b),blood
samples were tested by HA (Raidal et al., 1993) and PCR (Ypelaar et
al., 1999) assay. Crude DNA extracts were also made from the cor-
responding feather eluates prepared for HA testing (Bonne et al.,
2008b; Raidal et al., 1993) and tested using the optimised qPCR
assay.
Blood was collected by venepuncture of the jugular or cuta-
neous ulnar vein and spotted onto ﬁlter paper (Whatmann Grade
No. 3, Kent, United Kingdom), then allowed to dry at room tem-
perature as described by Riddoch et al. (1996). Feathers were
plucked and placed into clean 1.5mL microcentrifuge tubes or zip-
lock bags. To minimise contamination, latex examination gloves
(Ansell, Richmond, Australia) were worn when collecting samples
andwerechangedbetweeneachbird.ExtractionofDNAfromfeath-
ers
Viral DNA was extracted from feathers using the methods
described by Ypelaar et al. (1999). Five mm of feather calamus
was cut on a sterile surface and placed into a microcentrifuge
tube (Eppendorf, Hamburg, Germany). To this, 200L of 70% (v/v)
ethanol were added and the tube vortexed brieﬂy then the ethanol
was removed and 200L of sterile distilled water were then added
and the tube vortexed again. The sterile water was removed and
500L of lysis buffer [50mM KCl, 10mM Tris–HCl (pH 8.0), 2.5mM
MgCl2, 0.005% (v/v) Tween 20, 0.005% (v/v) Nonidet P40], con-
taining 250g/mL proteinase K (Qiagen, Hamburg, Germany) were
added. The feather in lysis buffer was incubated at 37 ◦C for 1–2h,
before being heated to 95 ◦C for 10min. The solution was cen-
trifuged and DNA was extracted from the supernatant with the
Qiagenbloodminikit(Qiagen,Hamburg,Germany),usingtheblood
and body ﬂuid spin protocol.
Crude DNA extracts of feather eluates prepared for HA testing
were also made. Feathers were incubated with 100L PBS at 60 ◦C
for 1h in a microcentrifuge tube (Eppendorf, Hamburg, Germany).
The solution was centrifuged brieﬂy after incubation and 10Lo f
the supernatant transferred to another microcentrifuge tube, then
boiled for 10min.
2.3. Extraction of DNA from dried blood spots
Viral DNA was extracted from dried blood spots using Qiagen
bloodminikit(Qiagen,Hamburg,Germany),usingamodiﬁeddried
blood spot protocol. Three spots of blood collected and dried on ﬁl-
ter paper were cut out using scissors or a hole punch and collected
in a microcentrifuge tube (Eppendorf, Hamburg, Germany). 180L
of lysis buffer (50mM KCl, 10mM Tris–HCl, pH 8.0, 2.5mM MgCl2,
0.005% (v/v) Tween 20, 0.005% (v/v) Nonidet P40) were added in
place of the Qiagen lysis buffer and the tube incubated at 85 ◦Cf o r
10min, then centrifuged. Twenty microlitres of proteinase K (Qia-
gen, Hamburg, Germany) were added to the tube, then the tube
was vortexed and incubated at 56 ◦C for 1h. After incubation, the
solution was centrifuged and DNA extracted from the supernatant
according to the manufacturer’s protocol.
2.4. Quantitative, real-time polymerase chain reaction assay
Primers were designed based on conserved regions of known
BFDV sequences (Kumar et al., 2004; Wishart and Fortin, 2001;
Wishart et al., 2000). Primers P5 (5 -GGA CGC AAA ATG AAG GAA
G-3 ) and P6 (5 -TAG CGA GAG GTT ATG CAA GC-3 ) (Geneworks,
Hindmarsh, Australia) were designed to amplify an 81bp frag-
mentofORFV1.Magnesiumchlorideconcentrationsandannealing
temperatures were optimised using an Eppendorf Mastercycler
Gradient thermocycler. The optimised PCR reactions consisted
of 2mM MgCl2,5 Lo f5 × polymerisation buffer containing
dNTPs, 3.34M SYTO9 ﬂuorescent dye (Invitrogen, Carlsbad, CA),
12.8pmol of each primer and 0.1U of Tth Plus DNA polymerase,
ultrapure water in a total volume of 23L (all reagents Fischer
Biotec, Perth, Australia, except SYTO9), plus 2L of extracted DNA.
Known-copy-number DNA standards were included in each run for
quantitation of viral load.
Known-copy-number DNA standards were generated using var-
ious dilutions of a synthetic oligonucleotide, BFDV qST (5 -ATG TCC
GGA CGC AAA ATG AAG GAA GTC GCA GCT GAA TTC CGA AAT TCC
TACGTCAGGCATGGGCGTGGCTTGCATAACCTCTCGCTATTGGTT-
3 ) (Geneworks, Hindmarsh, Australia). The oligonucleotide was
diluted to an initial concentration of 1×1012 copies/L, then seri-
ally diluted 1:100 to give standards of 1×1010,1×108 and 1×106.
The 1×106 standard was serially diluted 1:10 to give standards of
1×105,1 ×104,1 ×103,1 ×102 and the 1×102 standard diluted
1:2 to give a standard of 50copies/L. Two reactions using ultra-
pure water instead of DNA were used as negative controls in each
run.
Reactions were carried out in a Corbett Rotor-gene 3000 (Cor-
bett Research, Concorde, Australia) real-time thermocycler. Cycling
conditions consisted of an initial denaturation at 95 ◦C for 5min,
then 40 cycles of 95 ◦C for 20s, 58 ◦C for 30s and 72 ◦C for 20s,
followed by a ﬁnal extension step at 72 ◦C for 10min.
2.5. Melt curve analysis
A melt curve analysis was performed after each run, with the
mixture being cooled to 60 ◦C for 45s then heated in one-degree
increments to 95 ◦C. Fluorescence was measured for 15s at each
increment and a graph plotting the second derivative of the meltAuthor's personal copy
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Fig. 1. Mean viral load in blood and feather preparations of control (ﬁlled and clear
triangles)andvaccinatedbirds(ﬁlledandclearcircles)afterchallengewithlivebeak
and feather disease virus (BFDV). Peak viral load was greater in feather preparations
than in blood samples for both groups of birds. Bars indicate standard error.
curve displayed. The expected melting temperatures of the PCR
products were between 80 ◦C and 85 ◦C; the melting temperature
of the synthetic oligonucleotide was 82.3 ◦C.
2.6. Quantitation of viral load
The CT values of the known-copy-number standards were
graphed against time to construct a standard curve using the soft-
ware supplied with the Rotor-Gene. The CT of each of the samples
was then compared against the graph to give an estimate of viral
load, measured in copy numbers of viral DNA per microlitre of DNA
extract.
2.7. Statistical analysis
Calculation of r2 values of standard curves was performed using
the software supplied with the Rotor-Gene. Calculation of the coef-
ﬁcient of variation of the standards, the standard error of groups
of replicates and the sensitivity, speciﬁcity and positive and nega-




correlation between blood and feather viral loads was performed
using CoPlot (CoHort Software, 2005).
3. Results
3.1. A quantitative polymerase chain reaction assay for BFDV DNA
The qPCR assay successfully detected BFDV DNA in the DNA
extracts of all known positive samples from all psittacine species
tested.
The assay successfully detected BFDV DNA in the blood of all
control(non-vaccinated)corellas(Fig.1).Innon-vaccinatedcontrol
birds the geometric mean of the viral load±S.E. was estimated
at 105.331480614 ±100.4550889566 copies/L (range 104.160708572 to
106.761098506 copies/L) at 2 weeks post-challenge before dropping
to 104.527425601 ±100.5714412731 copies/L (range 102.915399835 to
106.443954022 copies/L) at 6 weeks post-challenge. Transient
low-level viraemia of between 101.763428 and 103.608205 copies/L
was detected in six vaccinated birds at various time points, but all
birds were seropositive at the times when viral DNA was present
in blood samples. The viral load in blood samples of vaccinated
birds followed a similar pattern to that of the non-vaccinated
control birds, with mean viral loads increasing in a curvilinear
fashion from 101.763428 copies/L at 2 weeks post-challenge to
a peak of 103.025858 ±100.1531190599 copies/L (range 102.872739 to
103.178977 copies/L) by 4 weeks post-challenge (Fig. 1). Speciﬁc
peaks were present in the melt curves of BFDV-positive samples
between 82 and 84.5 ◦C.
Intra-assay precision was good, with r2 values for the standard
curves achieving values between 0.92693 and 0.97477. Inter-assay
variation of the standards was only fair, as the mean coefﬁcient of
variation of the standards was 37.16%. The limit of detection (LOD)
of the assay was 50copies/L, however the effective limit of quan-
titation (LOQ) was 103 copies/L, as the coefﬁcient of variation of
the 103 and 102 standards was close to 100% and as such was con-
sidered too high. Even though the qPCR assay successfully detected
as few as 50copies/L of the standard, calculated quantities for the
“50copies/L” standard varied between 50 and 625copies/L.
The assay also detected BFDV DNA in the crude DNA
extracts of HA feather preparations (Fig. 1). The geometric
mean viral load±S.E. in feather extracts of control birds was
estimated at 103.554962655 ±10 0.4240215976 (range 102.418301291 to
104.314688651 copies/L) at 2 weeks post-challenge, rose to a
peakof105.676052006 ±101.342709388 copies/L(range103.413553509 to
109.532724649 copies/L) at 4 weeks post-challenge, then decreased
to 104.558206596 ±101.205153079 copies/L (range 102.633693927 to
109.279587759 copies/L) by 6 weeks post-challenge. Virus was
detectable by HA in the feather samples of only one control bird
at 4 and 6 weeks post-challenge, which were also the samples
that had the greatest amount of viral DNA present. Viral DNA
was detected in the feather extracts of 3 vaccinated birds at 2
weekspost-challenge,6vaccinatedbirdsat4weekspost-challenge
and 10 vaccinated birds at 6 weeks post-challenge. However,
none of these 3 birds had detectable viral DNA in the equiva-
lent blood sample at 2 weeks post-challenge. At 4 and 6 weeks
post-challenge, only 1 of 6 and 4 of 10 birds, respectively, had
detectable amounts of viral DNA in the equivalent blood sample
(between 101.9709454 and 105.6237159 copies/L). The samples which
were positive on qPCR of feather extracts but negative on blood
samples were considered to be false positives. The results of point-
biserial analysis of the correlation between the qPCR assay and
the standard PCR assay at various time points were not statis-
tically signiﬁcant (p>0.05). Analysis of the correlation between
the qPCR assay and the HA assay was not performed, since virus
was detectable by HA in the feather samples of only one control
bird at 4 and 6 weeks post-challenge. Correlation of viral load
between blood and feather samples was moderate (r2 =0.7465,
p<0.05) at 2 weeks post-challenge and very high (r2 =0.9999) at
4 weeks post-challenge, but there was no signiﬁcant correlation at
3 and 6 weeks post-challenge (r2 =0.0048 and 0.0027, respectively)
(Fig. 2).
Two sets of comparisons were made for the calculation of sensi-
tivity and speciﬁcity. Firstly, similar tests were compared. For blood
samples,thestandardPCRassaywasconsideredtobethegoldstan-
dardassayandwasusedforcomparisonwiththeresultsoftheqPCR
assay using blood samples. For feather eluates, the HA assay was
considered to be the gold standard assay and was compared with
the results of the qPCR assay which used DNA extracted from HA
samples. Sensitivity was 94.73% and speciﬁcity 87.61%, with posi-
tive and negative predictive values of 56.25% and 99%, respectively,
when the qPCR using blood samples was compared to the standard
PCR (also performed on blood samples). When comparing the qPCR
usingHAsamplestoHAtestresults,sensitivitywas100%andspeci-
ﬁcity65.42%,thepositivepredictivevaluedroppedto5.13%andthe
negative predictive value was 100%. Secondly, dissimilar tests were
compared (standard PCR with qPCR using HA samples and HA with
qPCR using blood samples). Comparing qPCR results from blood
samples to HA results gave a sensitivity and speciﬁcity of 100% and
71.43%, respectively, while comparing qPCR results from HA sam-Author's personal copy
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Fig. 2. Correlation between blood and feather viral loads of both vaccinated and control birds. (A) 2 weeks post-challenge, (B) 3 weeks post-challenge, (C) 4 weeks post-
challenge and (D) 6 weeks post-challenge. Values were highly correlated at 4 weeks post-challenge, but did not correlate at 3 and 6 weeks post-challenge.
ples with standard PCR results gave a sensitivity and speciﬁcity of
72.22% and 61.43%, respectively.
4. Discussion
Given the high prevalence of BFDV infection worldwide, sensi-
tive and speciﬁc detection methods which use standard methods
and consistent reagents are both highly desirable and necessary.
TheqPCRassaydescribedinthisstudyhasaverylowlimitofdetec-
tion and can be used to quantify the amount of virus present in the
blood and in feather preparations. As such, it should prove to be
a useful assay for the detection of viral DNA in samples of blood,
tissues, feathers and faeces.
Although it is well accepted that qPCR assays have a much
greater analytical sensitivity than standard PCR (Mackay, 2004;
Wong and Medrano, 2005), currently the standard PCR assay is
the gold standard for the detection of BFDV nucleic acid and hence
the comparative diagnostic sensitivity and speciﬁcity were deter-
mined. The analytical sensitivity of the qPCR assay was greater
than that of the standard PCR assay, as it detected viral DNA in
the blood of control birds that were negative by standard PCR
assay. However, because of this fact the analytical sensitivity could
not be determined precisely. Importantly, in this study it was
impossible to differentiate between true positive results below the
limit of detection of the HA and standard PCR assays and false
positive results. In this study the effect is likely to be minimal
since there was accurate information on the infection status of
the birds. The comparative diagnostic sensitivity and speciﬁcity
was good, however because of the greater analytical sensitivity
of the qPCR, the absolute diagnostic sensitivity and speciﬁcity is
likely to be higher. Even though the actual diagnostic sensitivity
is likely to be higher (and hence less samples required) ongoing
testingisalwaysrecommended(BelakandThoren,2004;Jacobson,
2004).
The precision and repeatability of the assay were within val-
ues accepted by the OIE (Jacobson, 1998); reproducibility could
not be assessed since testing in other laboratories was impracti-
cal. Negative predictive values were uniformly high and the low
positive predictive value when comparing the PCR and qPCR assays
on blood samples is likely to be a result of the increased sensitivity
of the assay. The effect of false positive results cannot be ignored
but remains to be elucidated. When comparing the HA assay with
the qPCR assay performed on feather samples, the extremely low
positive predictive value reﬂects the large number of false positives
as a result of environmental contamination. The assay should still
be useful for testing samples from naturally infected birds, pro-
vided that appropriate samples are collected and properly stored
and processed.
Not only did the qPCR assay detect viral DNA in birds that tested
negative by the standard PCR (Bonne et al., 2008b), but also it
demonstrated that the viral load in both vaccinated and control
birds increased for the ﬁrst 4 weeks after challenge. Vaccinated
birds had anti-BFDV antibodies before being challenged (Bonne et
al., 2008b; Shearer et al., 2008), thus vaccination did not prevent
viral replication. This is a common scenario with other vaccines
(Opriessnig et al., 2006) and is not surprising in this case. Given
this fact, it is likely that the chicks of vaccinated birds may still be
verticallyinfecteddespitethepresenceofantibodiesintheparents,
as occurs with PCV2 and CAV (Brentano et al., 2005; Larochelle et
al., 2000). If this does occur, the clinical and molecular signiﬁcance
of such infections and the impact of this mode of transmission on
quarantine and hygiene programs would need to be thoroughly
investigated. Prevention of vertical infection would be an impor-
tant measure in reducing the incidence of PBFD and consequentAuthor's personal copy
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secondary infections over a bird’s lifespan. Of course, maternal
antibody levels will wane soon after hatching and so horizontal
infection is still probably the primary route of infection.
An absolute method of quantitation was selected for this assay,
asitwasusefultoassignasetquantitytomeasurements.Noquanti-
tation method is foolproof, however and both absolute and relative
quantitation methods are both legitimate, provided that the assay
itself is properly validated (Peirson et al., 2003; Sellars et al., 2007).
Inthisassay,asfewas50copies/Lcouldbedetected,similartothe
assaydescribedbyRaueetal.(2004),howevertheactualLODinthat
assay is unknown as the authors relied on dilution factors rather
than quantitative data. The LOQ of this assay was determined to be
1000copies/L.ThedistinctionbetweenLODandLOQisimportant,
as clinical interpretations made from samples with positive results
below the limit of quantitation may be inaccurate.
Many qPCR assays normalise the data from the target gene or
organism against one or more genomic controls (Hendriks-Balk et
al., 2007). The data in this study were not normalised to a refer-
ence, or housekeeping, gene as candidate genes for normalisation
of gene expression data in psittacine birds have not been evalu-
ated. In fact, there have been surprisingly few studies investigating
the suitability of avian reference genes (Li et al., 2005; Yamashita
et al., 2007). Normalisation is also more important when testing
for cell-associated virus and this study was concerned with the
detection of circulating and excreted virus. For qPCR assays detect-
ing microbiological agents, unless the pathogen is being grown in
cell culture the real value of normalisation is that the normalised
data can account for differences in sample quantity and quality.
Appropriate control genes for qPCR assays used to study BFDV will
require studies to account for disease states, the tissue(s) sampled
and the species of host psittacine (Li et al., 2005; Maccoux et al.,
2007; Radoni´ c et al., 2005; Robinson et al., 2007; Spinsanti et al.,
2006; Sturzenbaum and Kille, 2001; Tang et al., 2007; Tricarico et
al., 2002). The evaluation of suitable reference genes for use in this
assay would certainly be an advantage, as feathers used for BFDV
PCR assays typically vary in size and the quality of pulp material
between growing and mature feathers varies dramatically. In prac-
tice, this may add extra cost and complexity to the assay and any
such beneﬁts gained from data normalisation would need to be
determined.
Because of the high degree of genetic variation between BFDV
isolates (Bassami et al., 2001; de Kloet and de Kloet, 2004; Heath
et al., 2004; Kondiah et al., 2006; Ritchie et al., 2003) intercalat-
ing dye chemistries are the method of choice for the detection of
BFDV DNA in quantitative PCR assays. The dye SYTO9 was chosen
for use in this assay in preference to SYBR green, as the melt-
ing curves are highly reproducible over a greater range than SYBR
green, it has less of an inhibitory effect on the PCR reaction and
does not appear to selectively detect particular amplicons (Monis
et al., 2005). The qPCR assay described in this study has proven
to be useful for the detection of BFDV DNA in blood samples,
but the high sensitivity of the assay makes the use of HA feather
preparations unreliable for the detection and quantitation of viral
excretion. Firstly, as with HA testing, the difﬁculty in ensuring con-
sistency in the amount of material tested makes standardisation
problematic. Secondly, false positive results were reasonably com-
mon. The increased incidence of false positive results from feather
preparations over time was almost certainly due to sample con-
tamination via aerosolised feather dander and faecal material. The
graph of viral load in feather extracts of vaccinated birds (Fig. 1)
suggestsviralreplication.However,thispatternmorelikelyreﬂects
the increased viral load in the environment as a result of virus
excretion by non-vaccinated birds. Although these results were
accurate in that they detected the presence of the virus, they did
not accurately represent the infection or health status of the birds
and this is an important fact to remember when making a diag-
nosis of infection or disease using the results of PCR-based assays
alone.
Choanal/cloacal swabs will most likely be more useful than
feather suspensions for the detection and quantitation of excreted
virus,buteachnewsampletypeshouldbeproperlyvalidatedbefore
useinroutinediagnostictesting(Hoorfaretal.,2004).Cloacalswabs
have been found to be useful for the detection of BFDV (Hess et
al., 2004) and pigeon circovirus (Todd et al., 2006), but need to
be validated for use in this assay. Since dry faecal material and
feather dander are so easily aerosolised, storage of swabs will be
important if environmental contamination is to be avoided. Poten-
tial applications of this assay include the measurement of viral
load in many tissues (including formalin-ﬁxed, parafﬁn-embedded
tissues)andfromcloacalswabs,aswellasthedevelopmentofquan-
titative multiplexed assays for the detection of common pathogens
affecting psittacine birds. Alternately, a qualitative (quantal) multi-
plex assay could be developed more simply using an intercalating
dye, in which the presence of the pathogen(s) is indicated by the
melting peaks of the PCR product. The qPCR could also be used
to determine the amount of infectious virus in a sample once
infectivity bioassays are conducted to determine the ID50 of BFDV
as has been done for HIV-1 (Coombs et al., 1993; Rusert et al.,
2004).
At present, the haemagglutination and haemagglutination-
inhibition assays are commonly used for the detection of virus
shed from feathers or faeces and anti-BFDV antibodies in psittacine
sera, respectively. Variations in erythrocyte, polyclonal antibody
and virus preparations and variations in these reagents make con-
sistency between tests difﬁcult to achieve. Consequently, most
laboratories rely on PCR-based assays to test for the presence of
viral DNA in blood, faeces or feathers, but the lack of consistent
and reliable assays for serology and the detection of excreted virus
is a problem. Variation in erythrocyte sensitivities between avian
species and individual birds (Sanada and Sanada, 2000; Sexton et
al., 1994) has been cited as a problem in the standardisation of
HA and HI assays (Johne et al., 2004). However, in regards to PCR
assays, poor sample collection and quality, inter-laboratory varia-
tion, improper attention to the prevention of contamination and
assay-based factors (such as pipetting error, reagent quality and
the presence of inhibitors) can also introduce unacceptable levels
of variation and render a test diagnostically and clinically useless
(Eastetal.,2004;Bonneetal.,2008a;Knutssonetal.,2004).Thesus-
ceptibility to contamination of such sensitive assays is highlighted
in this study.
RelianceonPCR-baseddiagnostictestscanalsoleadtofalseclin-
ical assumptions since the presence of viral DNA in a single sample
does not necessarily indicate active infection. Non-replicating DNA
may be present in blood for up to 3 months (Lazizi and Pillot, 1993)
andseropositivebirdsmaystillbePCRpositivewhilsttheyareclear-
ing the virus (Khalesi et al., 2005). Testing of these birds by PCR
alone would miss this important piece of information. Quantitative
assays for detection of nucleic acids are less likely to lead to false
clinical assumptions since they report the amount of nucleic acid
present rather than just its existence. Care should still be taken
in interpreting results when contamination is likely or when the
amount of detected nucleic acid is low, though. Nonetheless, pro-
vided these factors are considered, the qPCR assay described in this
studyshouldprovetobeasensitive,speciﬁcandaccuratediagnostic
tool for the detection and characterisation of BFDV infection.
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Currently, the only diagnostic test available routinely for the sero-diagnosis of BFDV is the
haemagglutination-inhibition (HI) assay. This test, whilst useful and applicable to samples from a wide
range of psittacine birds, is not an ideal assay; it requires erythrocytes from live animals, virus puriﬁed
from the feathers of infected birds and polyclonal antibody preparations in order to perform the assay.
Variations in these reagents make consistency between tests difﬁcult to achieve, underscoring the need
for a new test with standardised reagents for the sero-diagnosis of BFDV infection which has led to the
development of an antibody response. The methods used to develop a novel “blocking” (or “competi-
tive”) ELISA (bELISA) for the detection of anti-BFDV antibodies in psittacine sera are presented in this
paper. The assay was developed using a baculovirus-expressed recombinant BFDV capsid protein and a
newly developed monoclonal antibody raised against this protein. The assay was then validated with 160
samples from eastern long-billed corellas (Cacatua tenuiostris) vaccinated with the recombinant capsid
protein and challenged with live virus and samples from 82 cockatiels known to be HI negative. The
bELISA described in this study is a sensitive and speciﬁc diagnostic test and should have wide application
for the sero-diagnosis of BFDV.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Psittacine beak and feather disease (PBFD) is the most common
viral disease of psittacine birds and causes either a chronic debil-
itating feather disease in adult birds (Albertyn et al., 2004; Pass
and Perry, 1985; Rahaus and Wolff, 2003; Ritchie et al., 1989b)o ra
severe, acute disease syndrome in nestlings and African Grey par-
rots (Psittacus e. erithacus)( Doneley, 2003; Raidal and Cross, 1995;
Schoemaker et al., 2000). The causative agent, beak and feather dis-
easevirus(BFDV),isacircoviruswithasinglestrandedDNAgenome,
approximately 1.7–2.0kb in length (Bassami et al., 2001; Ritchie
et al., 1989b) and is considered to have a worldwide distribution
(Albertynetal.,2004;Hsuetal.,2006;Kiatipattanasakul-Banlunara
et al., 2002; Kock et al., 1993; McOrist et al., 1984; Pass and Perry,
1985; Rahaus and Wolff, 2003; Ritchie et al., 1989a). Surveys using
PCR-based assay methods have found prevalence rates of between
8% (Bert et al., 2005) and 39% (Rahaus and Wolff, 2003). The
reported seroprevalence varies between 16% and 62% (Khalesi et
al.,2005;RaidalandCross,1994)amongcaptiveﬂocksandbetween
41% and 94% in wild ﬂocks (Raidal et al., 1993a).
∗ Corresponding author. Tel.: +61 2 69334450; fax: +61 2 69332812.
E-mail address: shraidal@csu.edu.au (S.R. Raidal).
Currently, a haemagglutination-inhibition (HI) assay (Raidal et
al., 1993b; Ritchie et al., 1991) is the only method available for the
detection of anti-BFDV antibodies in psittacine sera. This assay is
useful detects both IgM and IgG antibodies from a wide range of
speciesofpsittacinebirds,butitsuffersfromanappreciableamount
of inter-test variation due to the variability in quality and quantity
between virus preparations and the sensitivity of the erythrocytes
used in the test to the virus. To overcome these limitations, a novel
blocking(orcompetitive)ELISAhasbeendevelopedwhichutilisesa
baculovirus-expressed recombinant BFDV capsid protein (Stewart
et al., 2007) and a newly developed monoclonal antibody raised
against this protein (Shearer et al., 2008b).
2. Materials and methods
Insofaraswaspractical,thebELISAwasdevelopedandvalidated
in accordance with guidelines established by the Ofﬁce Interna-
tional des Epizooites (O.I.E.) for the development of serological
assays for the diagnosis of infectious diseases (Jacobson, 2004).
2.1. Samples
Samples of blood, collected on ﬁlter paper and air-dried and
serum or plasma from 5 species of psittacine birds (including
0166-0934/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
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sulphur-crested cockatoos (Cacatua galerita), galahs (Eolophus rose-
icapillus) rainbow lorikeets (Trichoglossus haematodus), eclectus
parrots (Eclectus roratus) and gang-gang cockatoos (Callocephalon
ﬁmbriatum)) known to have naturally occurring anti-BFDV anti-
bodies were used to optimise the blocking ELISA (bELISA). These
were selected to include a range of HI antibody titres. A sample
of serum from a chicken inoculated with a baculovirus-expressed
recombinant BFDV capsid protein (Stewart et al., 2007) was used as
a low-HI antibody sample and normal chicken serum was included
as a known negative control.
To validate the bELISA, samples from eastern long-billed corel-
las (Cacatua tenuiostris) that were part of an experiment to assess
a recombinant BFDV capsid protein-based vaccine (Bonne et al.,
2009; Stewart et al., 2007) were tested using the optimised bELISA
assay. Samples of blood and serum or plasma, as described above,
were taken from vaccinated (n=15) and non-vaccinated control
(n=5) birds on 8 separate occasions, including the time of vaccina-
tion and the time of challenge with live virus. In total, 160 samples
were thus collected. In addition, samples from 82 cockatiels known
to be HI negative (Shearer et al., 2008a) were included to evaluate
the diagnostic speciﬁcity of the test. Samples included both dried
blood on ﬁlter paper and plasma.
For blood collected onto ﬁlter paper, two 6mm diameter spots
of blood on ﬁlter paper were excised using either scissors or a hole
punch and placed into a microcentrifuge tube (Eppendorf, Ham-
burg, Germany). One hundred microlitres of ELISA blocking buffer
(PBS, 0.05% (v/v) Tween 20, 5% (w/v) skim milk powder (Fonterra
Foodservices, North Ryde, Australia)) was then added in order to
make a 1:5 (w/v) suspension and serum eluted from the paper
by incubating the mixture for 1h at room temperature. Serum or
plasma samples were diluted 1:5 in blocking buffer.
2.2. Production of recombinant BFDV capsid protein
A full-length, baculovirus-expressed BFDV capsid protein was
expressed and puriﬁed as described by Stewart et al. (2007).
2.3. Optimisation of antigen and antibody dilutions using indirect
enzyme-linked immunosorbent assay
The indirect ELISA was optimised as described by Shearer et al.
(2008b). The recombinant protein was diluted to 0.25, 0.5, 0.75, 1.0,
1.25, 1.5, 2.0 and 2.5g/mL in 0.05M carbonate/bicarbonate buffer,
applied to duplicate 12-well rows of two Microlon 600 ELISA plates
(Greiner BioOne, Frickenhausen, Germany) and allowed to coat at
4 ◦C overnight. The plate was then washed with wash buffer (PBS,
0.05% (v/v) Tween 20), blocking buffer was added to all wells and
the plate incubated for 1h at room temperature. Two solutions of
the monoclonal antibody were prepared; a 1:25 and a 1:30 dilution
in blocking buffer. After washing the protein-coated plates again,
50L of blocking buffer were added to all wells of each plate. Then
50L of a 1:25 dilution of the monoclonal antibody were added to
the ﬁrst well of the ﬁrst row of each protein dilution and 50Lo fa
1:30dilutionaddedtotheﬁrstwellofthesecondrow.Themixtures
from the ﬁrst well of each row were then serially diluted across
the plates, leaving 50L of each dilution per well and the plates
incubated for 1h at room temperature. After washing again, HRP-
conjugated goat anti-mouse IgG (Sigma–Aldrich, St. Louis, USA), at
the manufacturer’s recommended dilution in blocking buffer, was
added to all wells of both plates and the plates incubated for 1h at
room temperature. The plates were washed again, then 50L/well
of a solution containing ABTS (BioRad Laboratories, Hercules, USA)
was added and colour allowed to develop for 15min at room tem-
perature. The colour development reaction was stopped by the
additionof2%(w/v)oxalicacidandabsorbanceat405nmmeasured
using a spectrophotometer.
2.4. Optimisation of the blocking enzyme-linked immunosorbent
assay for the detection of speciﬁc antibodies
Recombinant baculovirus-expressed BFDV capsid protein was
diluted to 2.5g/mL in 0.05M carbonate/bicarbonate buffer, added
to all wells of a Microlon 600 ELISA plate (Greiner BioOne, Frick-
enhausen, Germany) and allowed to coat at 4 ◦C overnight. The
plate was then washed with wash buffer, blocking buffer added
to all wells and the plate incubated for 1h at room temperature.
After another wash step, 50L of blocking buffer was added to
all wells of the ELISA plate. Then 50L sera from each of the 5
psittacine birds described above, eluted as previously described,
was added to the ﬁrst well of each row and serially diluted across
the plate. The plate was then incubated for 1h at room temper-
ature. After removing the sera, the plate was washed again and
50L/wellofamonoclonalantibodyagainsttherecombinantBFDV
capsid protein, diluted 1:400 in blocking buffer, was added and the
plate incubated for 1h at room temperature. After washing, 50L
of HRP-conjugated polyclonal anti-mouse IgG (Sigma–Aldrich, St.
Louis, USA), at the manufacturer’s recommended dilution in block-
ing buffer, was added to each well and the plate incubated for
1h at room temperature. After washing, 50L/well of a solution
containing ABTS (BioRad Laboratories, Hercules, USA) was added
and colour allowed to develop for 15min at room temperature.
The colour development reaction was stopped by the addition of
2% (w/v) oxalic acid and absorbance at 405nm measured using a
spectrophotometer. The percentage inhibition (PI) of the test sera
samples and negative cut-off value (based on the PI of the known
negative samples) were then calculated.
2.5. Validation of the bELISA
To validate the bELISA, 160 samples from eastern long-billed
corellas (C. tenuiostris) vaccinated with a recombinant BFDV cap-
sid protein (Bonne et al., 2009; Stewart et al., 2007) and challenged
with live virus were tested using the optimised bELISA. Samples
included both dried blood on ﬁlter paper and plasma. After testing,
the PI of the samples were compared to the corresponding HI titres.
In addition, samples from 82 cockatiels that had been assessed as
negative by HI (Shearer et al., 2008a) were also tested using the
optimised bELISA.
For blood collected onto ﬁlter paper one spot of blood on ﬁlter
paper was cut out using scissors or hole punch and collected into
a microcentrifuge tube (Eppendorf, Hamburg, Germany). 100Lo f
ELISAblockingbufferwasthenadded(tomakea1:10(w/v)suspen-
sion) and serum eluted from the paper by incubating the mixture
for1hatroomtemperature.Serumorplasmasampleswerediluted
1:10 in blocking buffer.
Tests to evaluate the precision, repeatability and accuracy of the
assay were also conducted; however it was not practical to evalu-
atereproducibilitybetweenlaboratories.Repeatabilityassayswere
conducted using pooled sera from 10 vaccinated birds. The intra-
assay coefﬁcient of variation was determined by performing 10




using 10 replicates of the pooled sera that were serially diluted 1:2
and the PI values plotted against the log2 of the dilution factor.
3. Results
3.1. Indirect enzyme-linked immunosorbent assay
The optimal amount of protein used in the indirect ELISA was
determined to be 250ng/well and the optimal dilution of mon-138 P.L. Shearer et al. / Journal of Virological Methods 158 (2009) 136–140
Fig. 1. Blocking ELISA (bELISA) mean percentage inhibition values of vaccinated
( – ) and control (···) birds after vaccination and challenge. Vaccinations are
indicated by an arrow (↑) and challenge with a triangle ( ). Bars indicate standard
error.
oclonal antibody was 1:400. The indirect ELISA performed well
at many other combinations of protein and monoclonal antibody
dilution, but the above protein amount and antibody dilution were
selected as they had a good positive absorbance value and a useful
dynamic range.
3.2. A novel blocking ELISA for the detection of antibodies to BFDV
Sera from each of the 5 species of psittacine birds with naturally
occurringanti-BFDVantibodiestestedpositivebybELISA,asdidthe
serafromthechickeninoculatedwiththerecombinantBFDVcapsid
protein. The optimal dilution of these sera for use in the bELISA was
determinedtobe1:10.Thisgaveausefuldynamicrangeandalower
limit of detection (greater analytical sensitivity) than the HI test.
All cockatiels that tested negative by HI were also negative by
bELISA. The corellas vaccinated with the recombinant protein had
peakmeanPIlevelsofbetween6.01%and44.26%atchallenge(after
the second vaccination) and between 62.43% and 90.22% after chal-
lengewithlivevirus(Fig.1).Non-vaccinatedcontrolbirdshadpeak
antibody levels of between 55.25% and 83.26% after challenge with
live virus. Importantly, although the samples from birds vaccinated
with the recombinant protein were HI-negative at the time of the
Fig. 2. Correlation of haemagglutination inhibition (HI titres) with blocking ELISA
(bELISA) percentage inhibition (PI).
second vaccination, the bELISA detected low levels of antibodies in
these samples. The correlation coefﬁcient between antibody lev-
els measured by bELISA and HI titres was high (r2 =0.8156, p<0.05)
(Fig. 2). Based on the results of the vaccine trial samples only, sensi-
tivity was 99.09% and speciﬁcity was 71.43% when compared to the
HI assay, with a positive and negative predictive value of 87.2% and
97.56% respectively. Using the results of the cockatiel sero-survey,
the bELISA was 100% speciﬁc and combining these results with the
results of the vaccine trial gave the same sensitivity and increased
thespeciﬁcityto88.41%andthenegativepredictivevalueto99.19%.
The mean PI value of the pooled sera was 64.28% and almost all
repeated samples fell within ±2 standard deviations of the mean
value (Fig. 3a). The intra- and inter-assay coefﬁcients of variation
were 3.61% and 6.94%, respectively and the bELISA was determined
tobelinearwithintheworkingrangeofthesamplestested(Fig.3b).
4. Discussion
At present, HI and HA assays are the best available assays for the
detection of anti-BFDV antibodies and excreted virus, respectively.
However, given the amount of variation inherent in both the HI and
HAassays,noveldiagnostictestsforboththevirusandthepresence
of anti-BFDV antibodies in serum are highly desirable. Presented in
this paper are the methods used to develop a novel blocking ELISA
forthedetectionofanti-BFDVantibodiesinpsittacinesera.Blocking
ELISAs have been developed for the detection of antibodies to other
Fig. 3. (A) Precision assay, note that almost all values fall within ±2 standard deviations from the mean; (B) Linearity assay using sera pooled from 10 vaccinated birds. The
percentage inhibition (PI) values are linear within the dynamic range of the test. Bars indicate standard error.P.L. Shearer et al. / Journal of Virological Methods 158 (2009) 136–140 139
avian viruses and have the distinct advantage over indirect ELISAs
that secondary antibodies speciﬁc to the immunoglobulins of the
speciesbeingtestedarenotrequired.Forcurrentlarge-scalescreen-
ing and sero-surveillance, blocking ELISAs have largely replaced
indirect ELISAs (Gorham, 2004).
The sensitivity and speciﬁcity of the blocking ELISA developed
in this study were within values deﬁned as acceptable by the OIE
(Jacobson, 2004) and should prove to be a useful diagnostic test
for BFDV. The analytical sensitivity was greater than the HI test,
as it detected antibodies in vaccinated birds that were HI nega-
tive and the comparative diagnostic sensitivity and speciﬁcity was
good. However, because of the greater analytical sensitivity of the
bELISA, the absolute diagnostic sensitivity and speciﬁcity is likely
to be higher. Given the calculated diagnostic sensitivity, 160 sam-
ples is adequate to validate the assay with 95% conﬁdence of an
accurate result (Jacobson, 1998). However, assuming the highest
calculateddiagnosticspeciﬁcityof88%,thenumberofknownnega-
tiveanimalsrequiredis1014.Theactualnumberofknownnegative
animals required is likely to be much less, since the actual diagnos-
tic speciﬁcity is likely to be higher. Since it is so difﬁcult to ﬁnd
psittacine birds that have not been exposed to the virus, ongoing
testing with birds of known antibody status is desirable.
The precision, repeatability and accuracy of the assay were
within values accepted by the OIE (Jacobson, 1998). The cut-
off value was determined from a 95% conﬁdence interval of the
negative control wells (Coligan et al., 2001) since it was almost
impossible to ﬁnd a group of birds known to be truly seronega-
tive. Assuming, though, that the cockatiels were truly seronegative,
the cut-off value calculated from a 95% conﬁdence interval of the
mean PI of those 82 samples was similar to that calculated using
the negative control wells only. As more samples are tested using
this assay, the methods of calculating a cut-off value can be com-
pared with receiver–operator curves to see which method is more
appropriate. The positive and negative predictive values were good
and given the high seroprevalence of BFDV, should translate well to
samples from naturally infected birds.
The correlation coefﬁcient between bELISA values and HI titres
from the vaccinated corellas (Bonne et al., 2009) was high, which
is somewhat surprising given the differing nature of the two tests.
The HI assay gives a deﬁned cut-off, whereas the bELISA allows for
continuous readings of PI values for samples with antibody levels
which fall in between HI end-points. This difference means that
although the correlation coefﬁcient was high no direct inference
between bELISA PI values and HI titres can be made as each HI end-
pointtitrecanbeassociatedwitharangeofbELISAPIvalues(Fig.2).
Thus,thebELISAisthepreferredantibodytest,asitallowsmorepre-
cise characterisation of antibody levels. The intra- and inter-assay
coefﬁcients of variation were good and in line with OIE assay val-
idation guidelines (Jacobson, 2004). Absorbance values fell within
the linear range of the assay for the samples tested, however eval-
uation of the assay’s behaviour for samples with PI values greater
than 64.28% was not possible.
Only one other ELISA has been developed to test for the pres-
ence of anti-BFDV antibodies in psittacine sera (Johne et al., 2004).
This was an indirect ELISA, utilising a truncated recombinant BFDV
capsidproteinandasecondaryantibodydirectedagainstpsittacine
IgY. This ELISA tested 11 serum samples from 7 different psittacine
species and thus has yet to be validated with a large number of
samplesofbirdswithknownantibodystatus.Additionally,nostud-
ies have yet been conducted investigating the cross-reactivity of
psittacine IgY and given that there are 78 genera and 332 species
within the Psittacidae, such studies may be prohibitively difﬁcult.
This means, though, that a sample from a rare species of psittacine
bird which tested negative by indirect ELISA could not be guaran-
teed to be truly negative. Consequently, we believe that a blocking
ELISA,asdescribedinthisarticle,islikelytobeamorereliablediag-
nostic test. The blocking ELISA also has the advantage that serum
containing both IgM and IgY can be reliably tested using the one
assay, as it does not rely on secondary antibodies directed against
either class of immunoglobulin.
Although the ELISA described in this article has been tested
with sera from 6 different species of psittacine birds and validated
with 160 samples, further testing is necessary to ensure that the
assay performs well with sera from as many species of psittacine
birds as possible. Any potential problems with consistency of the
test between species would theoretically be the result of differ-
ing cross-reactivities between the test serum and the recombinant
protein. Stewart et al. (2007) failed to ﬁnd any differences in
cross-reactivity between the recombinant protein and a number of
psittacineanti-BFDVantiserainbothwesternblottingandHI.Addi-
tionally, cross-reactivity work using sera from rainbow lorikeets,
short-billed corellas, a sulphur-crested cockatoo, a red lory (Eos
bornea)andagalah-corellahybridandvirusfromrainbowlorikeets,
a red lory, two swift parrots (Lathamus discolor), a sulphur-crested
cockatoo and a scarlet-chested parrot (Neophema splendida) failed
to ﬁnd evidence of antigenic serotypes (Khalesi et al., 2005). How-
ever,asimilarexperimentusingserafromtheabovebirdsandvirus
eluted from the feather of a cockatiel found that sera from some
of the birds did not inhibit agglutination by the cockatiel isolate,
suggesting that the cockatiel isolate may be sufﬁciently different
antigenically to be considered a separate serotype (Shearer et al.,
2008a).
The monoclonal antibody used in this study recognised BFDV
from a cockatiel, sulphur-crested cockatoo and a rainbow lorikeet
(Shearer et al., 2008b). This indicates that there is some antigenic
homology between isolates, even if the cockatiel BFDV isolate is
indeed a separate serotype. Whilst it is possible that the epitope
detected by this monoclonal antibody is not present in some BFDV
isolates, the fact that no serotypes have been discovered to date
suggests that enough major epitopes should be conserved between
isolates that polyclonal anti-BFDV sera will react with the recombi-
nant protein. Bound sera will thus block the monoclonal antibody
from binding, even if the test serum does not react with the exact
epitope detected by the monoclonal antibody. Thus, the bELISA
should be reliable for use with sera from many species of psittacine
birds, unless experimental evidence comes forth that novel BFDV
serotypes exist or that the epitope detected by the monoclonal
antibody is not immunodominant. Answers to questions about the
existence of a cockatiel-adapted BFDV serotype and the relative
infectivity and antigenic characteristics of various virus isolates
remain to be discovered. These answers may only be found by con-
ducting HI assays using sera from many cockatiels, tested against
virus eluted from the feathers from a range of psittacine birds.
The bELISA has a number of advantages over the HI test. First
andmostimportantly,thebELISAismuchmoreeasilystandardised
as the amounts of both the recombinant protein and monoclonal
antibody used in the assay can be quantiﬁed more accurately. Even
though both the recombinant protein and monoclonal antibody are
initially expensive to develop and produce, they are a much more
reliable and consistent source of reagents than the virus prepa-
ration, polyclonal antibodies and erythrocytes used in HI assays.
Virus used in the HI assay must be puriﬁed from the feathers from
persistentlyinfectedbirds.Thisprocessisexpensive,ethicallyques-
tionable, time consuming, results in low yields of virus and the
extraction procedure can be contaminated with host proteins. The
sensitivity of erythrocytes to BFDV may vary between individuals
within a species (Sanada and Sanada, 2000) and the sensitivity of
an individual bird’s erythrocytes may also vary over time. Varia-
tion in the amount of virus between preparations and decreased
HA activity of the virus over time compounds this problem. Even
though this variation may be standardised to an extent, HI assays
are still prone to an appreciable amount of inter-test variation.140 P.L. Shearer et al. / Journal of Virological Methods 158 (2009) 136–140
Other advantages of the bELISA over the HI assay are reduced
samplepreparationtimeandthepotentialtoshortenthetimetaken
to perform the assay if plates are pre-coated and blocked in bulk,
or if the monoclonal antibody is directly conjugated to HRP. How-
ever, the effect of these modiﬁcations on assay performance would
need to be assessed. The bELISA could also be adapted for the per-
formance of cross-reactivity assays; however possible differences
in afﬁnity of the monoclonal antibody for the different virus sam-
ples used as antigen in the assay would need to be determined and
taken into account.
Overall, the bELISA described in this paper should be a useful
toolforthesero-diagnosisofBFDVinfection.Itismorereadilystan-
dardised, simpler to perform, more repeatable and has a greater
analytical sensitivity than the HI assay. In the future it should
also provide valuable information in subsequent studies on the
pathophysiology of the virus, such as the ﬂuctuations in antibody
levels at various stages of disease and the transfer of maternal
antibodiesandtheireffectoninfectionandimmunity.Inthisexper-
iment it was able to provide the valuable information that the
vaccinated corellas had developed antibodies against the recom-
binant protein after the ﬁrst vaccination and it should also prove
to be very useful in the further optimisation of BFDV vaccination
protocols.
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